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THESIS ABSTRACT 
 
KCNQ1 is a homotetrameric voltage-gated potassium channel expressed in 
cardiomyocytes and epithelial tissues.  However, currents arising from KCNQ1 have 
never been physiologically observed.  KCNQ1 is able to provide the diverse potassium 
conductances required by these distinct cell types through coassembly with and 
modulation by type I transmembrane -subunits of the KCNE gene family. 
KCNQ1-KCNE K
+
 channels play important physiological roles.  In cardiac 
tissues the association of KCNQ1 with KCNE1 gives rise to IKs, the slow delayed 
outwardly rectifying potassium current.  IKs is in part responsible for repolarizing heart 
muscle, and is therefore crucial in maintaining normal heart rhymicity.  IKs channels help 
terminate each action potential and provide cardiac repolarization reserve.  As such, 
mutations in either subunit can lead to Romano-Ward Syndrome or Jervell and Lange-
Nielsen Syndrome, two forms of Q-T prolongation.  In epithelial cells, KCNQ1-KCNE1, 
KCNQ1-KCNE2 and KCNQ1-KCNE3 give rise to potassium currents required for 
potassium recycling and secretion.  These functions arise because the biophysical 
properties of KCNQ1 are always dramatically altered by KCNE co-expression. 
 We wanted to understand how KCNE peptides are able to modulate KCNQ1.  In 
Chapter II, we produce partial truncations of KCNE3 and demonstrate the transmembrane 
domain is necessary and sufficient for both assembly with and modulation of KCNQ1.  
Comparing these results with published results obtained from chimeric KCNE peptides 
and partial deletion mutants of KCNE1, we propose a bipartite modulation residing in 
 vii 
KCNE peptides.  Transmembrane modulation is either active (KCNE3) or permissive 
(KCNE1).  Active transmembrane KCNE modulation masks juxtamembranous C-
terminal modulation of KCNQ1, while permissive modulation allows C-terminal 
modulation of KCNQ1 to express.  We test our hypothesis, and demonstrate C-terminal 
Long QT point mutants in KCNE1 can be masked by active trasnsmembrane modulation. 
 Having confirmed the importance the C-terminus of KCNE1, we continue with 
two projects designed to elucidate KCNE1 C-terminal structure.  In Chapter III we 
conduct an alanine-perturbation scan within the C-terminus.  C-terminal KCNE1 alanine 
point mutations result in changes in the free energy for the KCNQ1-KCNE1 channel 
complex.  High-impact point mutants cluster in an arrangement consistent with an alpha-
helical secondary structure, ―kinked‖ by a single proline residue.  In Chapter IV, we use 
oxidant-mediated disulfide bond formation between non-native cysteine residues to 
demonstrate amino acid side chains residing within the C-terminal domain of KCNE1 are 
close and juxtaposed to amino acid side chains on the cytoplasmic face of the KCNQ1 
pore domain.  Many of the amino acids identified as high impact through alanine 
perturbation correspond with residues identified as able to form disulfide bonds with 
KCNQ1.  Taken together, we demonstrate that the interaction between the C-terminus of 
KCNE1 and the pore domain of KCNQ1 is required for the proper modulation of 
KCNQ1 by KCNE1, and by extension, normal IKs function and heart rhymicity. 
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PREFACE 
 
Two of my three data chapters are collaborations between my lab mates and me.  
Chapters II and III presented in this thesis have been published in peer-reviewed journals.  
In addition, I have made contributions to other projects and produced preliminary data 
published in grant proposals; these projects will not be presented within this thesis. 
Chapter III is collaboration between Jessica Rocheleau and me.  I began the 
chapter in September of 2003, and relinquished first-authorship to her in January of 2005 
upon her decision to join the Kobertz lab and my decision to pursue Chapter IV.  My 
contribution to Chapter III includes the mutagenensis for many of the mutant KCNE1 
constructs, as well as TEVC recordings for wild type IKs and some of the mutants.  Data 
analysis, including -periodicity indeces, was performed by Jessica.  It is my 
understanding that Jessica intends to present this work within her thesis. 
The preliminary experiments of Chapter IV were conducted by my co-author, 
Virla Berrios, however none of these results are included in the chapter; her results were 
inconclusive (see Chapter IV).  I was responsible for optimization of the crosslinking 
protocol as well as production of all biochemical and electrophysiological results 
presented in this thesis.  In my absence, Anatoli Lvov has continued with planned 
experiments involving whole-cell perforated patch clamp.  None of Dr. Lvov’s work is 
presented in this thesis.  Mutagenesis of KCNQ1 and KCNE1 was a collaborative effort 
between Virla and me. 
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CHAPTER I 
INTRODUCTION 
 
INTRINSIC PROPERTIES OF VOLTAGE-GATED POTASSIUM CHANNELS 
Voltage-gated ion channels are proteinaceous membrane-embedded pores.  When 
activated (open), voltage-gated ion channels allow the passive diffusion of ions down 
their electrochemical gradient.  Potassium selective voltage-gated ion channels are a 
subset of ion conducting complexes that under normal physiological conditions allow 
outward potassium current, which drives membrane potential negative towards the 
Nernst-predicted reversal potential of potassium.  Hyperpolarization of the plasma 
membrane is required for several functions (Hille, 1992). 
Cells utilize the electrochemical gradients existing across their plasma membrane 
to establish transmembrane electromotive force required for cellular excitability among 
other functions.  This transmembrane voltage occurs because membranes rest at the 
voltage at which net influx and efflux for each ionic species is minimized, referred to as 
the reversal potential for a particular ion.  For most resting cells, plasma membrane 
voltages are sufficiently negative, reducing the net current through the dominant resting 
ion channel type, potassium.  As conduction of other ions changes, membrane voltage 
subsequently changes and approaches the reversal potential for the new dominant 
conductance.  For example, a large increase in sodium conductance leads to a transient 
increase in the sodium influx and a concomitant increase in membrane potential towards 
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the reversal potential for sodium ions.  The reversal potential for any ion can be 
calculated as a function of the resting concentration gradient: 
 
(1) 
[ ] 60mV [ ]
log *log
[ ] [ ]
out out
ion
in in
RT ion ion
E
FZ ion Z ion

   , 
 
where R is the gas constant, T is temperature, F is Faraday’s constant, Z is the valence 
charge of the ion, and [ion] is the ionic concentration on one side of the membrane.  The 
reversal potential modifies Ohm’s Law, and provides a function describing current of a 
specific ionic species in an electrochemical gradient: 
 
(2) V IR  or gV I  . 
 
In an electrochemical gradient, 
 
(3) ( )ion m ion iong V E I   , 
 
where Vm is transmembrane potential (intracellular relative to extracellular), I is current 
(positive current is an efflux of positive ions), R is resistance, and g is conductance.  
Macroscopic conductance describes the entire population of functional channels on the 
cell surface, N, but is dependent not only on the conductance of a single open channel 
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complex, , but also on the percentage of functioning channels open on the cell surface, 
Po.  Considering these properties of conductance, equation 3 can be rewritten 
 
(4) ( ) ( )( ( ) )ion m ion ion o ionI t V E N P t    . 
 
In other words, the magnitude and direction (influx or efflux) of any ionic current at a 
given time can be described as a function of electrochemical driving force for that 
particular ion, the number of functioning ion-permissive channels on the cell surface and 
the single-channel conductance and open probability of each channel. 
Among other roles, voltage-gated potassium channels terminate the action 
potential.  In response to membrane depolarization due to quick sodium influx, a delayed 
potassium efflux activates.  This potassium conductance, combined with diminished 
sodium influx (due to sodium channel inactivation), reestablishes a negative membrane 
potential.  If the kinetics of this potassium efflux are sufficiently slow, potassium 
channels which have not deactivated allow excitable membranes to become refractory to 
future action potentials and can prevent tonic stimulation.  Because any positive shift in 
membrane potential is able to activate potassium channels, voltage-gated potassium 
channels lacking inactivation can also be involved in potassium recycling in non-
excitable cells (Snyders, 1999; Cooper & Jan, 2003; Warth, 2003). 
As typified by the Drosophila melanogaster potassium channel, Shaker (Figure 1-
1), voltage-gated potassium channels are tetrameric assemblies usually possessing six 
transmembrane helices and a pore-loop-helix motif between the fifth and sixth  
 4 
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Figure 1-1.  The stucture of Shaker-like voltage-gated potassium channels.  Above, 
schematic diagram of the canonical transmembrane structure of a single Shaker-like pore-
forming subunit viewed from within the plane of the plasma membrane.  The top of this 
diagram faces the extracellular side of the plasma membrane; the bottom of this diagram 
faces the intracellular side of the plasma membrane.  Shaker-like voltage-gated potassium 
channel subunits contain six transmembrane helices and a pore-loop-helix between the 
fifth and sixth transmembrane helices.  The structure also contains a small 
cytoplasmically exposed helix between the fourth and fifth transmembrane helices.  
Helices clustering to form the pore-domain or the voltage sensing domain are labeled.  
Center, crystal structure of a rat Shaker homologue, Kv1.2, viewed from the extracellular 
side.  A potassium ion (colored green) resides in the pore of this structure.  The voltage 
sensing domain is composed of the first four transmembrane helices (labeled for one of 
the four pore-forming subunits, right).  The pore domain and the selectivity filter are 
formed through the coordination of the fifth and six transmembrane helices and the pore-
loop-helix.  Each subunit is painted in a different color for clarity.  Notice the voltage 
sensors of each subunit associate with pore domain of an adjacent subunit.  Below, model 
of Kv1.2 gating motion, observed from within the plane of the membrane.  The S4-5 
linker helix (red), S5 and pore-loop-helix (gray) and the S6 gate (blue) are shown, while 
the voltage sensing domain has been omitted for clarity.  The top of the channel complex 
faces the extracellular milieu; the bottom of the channel complex faces the cytosol.  On 
the left, a computer model in which the S4-5 linker helix is in the hyperpolarized state, 
based in part on the closed gate conformation observed in the crystal structure of KcsA.  
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The closed state transitions to the X-ray crystal structure on the right in response to 
membrane depolarization.  Domain swapping of the voltage sensing domain positions the 
S4-5 linker helix adjacent to the S6 gate within the same subunit and allows movements 
of the voltage sensor to be tranduced into gating motions. 
 
Diagram (above) produced by S. Gage.  Crystal structures and computer models adapted 
from Long, S.B., E.B. Campbell, and R. Mackinnon, Voltage sensor of Kv1.2: structural 
basis of electromechanical coupling. Science, 2005. 309(5736): p. 903-8. 
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transmembrane helix.  Most of the functional properties of the potassium channel are 
intrinsically accomplished by the tetramer formed from this core potassium channel motif 
(Robbins, 2001). 
All voltage-gated channels must form a tight seal with the plasma membrane, 
providing high resistance to transmembrane ionic conductance in the deactivated, closed 
state.  This function is highlighted by crystal structures in which membrane 
phospholipids adopting rigid conformations have co-crystalized with the channel (Gonen 
et al., 2005; Long et al., 2007).  Plasma membrane content may play a critical role in 
establishing channel structure (Jiang et al., 2003a; Lee et al., 2005).  Several point 
mutations have been identified within the voltage sensing domain which decrease the 
resistance of the membrane to ion permeation (Starace et al., 1997; Starace & Bezanilla, 
2001; Tombola et al., 2005).  One such example is a histidine mutation in the voltage-
sensing domain; this mutant histidine residue is able to adopt multiple conformations, 
including one that is exposed to the cytosol and another that is exposed to the 
extracellular lumen.  This histidine can accept a proton on one side of the membrane, and 
release it on the other, allowing a proton current to arise from conduction across the 
voltage sensor (Starace et al., 1997; Starace & Bezanilla, 2001). 
Voltage-gated potassium channels are selectively permeable to potassium.  This 
selective permeability arises from the structure of the potassium channel selectivity filter.  
The selectivity filter, located on the extracellular face of potassium channels, has been 
likened visually to the shape of an ―inverted teepee‖.  The backbone amide oxygens from 
all four pore-forming subunits coordinate, forming the lattice of the selectivity filter.  
 8 
This lattice mimics the positions of oxygens within the aqueous chelation cage of a 
potassium ion, and minimizes the energy of potassium ion dissolution from water.  The 
selectivity filter of potassium channels is poorly permissive to conduction of other 
aqueous ions because the backbone oxygens within the selectivity filter are not able to 
adequately mimic the aqueous chelation of other ions (Doyle et al., 1998; Morais-Cabral 
et al., 2001; Zhou et al., 2001). 
All voltage-gated ion channels are able to change their conductance as a function 
of both time and membrane potential.  Potassium ion channels sense changes in 
membrane potential through movement of the voltage sensing domain.  The voltage 
sensor is composed of the first four transmembrane helices of each pore-forming subunit, 
but is dependent upon the basic positively charged arginines residing in the fourth 
transmembrane helix (S4).  Positive changes in membrane potential (for instance 
occurring as a result of sodium influx during action potential) repel the positively charged 
amino acids of the voltage sensor.  The nature of the resulting voltage sensor movement 
is still quite controversial, but either a translational or rotational movement in the voltage 
sensor (or both) results in tension on the N-terminal side of the S4-5 linker helix (Gandhi 
& Isacoff, 2002; Jiang et al., 2002b; Starace & Bezanilla, 2004; Posson et al., 2005; Ruta 
et al., 2005).  The fifth transmembrane helix (which constitutes part of the pore domain) 
acts as a fulcrum for the S4-5 linker helix.  As N-terminal side of the linker helix moves, 
the fifth transmembrane helix remains rigid.  The resulting tension and movement of the 
linker helix is transduced through Van der Waals contacts between the linker helix and 
the sixth transmembrane domain (the gate), pulling and pushing the gate into open 
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(activated) or closed (deactivated) conformations.  The open gate conformation allows 
ions to move passively down their electrochemical gradient along the ion conduction 
pathway of the channel complex, while the closed conformation sterically occludes the 
ion conduction pathway.  Activation is a stochastic event; at any membrane potential 
there is a dynamic equilibrium between activated and deactivated channel complexes – it 
is the ratio of these populations (Po) which in part determines macroscopic current 
(Aldrich et al., 1983; Long et al., 2005a, 2005b). 
Many voltage-gated potassium channels cannot stay open during prolonged 
depolarizations.  The magnitude of current can decrease through a mechanism distinct 
from deactivation, termed inactivation. Potassium channel inactivation is independent of 
gate movement and generally takes one of two forms.  Fast, N-type inactivation (with 
time constants faster than 500 ms) results from steric occlusion of the ion conduction 
pathway.  In the case of Shaker, this results from a covalently tethered ball-peptide on the 
N-terminus of the -subunit plugging the channel and occluding the passage of 
potassium ions.  Removal of the ball peptide eliminates fast inactivation; N-type 
activation can be restored by application of purified inactivation peptide to the 
intracellular face of Shaker (Zagotta et al., 1990; Murrell-Lagnado & Aldrich, 1993).  
Mammalian Kv channels also possess N-type inactivation, but this inactivation arises 
from co-assembly with accessory subunits possessing an inactivation peptide (Robbins, 
2001; Long et al., 2005a).  C-type inactivation is a slower-onset type of inactivation (with 
time constants greater than 1000 ms) mediated by pore-collapse.  C-type inactivation 
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occurs at sufficiently positive membrane potentials, but otherwise occurs with little 
voltage dependence (Hoshi et al., 1991; Morais-Cabral et al., 2001; Zhou et al., 2001). 
Though potassium channels intrinsically possess most of their required functions, 
they are still subject to environmental cues.  As alluded to above, Kv channels are able to 
assemble with and be modulated by several classes of small polypeptides.  These include 
Kvs, KChIPs and KCNE peptides (Robbins, 2001).  Gene expression and biosynthetic 
context are also important for native potassium channel function (Papazian, 1999).  The 
contribution of intracellular signaling proteins complicates potassium channel function 
even further.  These many factors further refine the activity of potassium channels, 
especially KvLQT1 (hereafter referred to by its gene name, KCNQ1).  It is the nature of 
modulation of KCNQ1 that is the subject of this thesis. 
 
KCNQ1 - Expressed alone in over-expression systems, the potassium channel 
pore-forming subunit KCNQ1 gives rise to a delayed, outwardly rectifying potassium 
current.  KCNQ1, as with the other members of the KCNQ family of voltage-gated 
potassium channels, has six transmembrane helices and a single pore-loop-helix motif; 
this structure is similar to other Shaker-like voltage-gated potassium channels (Robbins, 
2001).  Unlike Shaker-type potassium channels, KCNQ1 has a relatively small N-
terminal domain with a small helix-loop-helix motif, a PKA phosphorylation site at S27, 
and lacks a bona fide tetramerization domain (T1).  Instead of a large T1 domain, 
KCNQ1 has a large C-terminal domain which is required for association with several 
aqueous cell-signaling molecules (Figure 1-2).  This C-terminal domain is also required  
 11 
 
 12 
Figure 1-2.  The large intracellular C-terminus of KCNQ1 channel complexes.  Cylinders 
represent alpha-helices.  The C-terminus of all KCNQ subunits contains four -helices 
along with interhelical regions of variable length and as-of-yet undetermined secondary 
structure.  Within the C-terminal domain, the N-terminal pair of -helices (helices A & 
B) is important for interactions with calmodulin, an association which confers calcium 
sensitivity to these channel complexes.  The C-terminal pair of -helices is required for 
dimerization of the preassembled channel complex and tetramerization of the tetrameric 
channel complex, and confers specificity for heteromeric KCNE and KCNQ subunit 
association.  In KCNQ1, these helices also provide the docking site for Yotiao, an adapter 
protein involved in anchoring both kinases and phosphorylases, and are therefore critical 
in integrating channel function with extrinsic signaling pathways.  The C-terminal end of 
the KCNQ channel complexes also contains a consensus site for binding with ubiquitin 
ligases, but the necessity of this binding site is questionable. 
 
Figure taken from Haitin, Y. and B. Attali, The C-terminus of Kv7 channels: a 
multifunctional module. J Physiol, 2008. 586(7): p. 1803-10 
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for proper assembly during biosynthesis and choice of heteromeric association (Li et al., 
1992; Marx et al., 2002; Kanki et al., 2004; Dahimene et al., 2006; Howard et al., 2007; 
Haitin & Attali, 2008).  Further, KCNQ1 possesses an unusual type of inactivation.  
Much like C-type inactivation, the onset of inactivation in KCNQ1 is slow, but transition 
to the inactivated state is voltage-dependent, whereas classical C-type inactivation is 
voltage-independent within a positive range of membrane potentials (Hoshi et al., 1991; 
Pusch et al., 1998).  C-type inactivation in KCNQ1 also differs from other potassium 
channel complexes because the transition to the C-type inactivated state in KCNQ1 
reaches equilibrium or is masked by further channel activation.  The C-type inactivation 
observed with KCNQ1 over-expression is mostly a curiosity, considering KCNQ1 
currents have not been likened to any physiologically observed potassium current, and 
inactivation has not been observed with any KCNQ1-KCNE channel complex. 
 
KCNE PEPTIDES 
The KCNE gene family (Figure 1-3) encodes MinK (also known as IsK) and 
MiRP1-4 proteins (MiRP4 was originally called Kcne1-l).  To avoid any confusion, these 
proteins will be referred to by their gene names, KCNE1-5.  KCNE peptides are type I 
transmembrane peptides ranging in size between 103 and 170 amino acids, and are found 
in a variety of tissues (McCrossan & Abbott, 2004).  The hallmark of KCNE peptides is 
that each one is able to co-assemble with and dramatically modulate the gating properties 
of KCNQ1 potassium conducting complexes  
 14 
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Figure 1-3.  KCNE peptides.  Left, cartoon depicting the putative transmembrane 
topology of KCNE peptides.  KCNE peptides are short polypeptides containing a single, 
lipid bilayer-spanning domain (labeled ―TM‖, right).  As KCNE proteins are type I 
transmembrane peptides, the N-termini of KCNEs face the extracellular milieu and the C-
termini face the cytosol.  Right, amino acid alignment of all of the known members of the 
KCNE family.  KCNE peptides are as labeled on the left.  Transmembrane domains for 
KCNE peptides are boxed and labeled ―TM domain‖. 
 
Left, figure produced by S. Gage.  Right, figure adapted from McCrossan, Z.A. 
and G.W. Abbott, The MinK-related peptides. Neuropharmacology, 2004. 47(6): p. 787-
821
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(Barhanin et al., 1996; Sanguinetti et al., 1996; Schroeder et al., 2000b; Tinel et al., 
2000a; Angelo et al., 2002; Grunnet et al., 2003).  In fact, KCNQ1 is completely 
dependent upon its association with KCNE peptides – currents arising from KCNQ1 
homotetramers have not been detected in native tissues (Robbins, 2001).  However, the 
modulatory effects of KCNE peptides are not limited to the KCNQ1 potassium 
conducting complex; KCNE peptides are able to associate with a variety of potassium 
channel pore-forming subunits.  KCNE peptides each have at least one N-linked 
glycosylation site on the extracellular N-terminal side (McCrossan & Abbott, 2004).  
Structurally, KCNE peptides have been shown to be mainly alpha-helical on their 
juxtamembranous C-terminal domain, and are believed to be alpha-helical in their 
transmembrane domain (though interpretation of serial perturbation studies in the 
transmembrane domain is complicated by the presence of many protein contacts within 
this region, clustering to multiple faces of the alpha-helical face) (Rocheleau et al., 2006; 
Chen & Goldstein, 2007; Liu et al., 2007).  The variety of KCNEs and KCNE 
modulation reflect tissue-specific potassium conductance requirements and is addressed 
below. 
 
 Cardiac IKs current (KCNQ1-KCNE1) - The best studied of the heteromultimeric 
complexes formed from KCNQ1 is the cardiac IKs current.  IKs is the slow delayed 
outwardly rectifying potassium heart current.  Channels giving rise to IKs are formed by 
the association of KCNQ1 and KCNE1, also known as MinK and IsK.  IKs is one of 
several potassium currents responsible for maintaining action potential duration, and as 
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such, mutations in either gene can prolong time interval between the Q and T peaks on an 
EKG.  One such mutation, KCNE1-D76N, is notable since KCNE1 is still able to 
assemble with KCNQ1, but the resultant mutant KCNQ1-KCNE1 is completely non-
conductive at the plasma membrane (Splawski et al., 1997; Splawski et al., 2000).  The 
resulting Long QT Syndrome has been associated with torsade de pointes, syncope and 
fibrillations.  Autosomal dominant Q-T prolongation is called Romano-Ward Syndrome, 
while a recessive form of Long QT Syndrome associated with IKs is called Jervell and 
Lange-Nielsen Syndrome.  JLNS is also accompanied by complete bilateral deafness 
(Jervell & Lange-Nielsen, 1957; Ward, 1964; Barhanin et al., 1996; Sanguinetti et al., 
1996; Snyders, 1999). 
 Cardiac potassium currents function in careful syncopation to preserve cardiac 
rhymicity (Figure 1-4).  If the myocardium is too refractory to action potentials due to 
excess potassium current (for instance due to over-expression of IKs), myocardial fibers 
can exhibit wave break leading to arrhythmicity and, potentially, fibrillations (Munoz et 
al., 2007).  Given too much reduction in cardiac potassium currents, myocardial tissues 
may not be able to repolarize sufficiently, leading to early- afterdepolarizations, another 
cause of myocardial arrhythmicity (Satoh & Zipes, 1998).  Computer modeling also 
suggests that IKs plays a very important role in providing reserve for potassium channels.  
This model contains at least two closed states for each KCNQ1 subunit, but only one 
closed to open transition is slow.  This single slow gating transition allows IKs channels to 
dwell in a closed state capable of transitioning to the open state in response to heightened 
need for potassium efflux.  In response to sustained action potentials and dysfunction in 
 18 
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Figure 1-4.  Ionic currents involved in the cardiac action potential.  Above, a membrane 
voltage versus time diagram representing the cardiac action potential.  Below, current 
versus time representation of ionic currents involved in the action potential.  The name of 
each current is labeled on the left, while the known molecular identity of each channel 
complex is labeled on the right.  A cartoon depicting both the magnitude and direction 
(influx or efflux) of each cardiac ionic current is presented in the center.  Note that the 
direction depicits the movement of positive chareges, so the depiction for ICl actually 
shows Cl
–
 influx, which is electrically equivalent to a positive efflux.  The solid midline 
represents no net current.  Of these cardiac conductances, IKr (due to inactivation) and IKs 
(due to slow kinetics) dominate the latter parts of the cardiac action potential. 
 
Figure adapted from Snyders, D.J., Structure and function of cardiac potassium channels. 
Cardiovasc Res, 1999. 42(2): p. 377-90 
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other cardiac potassium currents, IKs act as a reserve of potassium conductance and 
prevent excessive Q-T prolongation.  A lack of the repolarization reserve from IKs leads 
this computer model to early-afterdepolarizations in response to sudden decreases in 
heart rate, an effect observed in Cs
+
-induced Long QT (Satoh & Zipes, 1998; Silva & 
Rudy, 2005). 
There is some controversy concerning how KCNE1 is able to modulate KCNQ1 
modulation (Tapper & George, 2000; Melman et al., 2001; Melman et al., 2002a; 
Melman et al., 2002b).  One line of research demonstrates KCNE modulation resides 
within the transmembrane domain of the peptide.  Transmembrane chimeras of KCNE1 
and KCNE3, upon co-expression with KCNQ1, alter KCNQ1; KCNE peptides containing 
the KCNE1 transmembrane domain display biophysical properties reminiscent of native 
KCNE1, while KCNE peptides containing the transmembrane domain of KCNE3 display 
properties reminiscent of native KCNE3.  Transmembrane KCNE modulation was 
resolved to an amino acid triplet (FTL in KCNE1, TVG in KCNE3).  A transmembrane 
interaction between KCNE peptides and KCNQ1 is supported by results demonstrating 
mutations within the voltage sensing domain of KCNQ1 recapitulate some of the 
biophysical properties observed in KCNQ1-KCNE channel complexes (Panaghie & 
Abbott, 2007; Shamgar et al., 2008).  If KCNE peptides do interact within membrane 
embedded regions of the KCNQ1 channel complex, this interaction does not result in 
changes in voltage sensor kinetics.  The voltage sensor can be chemically modified in 
response to membrane depolarization in a manner independent of channel gating 
(Rocheleau & Kobertz, 2008). 
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Transmembrane modulation does not reconcile data obtained from partial 
deletions of KCNE1.  Partial trunctions of KCNE1 clearly modulate KCNQ1 channel 
complexes, however the slow gating of IKs is perturbed as the C-terminus of KCNE1 is 
progressively truncated.  Both groups agree regions not directly involved in KCNE1 
modulation are required for assembly with KCNQ1 (Tapper & George, 2000). 
Can these observations be further reconciled?  It is noteworthy both KCNE1 and 
KCNE3 are highly homologous in regions identified by both groups (excluding the 
modulatory triplet identified by Melman and colleague).  Therefore, chimeras containing 
the modulatory triplet may reside in a KCNE context which is rather native-like (Figure 
1-3); containing such a native environment may lead the hypotheses derived from KCNE 
chimeras astray.  This paradox of KCNE modulation is the topic of Chapter II. 
KCNE1 is believed to reside near the ion permeation pathway of IKs channels.  
Mutations in the transmembrane domain of KCNE1 are able to coordinate Cd
2+
 ions.  
This coordination inhibits potassium efflux and partially occludes the ion conduction 
pathway (Wang et al., 1996; Tai & Goldstein, 1998; Tapper & George, 2001).  Likewise, 
mutations in the voltage sensor and the pore domain of KCNQ1 are able to mimic some 
of the effects of KCNE modulation (Melman et al., 2004; Panaghie & Abbott, 2007; 
Shamgar et al., 2008).  However, KCNE1 is still dependent upon the C-terminal domain 
of KCNQ1 to assemble with and modulate KCNQ1 currents (Schwake et al., 2003). 
Single channel recordings of IKs have been attempted by several labs.  However, 
interpretation of these recordings is complicated, since the smallest patches of IKs contain 
at least 3-4 functioning channels.  Further, IKs possesses a form of flickery gating that 
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allows a subconducting state, obscuring the results from these recordings.  Single channel 
conductance for IKs is reported at 4.5, 6 and 16 pS; KCNE1 increases KCNQ1 single 
channel conductance four-fold or more.  For both of the aforementioned reasons, this data 
should be considered with some skepticism (Pusch, 1998; Sesti & Goldstein, 1998; Yang 
& Sigworth, 1998). 
IKs currents are enhanced by cAMP-dependent phosphorylation by PKA at 
KCNQ1 S27 (Kurokawa et al., 2003).  Two other putative phosphorylation sites within 
the C-terminal domain of KCNQ1, S468 and T470, may also be important; mutation of 
these residues reduces IKs sensitivity to the small molecule inhibitor quinidine (Yang et 
al., 2003).  PKA is able to bind the channel complex through an association with the 
AKAPs, which occurs with a coiled-coil motif found in the C-terminus of KCNQ1.  
Though AKAP79 and AKAP15/18 both enhance IKs in a cAMP-dependent manner, the 
AKAP Yotiao has been given special attention (Figure 1-2) (Potet et al., 2001).  Yotiao 
does not just coordinate the actions of PKA and PP1 with KCNQ1 (Marx et al., 2002; 
Kurokawa et al., 2004), but the PKA-dependent phosphorylation of yotiao itself at S43 is 
able to modulate IKs currents (Kurokawa et al., 2004; Chen et al., 2005).  cAMP-
dependent phosphorylation is required for -adrenergic stimulation of IKs, as KCNQ1 
phosphorylation is increasd by overexpression of 2-adrenergic receptors (Dilly et al., 
2004).  Tubulin may also be required for proper localization of these intracellular 
signaling molecules, as disruption of microtubules with colchicine reduces cAMP-
dependent increases in IKs current (Nicolas et al., 2008). 
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IKs is also down-regulated through aqueous accessory proteins and signaling 
cascades.  Application of 17-estradiol is able to reduce currents, known through work 
on the KCNE1 homologue KCNE3 to be mediated by up-regulation in PKC 
phosphorylation (Moller & Netzer, 2006; O'Mahony & Harvey, 2008).  KCNQ1-KCNE1 
channels are inhibited by over-expression with Nedd4-2 ubiquitin ligase (also found in 
the heart).  A consensus PxY or ―PY‖ ubiquitin ligase binding-motif is found at the very 
C-terminal end of KCNQ1, however this motif is not required for Nedd4-2 association 
with KCNQ1-KCNE1 channel complexes (Jespersen et al., 2007).  IKs is also down-
regulated by association with the muscarinic receptor M1 (Selyanko et al., 2000). 
Association of KCNQ1 with KCNE1 also leads to changes in pharmacology, 
especially with the small molecule inhibitor chromanol 293B.  The IC50 for IKs is ten-fold 
lower than in the absence of KCNE1 (3 M versus 30 M).  Further, chromanol 293B 
inhibits the slower, non-instantaneous component of IKs (Bett et al., 2006).  
Though IKs is required for healthy termination of each cardiac action potential, the 
KCNQ1-KCNE1 complex is also required for potassium recycling into the endolymph of 
the inner ear (Figure 1-5).  Mutations that can give rise to Long QT can also give rise to 
the recessive Jervell and Lange-Nielsen syndrome, which involves deaf-mutism and QT-
prolongation (Jervell & Lange-Nielsen, 1957).  Deafness in persons afflicted with JLNS 
arises from gross morphological changes in cochlear structures within the inner ear.  
These changes arise from deficiencies in potassium efflux from the stria vascularis into 
the endolymph of the stria media. 
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Figure 1-5.  Cochlear Structure.  IKs channels reside in the stria vascularis, located on the 
periphery of the scala media.  The direction of the cyclic potassium current is indicated in 
dark arrows.  The high concentration of potassium in the scala media or endolymph 
results in depolarized membrane potentials in the stria vascularis, allowing IKs channels to 
remain open and participate in potassium efflux required to maintain high endolymph 
potassium concentrations.  Note also that KCNQ4 channels are found on the basolateral 
membranes of outer (and inner?) hair cells, where they are involved in establishing and 
adjusting membrane potential in response to auditory stimuli, resulting in potassium 
efflux that is dissipated through the stria vascularis. 
 
Figure taken from Robbins, J., KCNQ potassium channels: physiology, pathophysiology, 
and pharmacology. Pharmacol Ther, 2001. 90(1): p. 1-19 
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 Why is KCNQ1-KCNE1 complex able to perform any role in potassium recycling 
in a non-enervated tissue?  High extracellular potassium concentrations in the endolymph 
result in an altered potassium gradient for cells lining the stria media.  This altered 
electrochemical gradient shifts the Nernst-predicted reversal potential of potassium 
sufficiently towards positive potentials.  Because resting membrane potentials within the 
inner ear are determined by potassium channels, and membrane potentials are sufficiently 
positive to allow IKs channels to activte, a portion of the IKs population remains activated 
(IKs can not inactivate) allowing a continual potassium efflux required to maintain a 
potassium-rich endolymph (Sakagami et al., 1991; Vetter et al., 1996; Lee et al., 2000; 
Robbins, 2001). 
 
Epithelial KCNQ1-KCNE complexes - Potassium currents within epithelial 
tissues, especially those arising from KCNQ1 channel complexes (Figure 1-6), play many 
crucial roles in ion permeation.  Because the electrochemical gradient of potassium 
favors efflux at physiologically relevant membrane potentials, leak channels give rise to 
small potassium currents which in turn establish the membrane potential and allow for a 
small external pool of potassium ions (Warth, 2003). 
Though epithelial tissues are not enervated, those that possess electrogenic 
transport, for instance the proximal tubule of the kidney, may reach membrane potentials 
at which voltage-gated potassium channels can activate; this is due to the depolarizing 
effects of sodium transport into the cytoplasm.  Though the identity of the KCNE peptide 
within KCNQ1-KCNE channel complex is controversial, it appears that luminal secretion 
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Figure 1-6.  KCNE-modulated KCNQ1 channels play physiological roles in several 
types of epithelial cells.  A, IKs is involved in luminal potassium excretion and 
maintenance of negative membrane potentials in response to electrogenic transport and 
the resulting depolarization.  Further, KCNQ1 channels, modulated by KCNE3, are found 
on the basolateral membranes of these epithelial cells and are involved in potassium 
recycling required for sodium efflux into the bloodstream from the kidneys.  C and D, 
Colon epithelia (and analogous tracheal epithelium) possess KCNQ1-KCNE3 on their 
basolateral membranes.  KCNQ1-KCNE3 channels provide the potassium efflux required 
to fuel non-electrogenic transport of chloride into the cells, and produce the electromotive 
force necessary for chloride secretion from the apical membrane.  E, Apical KCNQ1-
KCNE2 channels in gastric parietal cells.  KCNQ1-KCNE2 channels provide potassium 
efflux into the gastric lumen, where this potassium pool fuels proton efflux and provides 
the electromotive force required for chloride secretion. 
 
Figure taken from Warth, R., Potassium channels in epithelial transport. Pflugers Arch, 
2003. 446(5): p. 505-13.
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of potassium ions in the kidneys is mediated in part by IKs (Sugimoto et al., 1990; 
Chouabe et al., 1997; Yang et al., 1997; Schroeder et al., 2000b; Vallon et al., 2005).  
This luminal potassium current helps to reestablish membrane potential sufficiently close 
to the reversal potential of potassium and thereby provides the driving force for 
electrogenic transport.  In addition, BK channel protein has also been detected in these 
cells (Warth, 2003; Levy et al., 2008).  As a further level of regulation, the presence of 
these channels allows both concomitant changes in cell volume due to transport from the 
kidney lumen as well as changes in intracellular Ca
2+
 concentration to modulate 
potassium efflux (Warth, 2003). 
Non-electrogenic transport is unable to depolarize epithelial membranes.  
Potassium channels that are active at hyperpolarizing potentials near the reversal 
potential for potassium (such as inwardly-rectifying currents, hyperpolarization activated 
currents or leak currents) would seem to play a more important role in epithelial tissues 
with non-electrogenic transport.  An early example of such a potassium leak current is the 
basolateral potassium conductance of tracheal epithelia.  Ion conductance through the 
basolateral and apical membranes of the epithelia were distinguishable; the conductance 
of the apical membrane was dominated by efflux of chloride through CFTR (Engelhardt 
et al., 1992; Haws et al., 1994; Wine et al., 1994), (observed by a secretagogue-induced 
increase in current by increasing extracellular chloride concentration).  Despite the 
presence of the chloride conductance, the basolateral potassium conductance establishes 
the membrane potential.  Perturbing potassium channels, either by adjusting extracellular 
potassium concentrations (changing the reversal potential for potassium) or by 
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application of Ba
2+
 externally (blocking potassium currents) led to large changes in 
membrane potential, resulting in changes in chloride secretion (Smith & Frizzell, 1984). 
In epithelia of the gastrointestinal tract and lungs, potassium efflux is coupled to 
subsequent potassium influx through transporters.  The pool of effluxed potassium ions 
helps fuel co-transport with: 1) sodium and chloride by NKCC1 in colon epithelia, or 2) 
proton excretion through anti-transport by K
+
,H
+
-adenosine triphosphase transporter in 
gastric parietal cells.  As with electrogenic transport, potassium efflux is also responsible 
for maintaining low membrane potential in these cells.  Though potassium efflux occurs 
mainly basolaterally, the effect on of this voltage shift is seen paracellularly.  The 
establishment of such a hyperpolarized potential on the membranes of these cells leads to 
the strong electromotive force required for chloride secretion.  In the case of colon 
epithelia, regulation of chloride secretion modulates osmotic balance and plays a role in 
water retention; in the case of secretory cells of the stomach, chloride secretion is coupled 
to pH reduction (Warth, 2003). 
The aforementioned epithelial currents have been identified.  It turns out that 
voltage-gated KCNQ1 channels are the pore-forming subunits giving rise to these leak 
currents.  How can KCNQ1, an outwardly-rectifying potassium channel, have any 
function in cells that are not enervated and do not possess electrogenic transport?  
KCNQ1 is able to activate even at hyperpolarizing membrane potentials when associated 
with either KCNE2 or KCNE3, an association which (at least partially) removes voltage-
dependence (Schroeder et al., 2000b; Tinel et al., 2000a; Dedek & Waldegger, 2001; 
Gage & Kobertz, 2004). 
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The interaction between KCNQ1 and KCNE2 (MiRP1) gives rise to a potassium 
current that shows little voltage dependence (Tinel et al., 2000a; Dedek & Waldegger, 
2001; Bendahhou et al., 2005; Lundquist et al., 2005).  KCNE2 colocalizes with KCNQ1 
mainly in the gastric parietal and oxyntic cells, where with Kir4.1, KCNQ1-KCNE2 
provides the hyperpolarized membrane potentials and the potassium efflux required for 
proton secretion and the driving force for chloride secretion (Dedek & Waldegger, 2001; 
Heitzmann et al., 2004; Kaufhold et al., 2008).  The importance of both KCNE2 and 
KCNQ1 is underscored by the fact that disruption of either gene in mice leads to 
abnormal gastric morphology combined with reduced response to histamine stimulation, 
and an increase in gastric pH.  The effects on pH were also observed with chromanol 
293B inhibition (Lee et al., 2000; Grahammer et al., 2001a; Lambrecht et al., 2005; 
Vallon et al., 2005; Roepke et al., 2006).  Current arising from KCNQ1-KCNE2 channels 
is pH sensitive and participates in a positive feedback loop; potassium efflux allows for a 
decrease in pH, which in turn increases potassium efflux.  The feedback loop breaks 
down when external pH decreases past pH 4.5, as further decreases in pH begin to inhibit 
KCNQ1-KCNE2 currents.  KCNE2/KCNE3 chimeras demonstrate that the extracellular 
N-terminal segment of KCNE2 provides the pH sensor (Grahammer et al., 2001a; 
Heitzmann et al., 2007), while the transmembrane domain of KCNE2 is believed to be 
alpha-helical like that of KCNE1 (Liu et al., 2007). 
Co-expression of KCNQ1 with KCNE3 (MiRP2) gives rise to an instantaneous 
current that is at least partially active at even very hyperpolarized membrane potentials 
and greater in current density as compared with KCNQ1-KCNE2 complexes (Schroeder 
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et al., 2000b; Bendahhou et al., 2005; Lundquist et al., 2005).  The channel complex is 
cAMP-sensitive and is localized to the basolateral membranes of various epithelial cells, 
including the entire gastrointestinal tract, where it provides potassium efflux (Smith & 
Frizzell, 1984; Lohrmann et al., 1995; Schroeder et al., 2000b; Dedek & Waldegger, 
2001; Grahammer et al., 2001a).  Just like IKs, KCNQ1-KCNE3 currents display 
heightened sensitivity to chromanol 293B inhibition as compared with those arising from 
homotetrameric KCNQ1 (with an IC50 reported as low as 1 M (Schroeder et al., 2000b; 
Gage & Kobertz, 2004; Bett et al., 2006)), and are suppressed by 17-estradiol (an effect 
mediated by PKC in a gender-specific manner (O'Mahony et al., 2007)).  Unlike IKs and 
KCNQ1-KCNE2 currents, KCNE3 modulated KCNQ1 currents are not sensitive to pH 
(Grahammer et al., 2001a; Heitzmann et al., 2007). 
KCNE3 is able to modulate KCNQ1 channels through the transmembrane 
modulatory triplet identified by Melman and colleagues discussed above (Melman et al., 
2001; Melman et al., 2002a).  Transmembrane modulation explains why the C-terminus 
of KCNE3, which bears great similarity and identity to that of KCNE1, does not lead to 
KCNE1-like kinetics.  The transmembrane domain of KCNE3 may interact directly with 
the KCNQ1 voltage sensing domain, resulting in increased accessibility to chemical 
modification (Nakajo & Kubo, 2007; Rocheleau & Kobertz, 2008).  However, there is 
still a paradox regarding KCNE modulation of KCNE1.  In order to resolve this 
controversy, partial truncations of KCNE3 will be examined in Chapter II. 
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Other KCNQ1-KCNE complexes - The remaining two members of the KCNE 
family are not as well studied nor understood.  Depending upon the study, KCNQ1-
KCNE4 (MiRP3) channel complexes in over-expression systems are either present on the 
plasma membrane and do not give rise to a potassium current (Grunnet et al., 2002; 
Grunnet et al., 2005; Lundquist et al., 2005) or activate at highly positive potentials that 
are physiologically unreasonable (Teng et al., 2003; Bendahhou et al., 2005).  Given that 
voltage clamp experiments measures conductance as a function of time and voltage, the 
complete lack of any conductance arising from KCNQ1-KCNE4 channel complexes 
makes it extremely difficult to ascertain function or electrophysiologically demonstrate 
any physiologically relevant role. 
KCNQ1-KCNE5 (KCNE1-like or Kcne1-l) channels are similarly difficult to 
study.  KCNE5 was first identified as one of several genes disrupted in Alport Syndrome, 
mental retardation, midface hypooplasia, and elliptocytosis, or AMME; however, loss of 
KCNE5 does not appear cause this syndrome (Piccini et al., 1999).  Although KCNQ1-
KCNE5 channels do give rise to delayed outwardly-rectifying currents, the voltage 
sensitivity has been shifted such that the channel activates only upon reaching very 
positive membrane potentials.  Upon activation the channel expresses currents that are 
kinetically reminiscent of IKs.  These two factors make KCNQ1-KCNE5 difficult to 
identify in any physiological context that includes IKs.  Since IKs activates at far less 
positive potentials, the small current levels arising from KCNQ1-KCNE5 at a particular 
membrane potential may indeed be present but overlooked in the presence of IKs (Angelo 
et al., 2002; Bendahhou et al., 2005; Lundquist et al., 2005). 
 34 
Yet these two channel complexes may play physiologically important roles.  
Viewed as negative regulators of KCNQ1 channel activity, it is possible that 
physiologically important currents such as IKs are ―fine tuned‖ by KCNE4 and KCNE5.  
If this is indeed the case, then KCNE4 may act as a negative regulator, reducing current 
levels, while KCNE5 may shift the collective voltage sensitivity of IKs.  Given 1) 
transcripts for every KCNE peptide are present in the heart with KCNQ1, and 2) these 
expression levels for these transcripts vary spatially and in the context of health within 
the heart (Bendahhou et al., 2005; Lundquist et al., 2005), it is not unreasonable that there 
may be multiple populations of KCNQ1-KCNEx channel complexes within the same 
tissue.  The role of KCNE4 and KCNE5 could therefore be viewed in much the same way 
as the role of KCNQ2-5 in generating diversity among M-currents (vide infra). 
Perhaps even more compelling is the possibility that KCNE4 and KCNE5 may 
assemble with a KCNQ1 and another KCNE within the same channel complex, a hint of 
which can be seen with KCNQ1-KCNE1-KCNE2 co-expression (Bendahhou et al., 2005; 
Lundquist et al., 2005; Toyoda et al., 2006; Morin & Kobertz, 2007; Manderfield & 
George, 2008).  A very powerful technique has just been developed in which only 
channels expressing a marked subunit can be selectively and conditionally blocked.  This 
technique has demonstrated that complexes including KCNQ1, KCNE1 and KCNE4 can 
give rise to a current similar to IKs.  This techniques has also demonstrated that hybrid 
potassium currents do arise from both KCNQ1-KCNE1-KCNE3 and KCNQ1-KCNE3-
KCNE4 potassium conducting complexes in Xenopus oocytes (Morin & Kobertz, 2007). 
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Promiscuity - Complicating the story of KCNE peptides even further, most 
KCNE subunits have been demonstrated to modify the properties of at least one channel 
in addition to KCNQ1 in over-expression systems.  Though there was a great rush to 
publish any sort of association with a KCNE subunit, there are ultimately two questions 
that should be asked: 
 
How is the potassium current being modified? 
Remember our modification of Ohm’s Law in an electrochemical gradient, 
 
(4) ( )( )ion o ion m ion ionN P V E I    , 
 
where N, number of functioning channels on the cell surface; Po, open probability; , 
single-channel conductance; changes in any of these factors can lead to ―current 
modification‖, an issue which is not unprecedented.  For example, artifacts of 
endogenous gene expression (Jiang et al., 2002a; Anantharam et al., 2003) in over-
expression systems have been shown to lead to aberrant changes in the biosynthetic 
(Krumerman et al., 2004; Chandrasekhar et al., 2006) and biophysical properties (Takumi 
et al., 1988; Anantharam et al., 2003) of a channel or channel subunits, thus altering their 
apparent function and identity.  Keeping this caveat in mind, one would expect changes 
in channel function that are either: 1) biophysical in nature (for instance changes in 
single-cell conductance, voltage sensitivity, and kinetics among others), or 2) not 
dependent upon expression system, should indicate true -subunit modulation. 
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Is the pairing of channel subunits physiologically relevant? 
The presence of protein or mRNA can be directly assessed in native tissues; 
however, this does not conclusively demonstrate the presence of a native ionic current.  
Demonstration that the current arising from a particular channel complex is biophysically 
reminiscent or identical to a physiologically observed current is more convincing; 
identification is complicated by the fact that native ionic currents are frequently 
accompanied by other ionic currents, and may be fine tuned by co-expression with further 
accessory subunits or by the presence of biophysically heterogeneous populations of ion 
conducting complexes.  Ultimately pharmacological and biophysical tricks are required 
for isolation and identification of these native currents. 
 
An exhaustive list of channel complexes modified by KCNE association can be 
found in McCrossan and Abbott (McCrossan & Abbott, 2004).  These associations are 
evidenced by slight changes in voltage sensitivity or kinetics and include evidence of 
direct KCNE interactions, but otherwise will not be elaborated further (Schroeder et al., 
2000a; Tinel et al., 2000b; McCrossan et al., 2003; Lewis et al., 2004).  Channel 
complexes that are particularly noteworthy and require inspection are discussed here. 
KCNE1 coexpression with hERG led to an increase in current density and a slight 
change in voltage sensitivity.  This was accompanied by changes in hERG currents in 
response to Long QT mutations in KCNE1.  Though hERG was able to co-
immunoprecipitate KCNE1, evidence regarding subcellular localization and any 
conclusions derived from this evidence were inconclusive.  Therefore, it is unclear if 
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KCNE1 modulates hERG currents in a biophysical or biosynthetic manner (McDonald et 
al., 1997; Bianchi et al., 1999). 
Co-expression of KCNE2 appears to play important roles in three different heart 
currents, where overexpression cannot recapitulate all of the biophysical properties of the 
native heart currents.  IKr, the rapid potassium current in part responsible for terminating 
each action potential, arises from hERG channels in the heart.  KCNE2 alters 
macroscopic IKr by modifying the single channel conductance as well as the voltage 
sensitivity, pharmacology, kinetics and inactivation of hERG channels.  hERG and 
KCNE2 are also able to co-immunoprecipitate (Abbott et al., 1999).  Still, there is some 
controversy as to whether this interaction is real.  Perhaps both camps are correct – 
KCNE2 transcript levels in the heart have been found to vary spatially and in response to 
stress induced by heart failure (Yu et al., 2001; Lundquist et al., 2005).  Alternatively, 
KCNE2 may be able to assemble with hERG preferentially in over-expression systems, 
protecting hERG from down regulation by endogenous KCNE or other accessory 
subunits (Anantharam et al., 2003). 
The second of these three native currents is If, the ―funny‖ pacemaker current that 
activates in response to increasingly negative membrane potentials.  This current prevents 
the myocardium from becoming too refractory to stimulation.  HCN channels, which are 
weakly potassium-selective but still conduct sodium (Santoro et al., 1998; Ludwig et al., 
1999; Snyders, 1999), underlie this current.  Co-expression of HCN channels with 
KCNE2 1) allows If to remain open at higher membrane potentials, 2) increases whole-
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cell conductance, and 3) alters If kinetics, speeding gating for HCN1-2 and slowing 
gating for HCN4 (Yu et al., 2001; Decher et al., 2003). 
Ito, the transient outward potassium current at the beginning of each action 
potential, arises mainly from Kv4.3-KChIP2, with some contribution from Kv4.2 
channels.  While Kv4.2 and Kv4.3 have activation and inactivation delayed by KCNE2 
co-expression, Kv4.3-KChIP2 activation kinetics were increased by KCNE2.  KCNE2 is 
also solely responsible for producing ―overshoot,‖ a transient increase in current observed 
in Ito when action potentials occur in quick succession (Zhang et al., 2001; Deschenes & 
Tomaselli, 2002; Radicke et al., 2006). 
The Kv3.4-KCNE3 channel complex appears to be of great physiological 
relevance.  Mutation of R83H in KCNE3 disrupts a putative PKC phosphorylation site 
and has been linked to periodic paralysis and hypokalemia in a manner apparently related 
to blood pH.  Mutation S82A, the putative PKC phosphorylation site of KCNE3 in 
Kv3.4-KCNE3 channel complexes, prevents phosphorylation of KCNE3, though it is 
unclear if the kinase substrate is removed or if this mutation is allosteric.  The 
observations that pH is also a factor and that protonated R83H inhibits KCNE3 
modulation, give credence to the identity of this channel complex.  Wild type KCNE3 
alters single channel conductance and allows Kv3.4 channels to activate in response to 
lower membrane potentials (Abbott et al., 2001; Abbott et al., 2006).  Transcript and 
protein levels for both KCNE3 and Kv3.4 are not only present in skeletal muscle but also 
in hippocampal neurons and PC12 cells, and increase in response to A1-42, a peptide 
implicated in Alzheimers disease.  Increases observed in protein and transcript levels 
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mirror increased IA potassium current in these tissues.  This correlation provides strong 
evidence that this current arises from the Kv3.4-KCNE3 complex, and implicates 
increased neuronal potassium efflux in the onset of Alzheimers.  It appears that Kv3.4-
KCNE3 plays crucial roles in multiple diseases (Pannaccione et al., 2007). 
hERG is not only enhanced by KCNE co-expression, but it can be repressed.  The 
association of KCNE3 with hERG, or the closely related Xenopus laevis MiRP2, is able 
to suppress hERG currents, but it is unknown if this association is of any physiological 
relevance.  Transcripts for both hERG and KCNE3 are present in the heart (Schroeder et 
al., 2000b; Anantharam et al., 2003; Bendahhou et al., 2005; Lundquist et al., 2005). 
Recently, KCNE4 and BK were shown to interact in kidney epithelia.  
Colocalization by immunofluorescence indicates that these channel subunits were 
localized to the same membranes, and KCNE4 did co-immunoprecipitate with BK, 
showing a more direct interaction.  Co-expression of KCNE4 with BK reduced dwell 
time at the plasma membrane and protein stability.  There was also a shift in BK voltage 
sensitivity towards more positive membrane potentials with internal Ca
2+
 concentrations 
≥ 0.1 M.  The change in BK voltage sensitivity may result from altered Ca2+ sensitivity 
of the BK-KCNE4 channel complex, modulation which is reminiscent of that seen with 
KCNMB1 and KCNMB4 subunits (Levy et al., 2008).  A similar role had already been 
described for KCNE4 modulation of Kv1.1 and Kv1.3.  Currents arising from 
homotetramers and heterotetramers of both pore-forming subunits were suppressed by 
co-expression of KCNE4 (Grunnet et al., 2003).  Only one report has surfaced in which 
KCNE4 has not played an inhibitory role in channel function (vide infra) (Strutz-
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Seebohm et al., 2006). Whether or not these KCNE4 interactions actually play 
physiologically important roles requires further investigation. 
KCNE1-4 peptides have also been reported to alter currents arising from KCNQ4 
homotetramers, though the nature of this modulation, at least for KCNE1, is biosynthetic 
(Schroeder et al., 2000b; Chandrasekhar et al., 2006; Strutz-Seebohm et al., 2006).  These 
interactions will be addressed (vide infra). 
 
M-CURRENTS 
In 1980, Brown and Adams discovered a potassium current in bullfrog 
sympathetic neurons that began activating subthreshold and did not inactivate.  This 
current could be studied using a protocol that held membranes at relatively high 
membrane potentials, followed by stepping to command voltages and measuring tail 
currents.  Currents arising from this channel were relatively slow compared with IA 
currents, and were suppressed by exposure to muscarine.  Because of this muscarinic 
suppression, they named this current IM (Brown & Adams, 1980). 
In a parallel line of work, homologues of KCNQ1, KCNQ2 and KCNQ3, were 
identified as localizing to gene loci involved in a benign form of epilepsy, benign familial 
neonatal convulsion (BFNC), occurring within the first months or year of a child’s life, 
rarely continuing into adulthood (Biervert et al., 1998; Charlier et al., 1998; Singh et al., 
1998).  Mutations in KCNQ2 have also been identified in myokymia (Dedek et al., 2001).  
Gene mapping also identified another KCNQ1 homologue, KCNQ4, which mapped to a 
gene locus involved in autosomal dominant deafness (DFNA2) (Kubisch et al., 1999).  A 
 41 
fifth member of the KCNQ family, KCNQ5, was subsequently identified (Lerche et al., 
2000; Schroeder et al., 2000a).  KCNQ2-5 all gave rise to potassium selective currents 
with kinetics slower than those observed for IA, and possessing pharmacology 
reminiscent of IM.  However, slight biophysical and pharmacological differences still 
existed.  These differences were settled when co-expression of KCNQ2 and KCNQ3 
revealed that IM arises mainly from homotetrameric KCNQ2/3 channel complexes (Wang 
et al., 1998) (though there was heated debate whether hERG channels may further 
diversify M-currents (Marrion, 1997; Stansfeld et al., 1997; Noda et al., 1998; Meves et 
al., 1999; Selyanko et al., 1999; Selyanko et al., 2002)).  KCNQ3 is able to form 
heterotetramers with KCNQ2, KCNQ4 and KCNQ5 (Schroeder et al., 1998; Wang et al., 
1998; Kubisch et al., 1999; Lerche et al., 2000; Schroeder et al., 2000a). 
IM is present throughout much of the nervous system where active IM makes 
neurons more refractory to action potentials, thus decreasing the likelihood of subsequent 
action potentials (Figure 1-7).  Though M-currents are not present in the same tissues as 
IKs, IM like IKs plays a crucial role in adjusting membrane potential and preventing tonic 
firing in excitable cells (Cooper & Jan, 2003). 
 M-currents and IKs do have several analogous properties.  Sections of the large, C-
terminal domain of KCNQ pore-forming subunits have been crystallized, and structures 
obtained from these crystals are highly homologous (Figure 1-2) (Howard et al., 2007; 
Wiener et al., 2008).  M-currents and IKs are also modulated by the same intracellular and 
extracellular signals.  -adrenergic stimulation enhances both M-currents and IKs (Sims et 
al., 1988; Dilly et al., 2004), while muscarinic receptors suppresses currents arising from  
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Figure 1-7.  Related KCNQ channel complexes give rise to M-currents, responsible for 
regulating neuronal excitability.  A, neuron in which M-channel function is unperturbed.  
B, neuron in which M-channel function has been lost.  Above, cartoons depicting 
membrane potential as a function of time.  The top of the shaded range denotes the 
potential at which voltage-gated sodium channels will activate.  If membrane potential 
reaches threshold, an action potential will result and self-propagate down the length of 
the neuron.  The height of the gray region is the difference in average membrane potential 
and the threshold for sodium channel activation.  This difference in membrane potential 
and threshold prevents stray neurotransmitters and weak synaptic stimulation from 
resulting in an action potential.  Below, M-channel efflux (denoted in solid, vertical 
height) as a function of time.  M-current is slowly activating and deactivating, resulting in 
an increase in resting potassium conductance and an increase in refractory behavior in 
these neurons.  Green arrows depicit excitatory signals stimulating the neuron.  If M-
currents are absent from the neuron, excitatory signals can result in tonic stimulation. 
 
Figure adapted from Cooper, E.C. and L.Y. Jan, M-channels: neurological diseases, 
neuromodulation, and drug development. Arch Neurol, 2003. 60(4): p. 496-500. 
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both (Brown & Adams, 1980; Schroeder et al., 2000a; Selyanko et al., 2000).  Down-
regulation of M-current is mediated by phosphorylation by PKC.  PKC associates with 
M-channel complexes through AKAPs, again analogous to IKs (except that this 
association can be disrupted by Ca
2+
 binding to calmodulin) (Hoshi et al., 2003; 
Higashida et al., 2005).  M-currents and IKs are also down-regulated by over-expression 
with ubiquitin transferase enzymes like Nedd4-2 (Ekberg et al., 2007; Jespersen et al., 
2007).  Both IKs and M-currents are also sensitive to intracellular Ca
2+
 concentrations.  
For IKs, increases in intracellular Ca
2+
 lead to an increase in current density, decreases in 
homomeric KCNQ1 inactivation and increased activation at lower membrane potentials 
through its C-terminal interaction with calmodulin (Ghosh et al., 2006; Shamgar et al., 
2006).  M-channels also sense intracellular Ca
2+
 levels through a homologous C-terminal 
interaction with calmodulin.  However, increasing intracellular calcium causes 
calmodulin to dissociate from KCNQ2, thereby reducing M-current density.  The 
interaction between calmodulin and KCNQ3 or KCNQ4 shows less dependence upon 
intracellular calcium concentrations, with the strongest association between KCNQ4 and 
calmodulin (Yus-Najera et al., 2002; Bal et al., 2008). 
 M-currents and KCNQ1 differ in several ways, though these differences have 
become less clear as new evidence comes to light.  All KCNQ channels possess large 
intracellular C-termini which are involved in accessory subunit interactions as well as 
specificity during assembly (Haitin & Attali, 2008).  KCNQ1 pore-forming subunits 
cannot co-assemble with KCNQ2-5, whereas the C-terminus of KCNQ3 is able to 
mediate heterotetrameric assemblies with KCNQ2, KCNQ4 and KCNQ5.  Possession of 
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a KCNQ1 C-terminal domain is also required for KCNE1 modulation of currents 
(Maljevic et al., 2003; Schwake et al., 2003). 
 KCNQ subunits are also found in different tissues.  KCNQ1 is found in cardiac 
and epithelial tissues and in the cochlea but not in the nervous system, adjusting to the 
tissue-specific potassium conductance requirements by co-assembly with KCNE peptides 
(Robbins, 2001).  KCNQ2-5 subunits are found primarily in the nervous system and 
auditory pathways (Biervert et al., 1998; Wang et al., 1998; Kubisch et al., 1999; 
Marcotti & Kros, 1999; Lerche et al., 2000; Schroeder et al., 2000a; Cooper et al., 2001; 
Devaux et al., 2004; Schwarz et al., 2006), but growing evidence has demonstrated the 
distinction of tissue specificity is not quite so clear.  KCNQ3 and KCNQ5 proteins have 
been detected in tracheal epithelia (Moser et al., 2008), and KCNQ5 transcripts have been 
found in skeletal muscle where there is a current that recapitulates some of IM 
pharmacology (Lerche et al., 2000; Schroeder et al., 2000a).  IM currents have also been 
observed in bullfrog smooth muscle (Sims et al., 1988). 
 Much like KCNQ1, M-current subunits form heteromeric potassium conducting 
complexes, adding to the physiological diversity of potassium conductance.  However, 
KCNQ2-5 achieve this diversity through formation of heterotetrameric channel 
complexes composed of different pore-forming subunits and not with modulation by 
KCNE peptides (Schroeder et al., 1998; Wang et al., 1998; Kubisch et al., 1999; Lerche 
et al., 2000; Schroeder et al., 2000a). 
 M-channels can also be physiologically expressed as homotetramers, another 
distinction between KCNQ1 and M-channels.  KCNQ4, which gives rise to IK,n , a 
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current involved in endolymph potassium recycling, is well established as mediating 
potassium efflux in outer hair cells (and possibly inner hair cells (Oliver et al., 2003)) of 
the cochlea (Figure 1-5).  Like IKs, IK,n is required for potassium recycling and normal 
cochlear physiology (Kubisch et al., 1999; Marcotti & Kros, 1999; Kharkovets et al., 
2000; Kharkovets et al., 2006).  Homotetrameric M-channels are also found in 
myelinated peripheral neurons.  The slow activating and deactivating potassium current at 
Nodes of Ranvier, Ks or IKs (this is confusing, but this current is distinct from cardiac IKs), 
has been demonstrated by immunofluorescence to arise from KCNQ2 homotetramers but 
can also arise from KCNQ3/2 heterotetramers.  It appears the cross-sectional diameter of 
Nodes of Ranvier correlate with the presence of KCNQ3 – the smaller the diameter, the 
more likely M-channels will contain KCNQ3 (Devaux et al., 2004; Schwarz et al., 2006), 
indicative of current diversity arising from gene expression. 
 Also in contrast to KCNQ1, M-channels are generally not considered to be 
modulated by association with KCNE peptides.  Currents arising from very few KCNQ2-
5 or KCNQ3/2,4-5 heteromeric channel complexes have been modified by association 
with KCNE peptides, but this modification appears to be due to changes in the 
biosynthetic pathways of the studied over-expression system (Schroeder et al., 2000a; 
Tinel et al., 2000b; Chandrasekhar et al., 2006; Strutz-Seebohm et al., 2006).  The one 
exception to this rule may be KCNQ4 homotetramers.  Co-expression of KCNE3 and 
KCNE4 with KCNQ4 homotetramers either suppresses or enhances current, respectively, 
in Xenopus laevis oocytes.  KCNQ4-KCNE4 is less cation-selective than KCNQ4; this 
association gives rise to currents that are instantaneous and active at all measured 
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membrane potentials, with very little observable activation and deactivation kinetics.  As 
there is no data regarding the presence KCNQ4-KCNE3 channel subunits on the plasma 
membrane, current suppression may result from lack of channel proteins on the cell 
surface, either through sequestration of channel subunits or through increased 
internalization.  Changes in KCNQ4 due to KCNE4 may also result from perturbation of 
the biosynthetic pathway; KCNQ4-KCNE4 complexes may be aberrant complexes that 
would not normally reach the plasma membrane (Schroeder et al., 2000b; Strutz-
Seebohm et al., 2006). 
 Examination of inactivation in KCNQ channels is complicated.  While KCNQ1 
clearly possesses inactivation, M-currents were identified originally because they lacked 
any inactivation (Brown & Adams, 1980; Robbins, 2001).  Although lack of M-current 
inactivation would seem to be a fundamental difference, this conclusion is premature.  
Homotetrameric KCNQ1 currents have not been physiologically observed; co-expression 
of KCNQ1 with KCNE1 appears to remove all inactivation (or alter the kinetics of 
inactivation, making them impossible to observe during deactivation), thus one could 
question whether inactivation of KCNQ1 really plays any physiological role (Pusch et al., 
1998).  Further, KCNQ4 and KCNQ5 appear to possess inactivation.  Homotetramers of 
KCNQ4 and KCNQ5, as well as KCNQ4 heterotetramers (KCNQ5 was not examined), 
all possess an inactivation that is dependent upon the depolarizing membrane potential, 
just like the inactivation observed in KCNQ1 (Pusch et al., 1998; Jensen et al., 2007).  
Therefore, the ability to possess inactivation may be yet another mechanism for KCNQ 
subunits to diversity IM. 
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CHAPTER II 
KCNE3 TRUNCATION MUTANTS REVEAL A BIPARTITE MODULATION OF 
KCNQ1 K
+
 CHANNELS 
 
ABSTRACT 
The five KCNE genes encode a family of type I transmembrane peptides that 
assemble with KCNQ1 and other voltage-gated K
+
 channels resulting in potassium 
conducting complexes with varied channel-gating properties.  It has been recently proposed 
that a triplet of amino acids within the transmembrane domain of KCNE1 and KCNE3 
confers modulation specificity to the peptide since swapping of these three residues 
essentially converts the recipient KCNE into the donor (Melman, Y.F., Domenech, A., de la 
Luna, S., and T.V. McDonald.  2001  J. Biol. Chem.  276:  6439-6444.).  However, these 
results are in stark contrast with earlier KCNE1 deletion studies, which demonstrated that a 
C-terminal region — highly conserved between KCNE1 and KCNE3 — was responsible for 
KCNE1 modulation of KCNQ1 (Tapper, A.R., and A.L. George.  2000  J. Gen. Physiol.  
116:  379-389.).  To ascertain whether KCNE3 peptides behave similarly to KCNE1, we 
examined a panel of N- and C-terminal KCNE3 truncation mutants to directly determine the 
regions required for assembly with and modulation of KCNQ1 channels.  Truncations 
lacking the majority of their N-terminus, C-terminus, or mutants harboring both truncations 
gave rise to KCNQ1 channel complexes with basal activation — a hallmark of KCNE3 
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modulation.  These results demonstrate that the KCNE3 transmembrane domain is sufficient 
for assembly with and modulation of KCNQ1 channels and suggests a bipartite model for 
KCNQ1 modulation by KCNE1 and KCNE3 subunits.  In this model, the KCNE3 
transmembrane domain is active in modulation and overrides the C-terminus’ contribution, 
whereas the KCNE1 transmembrane domain is passive and reveals C-terminal modulation 
of KCNQ1 channels. We furthermore test the validity of this model by utilizing the active 
KCNE3 transmembrane domain to functionally rescue a non-conducting, yet assembly and 
trafficking competent long QT mutation located in the conserved C-terminal region of 
KCNE1. 
 
INTRODUCTION 
The KCNE type I transmembrane peptides (~ 125 residues) are a family of tissue 
specific -subunits that associate with and fine-tune the electrical properties of several 
voltage-gated K
+
 channels (Abbott et al., 1999; Abbott et al., 2001; Yu et al., 2001; 
Zhang et al., 2001; Grunnet et al., 2003; McCrossan et al., 2003; Lewis et al., 2004).  In 
expression systems, KCNQ1 (Q1) K
+
 channels have affinity for all five KCNE peptides 
forming K
+
 conducting complexes with different voltage-activation, gating kinetics, 
unitary conductance and pharmacology (Barhanin et al., 1996; Sanguinetti et al., 1996; 
Sesti & Goldstein, 1998; Schroeder et al., 2000b; Tinel et al., 2000a; Angelo et al., 2002; 
Grunnet et al., 2002).  Of these complexes, the physiological roles of the Q1-KCNE1 
(E1) and Q1-KCNE3 (E3) complexes have been well-established.  In the heart, Q1-E1 
complexes constitute the slowly activating and deactivating cardiac IKs current (Barhanin 
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et al., 1996; Sanguinetti et al., 1996).  Mutations in either Q1 or E1 that disrupt channel 
function and prolong the cardiac action potential have been implicated in several 
inherited forms of long-QT syndrome (Splawski et al., 2000).  Q1-E3 complexes have 
been detected in the basolateral membranes of several epithelial tissues where these 
apparently constitutively open channels are critical for cyclic AMP-stimulated chloride 
secretion in colon and lung (Schroeder et al., 2000b; Grahammer et al., 2001b).  Given 
their connectivity to chloride secretion, Q1-E3 complexes may be potential targets for 
cystic fibrosis therapies (Cowley & Linsdell, 2002; Cuthbert & MacVinish, 2003). 
Numerous studies have examined the molecular interactions between E1 and Q1.  
Two independent cysteine mutagenesis studies have demonstrated that the E1 peptides 
are intimate with the ion conducting pore unit, yet these studies disagree on the peptides’ 
exact location (Wang et al., 1996; Tai & Goldstein, 1998; Tapper & George, 2001).  
Deletion studies of E1 have shown that the transmembrane segment is sufficient for 
assembly with Q1, whereas a C-terminal region of ~ 25 amino acids proximal to the 
cytoplasmic membrane is necessary for Q1 modulation (Takumi et al., 1991; Tapper & 
George, 2000).  These results are in sync with the long-QT mutations found in E1 that 
reside within this same region (Splawski et al., 1997; Bianchi et al., 1999).  However, 
recent studies with KCNE1/3 chimeras suggest that a triplet of amino acids within the 
transmembrane segment of either KCNE is sufficient for modulation of Q1 and it was 
proposed that the C-terminus – which is so well-conserved between E1 and E3 – is 
merely required for proper anchoring or positioning of the transmembrane domain 
(Melman et al., 2001).  In a subsequent report, this modulation specificity was further 
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rendered down to a single amino acid within the triplet:  T58/V72 in E1/E3 (Melman et 
al., 2002a).  To date, however, the interaction between E3 and Q1 has not been directly 
examined. 
We sought to determine the regions of E3 responsible for assembly with and 
modulation of Q1 channels by constructing a panel of E3 truncation mutants and co-
expressing them with Q1 channels.  We find a double truncation mutant composed 
essentially of the E3 transmembrane domain assembles with Q1 channels producing K
+
 
channel complexes that are open at hyperpolarizing potentials.  This mutant directly 
demonstrates that the E3 transmembrane domain is sufficient for assembly with Q1; by 
analogy we predict this will be the case for all KCNE peptides.  These results suggest a 
bipartite model for modulation of Q1 channels by E3 and E1 where the transmembrane 
domain is either active in modulation (E3) and masks the contribution of the C-terminus, 
or is passive (E1) and reveals C-terminal modulation of Q1.  We further corroborate the 
bipartite model by utilizing an ―active‖ E3 transmembrane domain to override a non-
functional long QT mutation located in the C-terminus of E1. 
 
RESULTS 
Expression of homomeric Q1 channels (Fig. 2-1A, left) gives rise to outwardly 
rectifying K
+
 currents that undergo inactivation, which can be readily detected upon 
repolarization as a hook in the tail currents since the rate of recovery from inactivation is 
faster than deactivation (Pusch et al., 1998).  In contrast, co-expression of Q1 with E3 
produces a K
+
 conducting complex that displays no inactivation and has large standing  
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Figure 2-1.  KCNQ1/KCNE3 channels have a large standing current at negative 
membrane potentials.  A, Two-electrode voltage clamp recordings from Xenopus oocytes 
injected with Q1 (left) or Q1/E3 (right).  Traces were recorded in KD98 with a 13 s 
interpulse interval.  Dashed line indicates zero current.  Inset, ―Activation Curve 
Protocol‖ of 2 s depolarizations used to elicit currents shown.  B, Voltage-activation 
curves from Q1 and Q1/E3 channels.  Tail currents were measured 3 ms after 
repolarization, fit to a Boltzmann, and the data normalized such that the upper asymptote 
was equal to 1.   Squares, Q1; Circles, Q1/E3.  Data was averaged from 6 oocytes each ± 
S.E.M.  Scale bars represent 1 A and 0.5 s. 
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currents at hyperpolarizing potentials (Fig. 2-1A, right).  The standing currents are caused 
by the large basal activation of the complex, which is compared to homomeric Q1 
channels using the voltage-activation relationship in Fig 2-1B.  Using this comparative 
analysis, the basal activation of the Q1-E3 complex is ~ 30% whereas Q1 channels are 
relatively closed (3%).  To directly determine the regions of E3 required for assembly 
with and modulation of Q1 channels, we constructed a panel of E3 truncation mutants 
(Fig. 2-2), co-expressed them with Q1 channels in Xenopus oocytes and analyzed them 
using two-electrode voltage clamp (TEVC). 
 We first examined whether removal of the N-terminus altered E3’s ability to 
assemble with and modulate Q1 channels.  A series of overlapping N-terminal partial 
truncation mutants were constructed such that every N-terminal amino acid, except for 
the first 4 residues, was absent in at least one construct.  All N-terminal mutants shown in 
Fig 2-3A rapidly activate and deactivate, lack inactivation, and have large standing 
currents at negative potentials in response to families of command voltages.  
Glycosylation of E3 appears to be required for complex assembly and/or function since 
severe N-terminal mutants that removed every putative N-linked glycosylation site did 
not express current when co-injected with Q1 (data not shown).  Like WT E3, expression 
of N-terminal truncation mutants alone did not yield any appreciable current over 
uninjected controls (data not shown).  In fact, all E3 mutants studied did not afford 
currents above background when injected without Q1 RNA.  Functional Q1-E3 N-
terminal truncation complexes were compared using voltage activation curves (Fig. 2-
3B).  This comparison is valid provided that the conducting complexes can be nearly  
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Figure 2-2.  KCNE3 truncation mutants.  Solid lines depict which amino acid residues 
remain in E3 truncation mutants.  Numbers across the top denote amino acid residue 
number.  TM, transmembrane domain; N, putative N-linked glycosylation site. 
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Figure 2-3.  KCNE3 N-terminal truncation mutants produce standing currents at negative 
potentials when co-expressed with Q1.  A, TEVC recordings from Xenopus oocytes 
injected with Q1 and either 5-40 (left), 10-51 (center), or 41-55 (right).  Traces were 
recorded in KD98 with a 13 s interpulse interval.  Dashed line indicates zero current.  
Inset, ―Activation Curve Protocol‖ of 2 s depolarizations used to elicit currents shown.  
B, Voltage-activation curves from E3 N-terminal truncation mutants.  Activation curve 
data were fit to a Boltzmann, and the data renormalized as described in Materials and 
Methods.  Squares, 5-40; circles, 10-51; triangles, 41-55.  Dotted lines indicate the 
voltage-independent activation of Q1 and Q1-E3 from the lower asymptotes of Q1 the 
corresponding Boltzmann fits.  Data was averaged from 4 – 6 oocytes ± S.E.M.  Scale 
bars represent 1 A and 0.5 s. 
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maximally activated to accurately fit the upper asymptote of the Boltzmann equation, as 
is the case for 5-40 and 10-51.  In the case of the 41-55 mutant, the curve is 
markedly right-shifted and not amenable to this comparative analysis.  Nonetheless, it is 
clear from the families of current traces that the N-terminal sequence (barring 
glycosylation) is not required for Q1/E3 complex assembly and function. 
Given the high degree of sequence homology between the C-termini of E1 and 
E3, we next determined whether the C-terminus of E3 is active in modulation of and 
assembly with Q1 channels.  Figure 2-4 shows representative data from a C-terminal 
truncation mutant (84) and a double truncation (10-51/84) mutant co-expressed with 
Q1.  From these data, it is clear that E3 peptides lacking their C-termini can assemble 
with Q1 channels and form conducting complexes that have standing currents at 
hyperpolarizing potentials with unaltered K
+
 selectivity (Fig. 2-4C).  However, removal 
of the C-terminus does come with a cost; these mutants display some inactivation, slower 
activation/deactivation kinetics, and a reduction in basal activation.  Moreover, roughly 
equal nanogram amounts of Q1 and C-terminal mutant RNA were required to afford E3-
like currents shown in Figure 2-4A; typical injection ratios (1/0.1 Q1/KCNE) afforded 
currents with more Q1 character (vide infra).  The electrophysiological properties of C-
terminal truncation mutants in Table 1 are compared with WT E3 and the N-terminal 
truncations, which were also injected at this near equal RNA ratio for comparison. 
Since the E3 transmembrane domain is able to modulate Q1 channels without the 
presence of a C-terminal domain, we next asked whether a dysfunctional mutation within 
the conserved C-terminus would affect Q1-E3 function.  E1 peptides containing the long  
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Figure 2-4.  KCNE3 C-terminal and combined N- and C-terminal truncation mutants 
also exhibit standing currents at negative potentials when co-expressed with Q1.  A, 
TEVC recordings from Xenopus oocytes injected with Q1 and either 84 (left) or 10-
51/84 (right).  Traces were recorded in KD98 with a 13 s interpulse interval.  Dashed 
line indicates zero current.  Scale bars represent 1 A and 0.5 s.  Inset, ―Activation Curve 
Protocol‖ of 2 s depolarizations used to elicit currents shown.  B, Voltage-activation 
curves from KCNE3 C-terminal and double truncation mutants.   Data were fit to a 
Boltzmann, and normalized as described in Materials and Methods.  Squares, 84; 
circles, 10-51/84.  Dotted lines indicate the voltage-independent activation of Q1 or 
Q1-E3 (E3).  Data was averaged from 4 oocytes each ± s.e.m.  C, External K
+
 
concentration was varied and the reversal potential was measured.  log [K
+
]ext is plotted 
against observed reversal potential.  WT and E3 truncation mutants co-expressed with Q1 
produced linear fits within error of 53 mV per decade.  Data was averaged from 4 – 6 
oocytes ± S.E.M. 
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Table 2-1.  Electrophysiological Properties of KCNE3 Truncation Mutants
a
 
Construct 
 
V½ (mV) 
 
z 
 
 
Basal 
Activation, A2 
 
deactivation (ms) 
fast slow 
 
Q1 
 
-23.8 ± 0.6 
 
1.39 ± 0.03 
 
0.03 ± 0.01 221 ± 10 
      
E3 23.5 ± 2.5 0.75 ± 0.03 0.31 ± 0.02 14.9 ± 0.3 124 ± 5 
      
5-40 25.3 ± 5.1 0.81 ± 0.07 0.35 ± 0.03 19.1 ± 1.2 130 ± 5 
      
10-51 24.6 ± 5.5 1.00 ± 0.05 0.30 ± 0.02 14.4 ± 0.6 102 ± 4 
      
41-55 86.4 ± 7.4 0.51 ± 0.01 0.12 ± 0.01 10.9 ± 0.2 115 ± 3 
      
84 10.1 ± 1.3 0.67 ± 0.02 0.07 ± 0.01 nd nd 
      
10-51/84 -10.0 ±  0.7 1.31 ± 0.05 0.14 ± 0.02 nd nd 
      
D90N 27.8 ± 4.1 0.59 ± 0.02 0.28 ± 0.02 13.7 ± 0.4 156 ± 28 
      
E1/E3 TM D76N 
 
4.5 ± 4.3 0.82 ± 0.03 0.08 ± 0.01 nd nd 
a
Data from individual activation curves and deactivation time constants in KD98, obtained from 
4 – 6 oocytes.  Activation curves were fit to a Boltzmann function as described in Materials and 
Methods.  Values are mean ± S.E.M.  Basal activation (A2) for all activation curves was 
determined by normalizing the data after the Boltzmann fit such that the maximal current fitting 
parameter (A1) was equal to 1.  V½ is the voltage of half-maximal activation and z is the slope 
factor.  Time constants of deactivation were fit to a single or double exponential as described 
in the Material and Methods.  nd, not determined. 
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QT causing mutation D76N have been previously shown to assemble with Q1 channels 
and traffic to the plasma membrane, but are essentially non-conducting complexes (Fig. 
2-5A, left) (Wang & Goldstein, 1995).  Incorporation of the corresponding mutation into 
E3 (D90N) and co-expression with Q1 results in currents nearly indistinguishable from 
wild type (Fig. 2-5A, right).  This functional rescue can be solely attributed to the E3 
transmembrane domain since an E1/E3 chimera possessing the E3 transmembrane 
sequence can also functionally rescue the D76N mutation, albeit with slower activation 
and deactivation kinetics (Fig. 2-5B).  Although these mutants produce functional Q1-E3 
complexes, they required injecting more mutant E3 RNA than Q1 to produce currents 
with primarily E3-character; injection of lower amounts of E3 resulted in currents with 
more Q1-character, as was previously observed with the E3 D90N mutation (Fig. 2-6A) 
(Abbott & Goldstein, 2002).  These results demonstrate that the E3 transmembrane 
domain is capable of functionally overriding the modulatory effects of the KCNE C-
terminus. 
To afford the characteristic Q1-E3 currents with the D90N and C-terminal 
truncation mutants, an unusually high injection ratio of Q1:E3 RNA was required, 
suggesting that the C-terminus might be important for cellular assembly and trafficking 
of the Q1-E3 complex.  Supporting this notion was the presence of inactivation in the tail 
currents with the 84 and D90N mutants at the lower injection ratios (Fig. 2-6A). This 
inactivation was not present in either WT Q1-E3 complexes or in complexes where the 
majority of the E3 N-terminus is removed (10-51).  Therefore, its presence with the 84 
and D90N mutants indicated that a mixed population of Q1 channels (unpartnered and  
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Figure 2-5.  A Long QT mutation in the C-terminus of KCNE1 is masked by the KCNE3 
transmembrane domain.  Inset, ―Activation Curve Protocol‖ of 2 s depolarizations used 
to elicit currents shown.  Scale bar represents 1 A and 0.5 s for all recordings.  A, TEVC 
recording from Xenopus oocytes injected with Q1 and either E1 D76N (left) or E3 D90N 
(right).  B, Representative TEVC recordings from oocytes co-injected with Q1 and a 
chimeric partner protein, E1 D76N with the E3 transmembrane (TM) sequence.  All 
oocytes were injected with equal amounts and ratios of Q1 and E1 or E3 RNA, and were 
recorded in KD98 using a 13 s interpulse interval.  Dashed lines indicate zero current. 
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Figure 2-6.  KCNE3 C-terminal mutants demonstrate a functional dependence on cRNA 
injection ratios.  A, Representative two-electrode voltage clamp recordings taken from 
oocytes injected with varying amounts of E3, between 2.5x and 0.05x of Q1.  Currents 
were recorded in KD98, using a 13 s interpulse interval.  The Q1:E3 ratio is labeled 
across the top.  Top row, E3 (square), second row, 10-51 (circle), third row, 84 
(diamond), bottom row, D90N (triangle).  Dashed lines indicate zero current.  Scale bars 
represent 1 A and 0.5 s.  Inset, ―Activation Curve Protocol‖ of 2 s depolarizations used 
to elicit currents shown.  B, Percent current remaining after inhibition with 10 M 
chromanol 293B.  Oocytes were held at – 80 mV and depolarized for 2 s to + 40 mV with 
a 28 s interpulse interval.  Current levels were allowed to stabilize for ≤ 5 min before 10 
M chromanol 293B was perfused in.  Chromanol block typically reached equilibrium 
within 5 min of wash in.  Dashed line indicates the percentage of current remaining in 
oocytes expressing Q1 alone.  Data was averaged from 3 – 11 oocytes ± S.E.M. 
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 E3-partnered) was functioning at the cell surface.  To confirm that unpartnered Q1 
channels were present and functioning at the plasma membrane, we used chromanol 
293B, which inhibits Q1-E3 complexes at a 10-fold lower concentration than homomeric 
Q1 channels (Schroeder et al., 2000b).  In the presence of 10 M chromanol 293B, WT 
and 10-51 mutant Q1-E3 complexes were consistently inhibited at ~ 85%, independent 
of the ratio of RNA injected (Fig. 2-6B).  Conversely, as less D90N or 84 RNA was 
injected, chromanol 293B inhibition decreased, approaching the amount of inhibition 
observed with unpartnered Q1 channels at 10 M chromanol 293B (Fig 2-6B, dotted 
line).  Vehicle (0.1 % DMSO) alone had no effect on WT or mutant Q1-E3 complexes 
(data not shown).  At the highest RNA injection ratio, there was consistently less total 
current remaining for the 84 and D90N mutant than with either WT or the N-terminal 
truncation mutant (10-51).  Attempts to inject even more E3 mutant DNA to determine 
whether unpartnered Q1 channels remained at the cell surface with the 1/2.5 Q1/E3 ratio 
were thwarted by extensive oocyte death.  Nonetheless, lowering the Q1:E3 RNA 
injection ratio with the C-terminal and D90N mutants decreased chromanol 293B 
inhibition and mirrored the increase in inactivation, suggesting that unpartnered Q1 
channels were functioning at the plasma membrane.   These results implicate the C-
terminus in Q1-E3 complex assembly. 
 We next determined whether the C-terminal and D90N mutant protein was failing 
to form properly assembled complexes with Q1 and traffic to the plasma membrane, or 
whether the mutant proteins were merely being degraded.  To distinguish injected E3 
protein from endogenous KCNE peptides recently identified in Xenopus oocytes 
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(Anantharam et al., 2003), we utilized a HA-tagged version of E3 that has been 
previously used for biochemical experiments (Abbott et al., 2001; McCrossan et al., 
2003; Lewis et al., 2004).  Incorporation of the N-terminal HA-tag caused a unique form 
of K
+
-enhanced, cumulative inactivation in all Q1-E3 complexes, including wild type 
(Figs. 2-7A & B).  Initial recordings in low external K
+
 (ND96) required holding at – 80 
mV for several minutes using test depolarizations to monitor recovery from inactivation.  
Perfusion of 98 mM K
+
 slowly inactivated the HA-tagged Q1-E3 complex, which could 
not be reversed with hyperpolarizing pulses (Fig. 2-7B).  Since the E3-HA-tagged Q1-
complex does not recover from inactivation with voltage in high external K
+
, no recovery 
―hooks‖ in the tails were observed upon repolarization.  Subsequent perfusion with ND96 
could partially relieve cumulative inactivation, but the currents never returned to their 
original values.  To ameliorate K
+
-enhanced cumulative inactivation of the HA-tagged 
Q1-E3 complexes, we replaced the external K
+
 with 10 mM Rb
+
 (Fig. 2-7C).  At this 
concentration of Rb
+, we could readily detect the ―hook tails‖ associated with 
homotetrameric Q1 inactivation since inward currents are about threefold larger with 
external Rb
+
 in comparison to K
+ 
(Seebohm et al., 2003). Using these conditions, Q1-
complex assembly with the C-terminal truncation mutant (84) remained dependent on 
the ratio of RNA injected and homotetrameric Q1 channels could be detected at both 
injection ratios.  Remarkably, addition of the epitope tag to the D90N mutant essentially 
rescued the assembly defect of this mutant (Fig. 2-7C). 
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Figure 2-7.  Functional characterization of KCNQ1/KCNE3-HA complexes.  A, Q1 
complexes formed with HA-tagged E3 exhibit potassium dependent inactivation.  TEVC 
recordings of oocytes expressing Q1 and E3-HA were bathed in ND96 (left) and KD98 
(right).  Both recordings are shown at the same scale, and use a 13 s interpulse interval.  
Insets, ―Activation Curve Protocol‖ of 2 s depolarizations used to elicit currents shown.  
B, Current versus time plotted for potassium concentration changes for the Q1-E3-HA 
complex shown in A.  Oocytes were held at – 80 mV, and depolarized for 2 s to + 40 mV, 
with a 28 s interpulse interval.  Squares denote the current measured at + 40 mV, 
triangles at – 80 mV 100 ms before the respective capacitive transients.  C, HA-tagged 
E3 shows altered dose-dependence for the C-terminal truncation mutant.  TEVC 
measurements of oocytes injected with 0.4x (left) or 0.05x (right) E3-HA relative to Q1.  
Currents were recorded with 10 mM Rb
+
 (RD10), and oocytes were held at – 40 mV, 
with an 11.5 s interpulse interval.  Top, E3-HA, middle, 84-HA, bottom, D90N-HA.  
Scale bars represent 1 A and 0.5 s. 
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 Since Q1-complex assembly with the HA-tagged 84 mutant remained 
dependent on the amount of RNA injected in functional experiments, we next determined 
whether the E3 C-terminal mutants were proteolytically stable. HA-tagged E3 proteins 
were isolated from crude oocyte membranes after 3 – 5 days of co-expression with Q1.  
Three oocytes worth of membranes from each sample at the 1/0.4 Q1/E3 ratio were 
analyzed by SDS-PAGE and transferred to nitrocellulose for E3 detection.  Immunoblots 
in Figure 2-8A showed a similar complex pattern of bands for both WT E3 and D90N, 
which is consistent with several N-linked glycoforms.  The 84 C-terminal truncation 
mutant protein also afforded an abundant signal on the immunoblot; however, only a 
single, intense band was observed at 20 kD.  The 84 protein was also detected at the 
lower 1/0.05 Q1/E3 ratio (Fig. 2-8B). 
The markedly different pattern of protein bands for WT and 84 suggested that 
the C-terminal truncation mutant was largely residing in the endoplasmic reticulum (ER), 
which could be directly tested utilizing E3’s N-linked glycosylation.  N-glycosylated 
membrane proteins in the ER possess immature glycans (~ 3 kD/glycan), whereas the N-
linked glycans on membrane proteins that have trafficked through the Golgi mature and 
often increase in size due to the various trimming and additions of glycosides.  To 
identify the maturity of the N-linked glycans on WT and 84, two glycosidases were 
used:  endoglycosidase H (Endo H), which cleaves only the immature glycoform, and 
PNGase F, which removes all forms of N-linked glycosylation.  SDS-solubilized 
membranes containing WT and 84 protein were enzymatically degylcosylated and 
separated on Tris-Tricine gels to resolve the ~ 10 – 20 kD unglycosylated proteins (Fig. 
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Figure 2-8.  WT and C-terminal mutant HA-tagged KCNE3 peptides are glycosylated 
and not proteolytically degraded in oocytes.  Crude membranes for the immunoblots were 
prepared 3 – 5 days after co-injection with Q1 and the indicated E3 construct.  A, 
Immunoblot of HA-tagged E3 peptides from SDS-solubilized membranes isolated from 
oocytes injected at a Q1/E3 ratio of 1/0.4.  Membranes from 3 oocytes were loaded in 
each lane and resolved with a 15% Tris-glycine SDS gel.  Molecular weight standards are 
labeled on the left for both blots.  B, Immunoblots of enzymatically deglycosylated E3 
and 84 HA-tagged proteins were separated on 16.5% Tris-tricine SDS gels.  E3 (4 
oocytes/lane) and 84 (6 oocytes/lane) were digested with endoglycosylase Hf (Endo H) 
or PNGase F.  Lane marked (–) represents untreated samples.  Loaded in the lane marked 
1/0.05 are solubilized membranes from 17 oocytes expressing Q1/84 injected at the 
lowest Q1/E3 ratio examined.   Membranes from uninjected oocytes are denoted and 
were loaded at the left (4 oocytes) and right (17 oocytes).  Mature and immature 
glycosylation is denoted, as determined by enzymatic deglycosylation.  C, Cell surface 
expression of HA-tagged E3 proteins was quantitated by single oocyte 
chemiluminescence.  Oocytes were injected with a 1/0.4 Q1/E3 ratio, allowed to incubate 
for 5 days, and the cell surface tagged proteins were labeled with an anti-HA antibody 
followed by a secondary HRP-conjugated antibody.  Single oocyte luminescence was 
quantitated in a luminometer and is reported in relative light units (RLU).  Q1 sample is 
from control oocytes injected with only Q1 RNA.  Error bars are standard error 
measurement from 15 – 19 oocytes. 
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2-8B).  Endo H treatment of WT E3 removes only a single band at 23 kD.  Although the 
deglycosylated product cannot be observed at this exposure, extended exposures revealed 
a faint band at 17 kD, suggesting that the majority of the protein has mature N-linked 
glycosylation (data not shown).   PNGase F treatment of WT E3 demonstrated that the 
remaining, slower mobility bands were due to N-linked glycosylation, as all bands 
collapsed to a single species at ~ 17 kD.  In contrast, both glycosidases equally acted on 
the single band in the 84 sample identifying the N-linked glycan as the immature form 
found in the ER.  Given the small size of the 84 mutant, the slight difference in protein 
mobility for the differently deglcosylated samples is presumably due to the remaining 
monosaccharides left behind after Endo H treatment.  PNGase F, in contrast, removes all 
of the carbohydrate from each N-glycosylation site resulting in a protein with a smaller 
molecular weight.  These results demonstrate that the C-terminus is important for 
assembling Q1-E3 complexes that efficiently exit the ER.   
As shown in Figure 2-8B, the PNGase F treated 84 samples were routinely 
stronger in intensity than when treated with Endo H.  This difference suggested that some 
mature glycoforms of 84 may have been present, but were not detectable in the 
immunoblot due to the heterogeneity of mature glycosylation that often causes an under 
representation of the protein signal.  To ensure that a small portion of the HA-tagged 84 
was reaching the plasma membrane, we used whole oocyte cell surface labeling in 
combination with chemiluminescence to detect the extracellularly HA-tagged E3 proteins 
on the cell surface (Zerangue et al., 1999).  Oocytes co-expressing Q1 with HA-tagged 
E3 proteins were labeled with anti-HA antibody followed by labeling with a secondary-
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HRP conjugated antibody.  The amount of secondary antibody on the cell surface of each 
oocyte was quantitated using a luminometer.  Strong cell surface signals were observed 
for WT and D90N (Fig. 2-8C).  Cell surface expression of 84 was easily detected over 
Q1 injected background controls, but was noticeably less than WT and D90N.  These cell 
surface expression data are in agreement with the biochemistry and electrophysiological 
experiments, which in total, demonstrate that the E3 C-terminus aides in cellular 
assembly and trafficking of the Q1-E3 complex. 
 
DISCUSSION 
In this study, we have used the dramatic changes in Q1 channel function to assess 
Q1-E3 complex assembly, and by definition, the region of E3 responsible for basal 
activation of the complex.  Through a series of truncation mutants, exemplified by a 41-
residue double truncation mutant that is active, yet lacks the majority of its N- and C-
termini, we have shown that the transmembrane domain of E3 is sufficient for assembly 
with and modulation of Q1 channels.  A comparative analysis of gating revealed that 
truncation of the majority of the N-terminus does not appreciably alter Q1-E3 basal 
activation as long as one putative N-linked glycosylation site is retained.  The importance 
of N-linked glycosylation in Q1-KCNE complex formation and function has been 
previously observed with E1 (Takumi et al., 1991; Freeman et al., 2000).  A requirement 
of using tail current analysis to compare the basal activation of these mutants is that the 
channel complexes must be sufficiently activated past their midpoint of activation to fit 
the data accurately to a Boltzmann.  Any uncertainty in the upper asymptote of the fit will 
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greatly affect the value determined for the basal activation.  The 41-55 highlights this 
caveat since its basal activation is apparently reduced; however, this mutant clearly forms 
complexes with Q1 channels that are open at hyperpolarizing potentials, which cause a 
substantial lowering of the oocyte resting potential similarly to WT E3. 
Mutants that allow unpartnered Q1 channels to escape the ER and function at the 
plasma membrane would also affect the measurement of basal activation.  The lower 
basal activation of the C-terminal truncation mutants may be due in part to unpartnered 
Q1 channels affecting the activation curve analysis, which was supported by the 
following three observations in electrophysiological experiments where the Q1/E3 RNA 
injection ratio was systematically varied.  1) The C-terminal truncation and D90N point 
mutants required injecting more E3 RNA than Q1 to afford the characteristic Q1-E3 
currents.  Moreover, as relatively less E3 RNA was injected, the resulting currents 
resembled unpartnered Q1 channels.  In contrast, Q1-complexes with WT and the N-
terminal E3 truncation mutant (10-51) always afforded Q1-E3-like currents over a 
similar 50-fold range of E3 RNA.  2) The presence of homotetrameric Q1 inactivation, as 
observed by the hook in the tails currents upon repolarization, was detected only with the 
C-terminal mutants and increased as less E3 RNA was injected.  3) The chromanol 293B 
sensitivity, an indirect measurement of Q1-E3 complex assembly, was reduced for the C-
terminal mutants and was also dependent on the Q1/E3 RNA injection ratio.  These 
observations strongly imply that a heterogeneous population of Q1 channels is at the cell 
surface when co-expressed with E3 C-terminal mutants; however, these observations do 
not rule out the possibility that there are more than two populations of Q1 channels 
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functioning at the plasma membrane.  The diminished assembly capacity of the C-
terminal mutants, which allows unpartnered Q1 channels to traffic to the plasma 
membrane, also explains an apparent inconsistency with a previous investigation of the 
D90N mutant.  Injection at more typical Q1/KCNE RNA ratios (1/0.1) results in currents 
with primarily Q1-character, as was previously observed with this mutant (Abbott & 
Goldstein, 2002).  It is not until a large excess of D90N RNA is injected that Q1-E3 
currents are consistently observed. 
Biochemical examination of the E3 C-terminal mutant proteins necessitated the 
use of an epitope-tagged E3 construct since oocytes contain endogenous KCNE peptides 
(Anantharam et al., 2003).  Although this particular HA-tagged E3 construct has been 
previously used in biochemical experiments (Abbott et al., 2001; McCrossan et al., 2003; 
Lewis et al., 2004), in our hands, we observed a unique form of inactivation when it 
assembled with Q1 that was enhanced by high external K
+
 and not reversible with 
hyperpolarizing pulses under these high K
+
 conditions.  Surprisingly, incorporation of the 
HA-tag into the D90N mutant enabled this assembly defective mutant to readily assemble 
with Q1 channels.  We observed efficient Q1-D90N-HA complex assembly in all three 
assays tested:  RNA titration, maturation of glycosylation and cell surface expression.  
The HA-tag had little effect on the 84 mutant, as it remained assembly impaired and 
dependent on RNA injection ratios.  While the addition of the HA tag does add 2 extra 
negative charges per KCNE subunit, and it is has been shown that these charges are in the 
vicinity of the outer vestibule of the Q1 channel (Chen et al., 2003), any proposed 
mechanisms for either of these two observed phenomena would be conjecture. 
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 The finding that the majority of the 84 mutant protein possesses the immature 
form of N-linked glycosylation indicates that the C-terminus assists in the proper 
assembly of Q1-E3 complexes that can efficiently exit the endoplasm reticulum.  In 
addition, the fact that only the immature core oligosaccharide is observed for the 84 
mutant, and not the unglycosylated peptide, demonstrates that C-terminal truncation 
mutant is recognized by oligosaccharyltransferase and is treated as a bona fide substrate.  
The presence of the immature glycan on 84 is also consistent with Q1-KCNE complex 
formation occurring in the ER, which is in agreement with several recent studies that 
suggest Q1-KCNE complex formation occurs in the ER (Bianchi et al., 2003; 
Krumerman et al., 2004).  Although no mature form of 84 was directly observed in the 
Western Blots, cell surface labeling of individual oocytes confirmed that at least a small 
portion of the 84 mutant protein was indeed at the cell surface.  The presence of 
immature 84 protein in both the low and high RNA injection ratios indicates that the 
protein resides in the ER, but is unable to prevent unpartnered Q1 channels from escaping 
the ER.  These results, however, do not directly address whether the majority of the 84 
protein is retained in the ER, and not assembled with Q1, or whether the assembled Q1-
E3 complexes lacking an E3 C-terminus are not passing the protein quality control (QC) 
mechanisms in the ER.  The most likely QC proteins involved in ER retention are 
calnexin/calreticulin since the 84 mutant lacks a C-terminus eliminating the possibility 
of a cytoplasmic ER retention signal (Ellgaard & Helenius, 2003).  The lack of an ER 
retention signal also argues that 84 mutant is retained in the ER and not refluxing back 
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from the cis-Golgi since COPI proteins require these motifs for retrograde trafficking 
(Ellgaard & Helenius, 2003). 
Our findings directly bear on the controversy regarding the locations of the 
assembly and modulation domains of E1 and E3.  The current debate revolves around 
assigning assembly and modulatory properties to two distinct locations: the 
transmembrane domain and a highly conserved region within the C-terminus.  Deletion 
analysis of E1 initially demonstrated that the transmembrane domain was sufficient for 
assembly with Q1 channels, but the C-terminus was required for modulation (Tapper & 
George, 2000).  More recent E1/E3 chimeras suggest exactly the opposite:  the 
transmembrane sequence houses the modulatory domain while the C-terminus anchors 
and properly positions the KCNE peptide within the Q1 channel complex (Melman et al., 
2001).  In the context of these previous reports, the results from our E3 truncation and 
point mutants suggest a bipartite model for assembly and modulation.  In this model (Fig. 
2-9), the transmembrane domain and the conserved C-terminal region both play a role in 
assembly.  The transmembrane domain is the primary player in Q1-KCNE complex 
assembly, but the C-terminus also aids in assembling competent complexes, as evidenced 
by the ―assembly-challenged‖ E3 C-terminal truncation mutants, E3 D90N mutant and 
D76N E1/E3 chimera.  For modulation, the KCNE transmembrane sequence is either 
active or passive in basal activation.  In the case of E3, the transmembrane domain is 
active and overrides the C-terminus, affording a Q1 channel complex with large basal 
activation.  Conversely, the E1 transmembrane domain is passive and reveals C-terminal 
modulation of Q1, producing slowly activating and deactivating IKs currents.  The  
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Figure 2-9.  A bipartite model for modulation of KCNQ1 by KCNE1 and KCNE3.  Net 
diagrams of the transmembrane domains of E1 and E3 are aligned; amino acid residues, 
denoted as circles, are shaded based on conservation.  Black circles, identical amino 
acids; gray circles, similar amino acids; horizontally striped circles, high-impact amino 
acids identified by chimeric studies; vertically striped circles, D76 and D90; no fill, non-
similar amino acids; TM, transmembrane domain. 
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bipartite model also predicts that a dysfunctional C-terminus would have no effect on E3 
modulation of Q1, but would be detrimental to Q1-E1 complex function.  Incorporation 
of such mutation into E3 (D90N) had no effect on Q1-E3 complex function, whereas this 
same Long QT mutation in E1 renders the complex non-functional.  And with some 
ghoulish tinkering (placing the E3 transmembrane sequence into the E1 D76N mutant), 
we demonstrated that the E3 transmembrane domain alone was sufficient to mitigate the 
disruptive effects of this C-terminal mutation. 
Is bipartite assembly and modulation exclusive to E1 and E3?  Based on sequence 
homology, previous deletion studies with E1 (Tapper & George, 2000) and our E3 
truncation mutants show that the KCNE transmembrane segment is a general, minimal 
Q1 assembly domain.  Although the KCNE C-terminus is not as conserved as the 
transmembrane domain throughout the entire family, there is some evidence that the E1 
C-terminus may also be important for Q1-E1 complex assembly.  Previous E1 deletion 
studies initially suggested that the C-terminus was solely involved in modulation since 
removing it did not prevent complex formation with Q1 channels (Tapper & George, 
2000).  However, complex formation was not readily apparent from the current traces 
(the raw data was nearly indistinguishable from unpartnered Q1 currents) and a cysteine 
residue had to be incorporated into the E1 transmembrane domain so that Q1-E1 complex 
formation could be detected by cadmium inhibition.  Although cadmium inhibition was 
clearly detected in these mutants, it was noticeably less than WT Q1-E1 complexes 
(Tapper & George, 2000), suggesting that a population of unpartnered Q1 channels may 
have also been present and functioning at the cell surface.  Further examination of the C-
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terminus of E1, as well as the remaining KCNE peptides, will reveal whether this region 
facilitates Q1-KCNE complex formation in the entire KCNE family. 
Transmembrane modulation, and thus the bipartite model, may be limited to 
KCNE modulation that involves altering the basal activation of Q1 channels.  Given the 
reported proximity of the KCNE transmembrane segment to the S6 helix (Wang et al., 
1996; Tai & Goldstein, 1998; Tapper & George, 2001), we view E3 transmembrane 
modulation of Q1 similarly to the constitutively activated S6 mutants in the Shaker K
+
 
channel described by Swartz and co-workers (Hackos et al., 2002).  Whether the basal 
activation of the Q1-E3 complex is due to a sub-conducting leaky closed state, a 
perturbed closed to open equilibrium, or a supplantation of an obliterated cytoplasmic 
gate by an alternative voltage-activated gating mechanism is yet to be determined.  This 
perspective of channel gating provides a rationalization of the E1/E3 chimera data where 
a single point mutation (Melman et al., 2002a; Melman et al., 2002b) can essentially 
convert E1 into E3 by inducing basal activation by one of the aforementioned gating 
mechanisms. 
Our discovery of C-terminal E3 mutants that are assembly compromised brings 
up an important issue that has not been directly addressed in the KCNE literature.  
Several elegant studies have shown significant electrophysiological changes when KCNE 
peptides are co-expressed with many types of voltage-gated K
+
 channels; however, the 
percent of functioning K
+
 channels assembled with KCNE peptides at the cell surface 
was never directly determined.  While we could show that the C-terminal E3 mutants 
were ―assembly-challenged‖ using RNA ratio titration experiments in combination with 
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chromanol 293B pharmacology, we could not accurately determine the fraction of 
unpartnered Q1 channels at the cell surface.  The development of new methods that 
directly determine the ratio of partnered and unpartnered K
+
 channels functioning at the 
plasma membrane would be of great value in structure/function studies of K
+ 
channel-
KCNE complexes and may help corroborate the physiological relevance of many of these 
newly identified complexes. 
 
MATERIALS AND METHODS 
 Mutagenesis and cRNA preparation - KCNQ1 and KCNE3 were subcloned into 
vectors containing the 5’ and 3’ UTRs from the Xenopus -globin gene for optimal 
protein expression.  KCNE3 mutations were introduced using Quikchange (Stratagene) 
and confirmed by DNA sequencing.  The HA-tag, PYDVPDYA, was incorporated into 
the N-terminus of E3 between residues 11 and 12 (Abbott et al., 2001).  Plasmids were 
linearized with MluI, and RNA synthesized by run-off transcription using SP6 
(Promega). 
 
 Oocyte preparation and cRNA injection - Mature oocytes were surgically 
extracted from anesthetized Xenopus laevis.  Isolated oocytes were mechanically 
separated and bathed in OR2 (mM):  82.5 NaCl, 2.5 KCl, 1 MgCl2, 5 HEPES, pH 7.4 + 2 
mg/ml collagenase (Worthington Biochemical Corp.) for 85-95 minutes to remove 
ovarian material and follicles.  After rinsing, oocytes were incubated overnight at 18
 ˚C in 
ND96-bathing (ND96B) solution + gentamicin (mM): 96 NaCl, 2 KCl, 1.8 CaCl2, 1 
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MgCl2, 5 HEPES, 50 g/ml gentamicin (Sigma), pH 7.4.  Oocytes were microinjected 
with RNA 12-50 hours after extraction with 27.6 nl total volume of cRNA solution.  
Oocytes were injected with (ng/oocyte):  Q1, 15; Q1/E3, 7.5/3.5; Q1/E3 truncation, 5/3.5; 
Q1/KCNE DN mutant, 7.5/18.5.  For experiments in which E3 cRNA injection ratios 
were compared, Q1 was kept constant at 7.5 ng/oocyte, while the quantity of E3 was 
varied, 18.5, 3.0, 0.7, and 0.4 ng/oocyte.  Likewise, in experiments utilizing HA-tagged 
E3 constructs, Q1 was kept constant at 7.5 ng/oocyte, and was co-injected with E3 (3.0 or 
0.4 ng/oocyte).  In controls where only Q1 or E3 was injected, an equivalent volume of 
DEPC water was also injected.  Injected oocytes were incubated at 18 ˚C in ND96B for 2 
– 7 days before conducting experiments. 
 
 Electrophysiology - Currents were measured using two-electrode voltage clamp 
(OC-725-C, Warner Instrument Corp.) and data acquired with Digidata 1322A (Axon 
Instruments) running Clampex 8.2 (Axon Instruments) at RT.  Electrodes were filled with 
3M KCl, 5 mM EGTA, 10 mM HEPES, pH 7.6, and had resistance between 0.2 – 1.5 
M.  A home-made gravity-fed perfusion chamber was used, in which complete solution 
exchange occurred within ~ 10 s. 
Q1-E3 channels are open at negative membrane potentials, and thus several steps 
were taken to ensure that the currents measured are from K
+
 selective currents and not 
from non-specific leak.  Oocytes injected with wild type (WT) and mutant E3 cRNA 
were only recorded from if the resting membrane potential was more negative than – 75 
mV in ND96 since oocytes with more positive resting potentials routinely had non-
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specific leak and/or were dead.  ND96 (mM): 96 NaCl, 2 KCl, 0.3 CaCl2, 1 MgCl2, 5 
HEPES, pH 7.0.  For experiments utilizing solutions with K
+
 concentrations greater than 
ND96, the current at – 80 mV was measured in ND96 before and after each experiment.  
Data was only included if current at – 80 mV returned to the original level in ND96 after 
treatment with high K
+
 solution.  The majority of the E3 mutants had positive current at – 
80 mV due to outward ―leak‖ of potassium, presumably through the Q1-E3 channels.  For 
Q1, the leak current at – 80 mV was between – 0.01 and – 0.04 A in ND96.  All traces 
shown were not leak subtracted. 
Tail currents for activation curves were measured in KD98 (mM): 98 KCl, 0.3 
CaCl2, 1 MgCl2, 5 HEPES, pH 7.0.  Upon switching the external solution to KD98, 
oocytes were held at – 80 mV until the inward current plateaued.  The tail current 
protocol was a series of command pulses to potentials between – 100 and + 60 mV in 10 
mV increments for 2 s, after which oocytes were returned to – 80 mV.  The interpulse 
interval was 13 s. 
Reversal potentials were measured at several external potassium concentrations, 
each isotonically balanced with sodium.  The reversal potential protocol was a holding 
potential of – 80 mV, depolarizing to + 40 mV for 2 s, followed by repolarization to 
potentials around the Nernst-predicted value of EK in 2 mV steps to determine the 
reversal potential. 
Chromanol 293B inhibition was measured in ND96C (mM): 96 NaCl, 2 KCl, 1.8 
CaCl2, 1 MgCl2, 5 HEPES, pH 7.4.  Chromanol 293B (Tocris) was added to ND96C from 
a 10 mM stock in DMSO.  The final concentration of DMSO in ND96C was 0.1%.  
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Oocytes were held at – 80 mV and subjected to + 40 mV depolarizations for 2 s every 30 
s until the current level stabilized (≤ 5 min).  After the current stabilized, 10 M 
Chromanol 293B was perfused until inhibition was complete (~ 5 min), and the 
remaining current was measured.  
Oocytes expressing complexes with HA-tagged E3 proteins became appreciably 
inactivated during incubation at 18 
o
C in ND96B.  Cumulative inactivation was removed 
by holding at – 80 mV in ND96 with periodic test depolarization to + 40 mV to monitor 
relief of inactivation.  After relieving inactivation, oocytes were subjected to a family of 
depolarizations from – 100 to + 40 mV in 20 mV steps with a 13 s interpulse interval.  
Cumulative inactivation was monitored utilizing a 2 s test depolarization from – 80 to + 
40 mV at 30 s intervals.  At first, isochronal current measurements were taken 100 ms 
before the respective capacitive transients at – 80 and + 40 mV in ND96 solution.  Then, 
the bath solution was changed to KD98, and the current was then measured until there 
was no change in current between test depolarizations.  A family of currents was then 
measured in KD98 using the same depolarization protocol used with ND96.  Recovery 
from cumulative inactivation was monitored by returning the bath solution to ND96 and 
measuring the current at – 80 mV and + 40 mV as described above. 
To detect the voltage-dependent inactivation of homotetrameric Q1 channels with 
the HA-tagged E3 constructs, the oocytes were held at – 40 mV and in bathed RD10 
solution, which minimized cumulative inactivation, yet enabled the visualization of 
inward currents (mM): 88 NaCl, 10 RbCl, 0.3 CaCl2, 1 MgCl2, 5 HEPES, pH 7.4).  The 
pulse protocol used a holding potential of – 40 mV, a 2 s test pulse between – 100 and + 
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60 in 20 mV increments, followed by a tail pulse to – 80 mV for 1.5 s.  The interpulse 
interval was 11.5 s. 
 
Data Analysis - The amplitude of the tail currents were measured 3 ms after 
return to – 80 mV and plotted versus the depolarized potential.  The resultant activation 
curves were initially fit to a Boltzmann function, y = A2 + (A1-A2)/(1+e
(V-V½
 
)*(-zF/RT)
), 
where V½ is the midpoint of activation and z is the maximum slope.  The upper and lower 
asymptotes, A1 and A2, respectively, were left to vary, allowing data to be fit in cases 
where channels did not fully close or were not fully activated in the voltage ranges that 
can be used with oocytes (-100 to +60 mV).  After the initial fit, the tail current 
amplitudes were normalized such that the upper asymptote (A1) was equal to 1.  These 
data were refit to the Boltzmann function, and the lower asymptote (A2) of the second fit 
was used to compare basal activation of the wild type and mutant Q1-E3 complexes.  
Deactivation time constants were measured by fitting the current at – 80 mV following a 
(40 – 60 mV) depolarization to a single or double exponential.  Time constants of 
deactivation were not determined in samples where recovery from inactivation obscured 
the fast component of deactivation. 
 
Oocyte membrane preparation - 3 – 5 days after injection with 7.5 ng Q1 and E3 
(3.0 or 0.4 ng cRNA/oocyte), several oocytes were checked for functional K
+
 conducting 
complexes and each batch of oocytes was homogenized at 4 
o
C in 0.9 ml homogenization 
buffer, 100 mM HEPES, pH 7.6, 1 mM EDTA, 50 mM DTT, and 100 g/ml PMSF.  
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Subsequent steps were performed 4 
o
C.  The cell debris from the homogenate was 
pelleted (3000g, 10 min), and the supernatant was collected.  The pellet was vigorously 
resuspended in homogenization buffer (0.9 ml) and cell debris was pelleted again (3000g, 
10 min).  The supernatants were combined and overlaid on a 15% sucrose cushion, 
prepared with 100 mM HEPES, pH 7.6, and 10 mM N-ethyl maleimide.  Samples were 
subjected to ultracentrifugation (175,000g, 75 min) and pelleted membranes were 
detergent solubilized at RT in:  1% SDS, 150 mM NaCl, 100 mM DTT, 10 mM TRIS-
HCl pH 7.5.  Since a proportionally smaller volume of solubilization buffer was used for 
oocytes injected with 0.4 ng of mutant E3 cRNA, these membranes were solubilized with 
5% SDS to aid in solubilization. 
 
SDS-PAGE and Western - SDS solubilized membranes were diluted with 1/5 
volume of 6x SDS-PAGE loading buffer and the proteins were separated on either a 15% 
SDS-PAGE (TRIS/glycine) or 16.5% (TRIS/tricine) (Schagger & von Jagow, 1987).  
Proteins were transferred to nitrocellulose (0.2 m pore size) at constant amperage (0.2 – 
0.3 A) for 1 hr.  Blots were blocked for 45 min at RT in blocking buffer (5% non-fat milk 
in western wash (150 mM NaCl, 10 mM TRIS-HCl, pH 7.4, and 0.2% Tween-20)).  The 
blots were incubated overnight at 4 
o
C with 100 ng/ml rat monoclonal -HA (Roche) in 
blocking buffer.  Blots were washed in western wash (3 x 5 min) and incubated for 45 
min at RT with 200 ng/ml goat -rat HRP (Santa Cruz) in blocking buffer.   After 
washing (3 x 5 min) in western wash, the blot was developed in SuperSignal West Dura 
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Extended Duration Substrate (Pierce) for 5 min and the immunoreactive bands were 
captured using a Fujifilm LAS-3000 CCD Camera. 
 
PNGase F and Endo H analysis - SDS solubilized membranes as described 
above were diluted to 0.5% SDS with an equal volume of water, then raised to 1% NP40 
and 50 mM sodium citrate, pH 5.5, or 50 mM sodium phosphate, pH 7.5, and digested 
with Endo Hf or PNGase F (New England Biolabs), respectively, at 37 
o
C for 1 hr.  After 
digestion, samples were raised to a total of 75 mM DTT and 3.5% SDS, then mixed with 
6x gel loading buffer and the proteins were resolved on SDS-PAGE and analyzed by 
western blot as described before. 
 
Cell Surface Labeling and Luminometry - The level of cell surface HA-tagged 
E3 proteins were measured by luminometry as reported (Zerangue et al., 1999).  Oocytes 
were injected with 7.5 ng Q1 and WT or mutant E3-HA (3.0 or 0.4 ng).  Control oocytes 
were injected with only 7.5 ng Q1 cRNA.  On day 5 post injection, a few oocytes were 
checked for functioning channel complexes, and then the oocytes were cooled to 4 
o
C in 
ND96B to prevent further trafficking.  Oocytes were blocked for 30 min with 1% BSA in 
ND96B.  Oocytes were then incubated for 1 hr with 1 g/ml Rat monoclonal -HA 
(Roche) in 1% BSA in ND96B .  Oocytes were washed (8 x 5 min) with 1% BSA in 
ND96B and incubated for 40 min with secondary -rat F(ab)2 antibody (Jackson 
ImmunoResearch) added at 2 g/ml in 1% BSA in ND96.  Secondary antibody was 
removed and washed once with 1% BSA ND96 for 1 hr followed by a second wash in 
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ND96B for 1 hr.  Oocytes were individually placed in wells with 50 l of ND96B 
solution, mixed with 50 l of SuperSignal ELISA Femto Maximum Sensitivity Substrate 
(Pierce) and the signal at 405 nm was integrated for 15 s using a Mediators PhL 
Luminometer (Aureon Biosystems).  Data is given in relative light units, RLU, and 
comes from the same batch of oocytes. 
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CHAPTER III 
SECONDARY STRUCTURE OF A KCNE CYTOPLASMIC DOMAIN 
 
ABSTRACT 
Type I transmembrane KCNE peptides contain a conserved C-terminal 
cytoplasmic domain that abuts the transmembrane segment.  In KCNE1, this region is 
required for modulation of KCNQ1 K
+
 channels to afford the slowly activating cardiac 
IKs current.  We utilized alanine/leucine-scanning to determine whether this region 
possesses any secondary structure and to identify the KCNE1 residues that face the 
KCNQ1 channel complex.  Helical periodicity analysis of the mutation-induced 
perturbations in voltage-activation and deactivation kinetics of KCNQ1-KCNE1 
complexes defined the KCNE1 C-terminus is -helical when split in half at a conserved 
proline residue.  This helical rendering assigns all known Long QT mutations in the 
KCNE1 C-terminal domain as protein-facing.  The identification of a secondary structure 
within the KCNE1 C-terminal domain provides a structural scaffold to map protein-
protein interactions with the pore-forming KCNQ1 subunit as well as the cytoplasmic 
regulatory proteins anchored to KCNQ1-KCNE complexes. 
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INTRODUCTION 
KCNE type I transmembrane peptides are a class of membrane-embedded -
subunits that assemble with and modulate the function of voltage-gated K
+
 channels 
(McCrossan & Abbott, 2004).  The physiological importance of these small (~ 100 – 150 
aa) -subunits on K+ channel function is underscored by the genetic mutations in KCNE1 
(E1) and KCNE2 (E2) that cause abnormalities in the cardiac rhythm (Splawski et al., 
2000).  Outside of the heart, mutations in E1 also cause endolymphatic collapse in the 
developing ear and a C-terminal mutation in KCNE3 (E3) has been implicated in periodic 
paralysis since it alters Kv3.4 channel function (Letts et al., 2000; Abbott et al., 2001).  
All five KCNE peptides have been shown to assemble with and differentially modulate 
KCNQ1 (Q1) K
+
 channels (McCrossan & Abbott, 2004).  Q1-E1 complexes produce the 
slowly activating and deactivating cardiac IKs current whereas Q1 assembly with either 
E2 or E3 gives rise to constitutively conducting complexes that rapidly activate and 
deactivate.  Complexes with E4 and E5 slow the activation kinetics of Q1 channels 
similarly to E1; however, co-assembly with these recently discovered KCNEs results in 
K
+
 channel complexes that conduct only at extremely depolarizing potentials.  Q1-KCNE 
complex gating is also modulated by several intracellular proteins.  Calmodulin, PKA, 
protein phosphatase I (PP1), and A-kinase anchoring proteins (AKAPs) are all 
cytoplasmic proteins that interact with membrane-embedded Q1-KCNE complexes 
(Marx et al., 2002; Kurokawa et al., 2003; Shamgar et al., 2006). 
Although KCNE peptides modulate Q1 function differently, 4 KCNE peptides 
share a conserved cytoplasmic sequence (~ 20 aa) that is adjacent to the transmembrane 
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domain.  Function-structure studies with E1 have shown that this domain is required for 
Q1 channel modulation (Takumi et al., 1991; Tapper & George, 2000).  Moreover, one-
third of the known genetic missense point mutations in E1 that cause Long QT syndrome 
reside in this cytoplasmic region (Splawski et al., 2000; Schulze-Bahr et al., 2001; Ma et 
al., 2003; Lai et al., 2005; Napolitano et al., 2005).  Therefore, we utilized perturbation 
mutagenesis to determine whether this cytoplasmic domain possesses any secondary 
structure and to identify residues that face the Q1 channel complex.  Alanine and 
tryptophan scanning have been previously used to examine the secondary structure and 
protein-facing residues of both water-exposed and membrane-embedded domains of 
voltage-gated K
+
 channels (Monks et al., 1999; Hong & Miller, 2000; Li-Smerin et al., 
2000a, 2000b).  Using alanine and leucine mutagenesis, we observed two distinct classes 
of E1 mutants:  those that strongly shift the voltage-dependence of activation favoring the 
closed state, and those that resemble the wild type complex.  Periodicity analysis of our 
results revealed that the cytoplasmic C-terminal domain of E1 is helical when broken into 
two segments separated by a proline residue.  This suggests that either the E1 C-terminus 
is a kinked -helix, or the helix experiences two different protein environments above 
and below this junction point.  Moreover, this helical projection defines 4 out of 4 
dysfunctional mutations that cause Long QT syndrome as facing the Q1 channel 
complex.  Given that this C-terminal domain is conserved in all but one of the known 
KCNE peptides, our E1 results predict that E2, E3 and E5 will possess a domain with 
similar structure when associated with Q1 channel subunits.  In total, these results 
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provide a structural motif from which to interpret the link between Q1-KCNE gating and 
intracellular regulation. 
 
RESULTS 
 The C-terminal sequence that abuts the predicted transmembrane domain of E1 
has been shown to be vital for Q1 modulation (Tapper & George, 2000), which suggests 
that a protein-protein interaction exists between Q1 and E1 in this region.  To identify the 
C-terminal residues of KCNE peptides that face the Q1 channel complex and to 
determine whether this region possesses any secondary structure, we individually 
mutated each residue in E1 to alanine, expressed these mutants with Q1 channels in 
Xenopus oocytes, and measured the changes in Q1-E1 complex gating using TEVC.  For 
native alanine residues, leucine was used to induce a perturbation; for native serine 
residues, both alanine and leucine mutants were examined. 
Of the 19 E1 C-terminal residues examined, only one mutant, D76A, did not 
express current.  This was expected given that the Long QT mutation (D76N) and the 
equivalent mutation in rat affords a non-functional Q1 channel complex  (Wang & 
Goldstein, 1995; Splawski et al., 1997; Bianchi et al., 1999).  Currents elicited from 
voltage depolarizations of wild type (WT) and representative mutant Q1-E1 complexes in 
high external K
+
 are shown in Figure 3-1A.  To compare the voltage-gating of the WT 
and mutant Q1-E1 complexes, we generated activation curves by measuring the tail 
current after repolarization and plotted it versus the depolarization potential.  Standard 
tail-current analysis requires that the channel reaches equilibrium between the open and  
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Figure 3-1.  KCNE1 alanine mutants show diverse gating properties.  A, two-electrode 
voltage clamp recordings of wild type, H73A, and E83A mutant channels expressed in 
Xenopus oocytes.  Currents were recorded in KD98 solution.  Dotted line indicates zero 
current.  Scale bars represent 1 A and 0.5 s.  Inset, protocol of 4 s depolarizations from 
– 80 mV to 60 mV at 10 mV increments used to elicit currents shown.  B, voltage 
activation curves for wild type and representative mutant channel complexes calculated 
from tail current analysis.  Solid curves represent Boltzmann fits to the data.  Data was 
averaged from 5 – 10 oocytes each ± S.E.M. 
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closed states before repolarization; however, Q1-E1 complexes do not reach equilibrium 
even after 90-second depolarizations (Takumi et al., 1988), which necessitated an 
isochronal (4 s) tail current measurement.  Normalized tail currents were plotted against 
depolarization potentials and the resultant activation curves (Figure 3-1B) were fit to a 
Boltzmann equation.  From the Boltzmann fit, the voltage of half maximal activation 
(V1/2) and slope factor (z) were determined for WT and each mutant Q1-E1 complex 
(Table 3-1).  These parameters were used to calculate the isochronal free energy of Q1-
E1 complex opening at zero voltage (Giso), and for each mutant, Giso was also 
determined (Giso
mutant
 –Giso
WT
).  As in previous perturbation studies (Monks et al., 
1999; Hong & Miller, 2000; Li-Smerin et al., 2000a, 2000b), we defined residues with a 
|Giso| > 1 kcal/mol as high impact.  Using this arbitrarily defined cut-off, 9 mutants 
scored as high impact, all of which resulted in stabilization of the closed state and 
acceleration of the deactivation kinetics when compared to WT.  For the native serine 
residues, where alanine and leucine substitutions were individually examined, both S68A 
and S68L were defined as high impact, only S74L scored as high impact, and both S84 
mutants were low impact. 
 To determine whether there was a periodicity of high and low impact mutants, the 
C-terminal residues were plotted on a helical wheel (Figure 3-2, center).  An -helical 
pattern was not immediately apparent by simple visual inspection, nor by Fourier 
periodicity analysis (vide infra).  While plotting our data on a helical wheel diagram, we 
initially observed a helical pattern for the bottom half of the region that abruptly 
disappeared conspicuously after a proline residue.  Proline disruption of helical segments 
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Table 3-1.  Electrophysiological Properties of KCNE1 Mutants
a
 
Construct 
 
V½ (mV) 
 
z 
 
 
G
 

G
 
deactivation 
(ms) 
 
E1 31.3 ± 1.1 1.56 ± 0.03 1.02 ± 0.05 -- 665 ± 80 
      
S68A 60.0 ± 1.2 2.20 ± 0.06 3.04 ± 0.09 2.02 ± 0.10 131 ± 5 
      
S68L 51.8 ± 1.6 1.90 ± 0.13 2.26 ± 0.15 1.24 ± 0.16 139 ± 7 
      
S68D 43.6 ± 1.0 1.90 ± 0.07 1.91 ± 0.08 0.89 ± 0.09 156 ± 6 
      
S68E 44.8 ± 1.0 2.05 ± 0.12 2.11 ± 0.09 1.09 ± 0.10 145 ±14 
      
K69A 28.1 ± 1.6 1.84 ± 0.03 1.19 ± 0.06 0.17 ± 0.08 350 ± 28 
      
K70A 56.1 ± 0.6 2.24 ± 0.06 2.90 ± 0.09 1.88 ± 0.10 105 ± 4 
      
K70Q 54.5 ± 0.8 2.04 ± 0.08 2.27 ± 0.08 1.25 ± 0.09 132 ± 3 
      
L71A 42.6 ± 2.6 2.04 ± 0.08 2.02 ± 0.18 1.00 ± 0.19 256 ± 16 
      
E72A 43.0 ± 0.8 1.90 ± 0.02 1.88 ± 0.03 0.86 ± 0.06 362 ± 18 
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H73A 52.3 ± 3.2 2.03 ± 0.02 2.40 ± 0.10 1.38 ± 0.11 176 ± 3 
      
S74A 34.1 ± 0.9 1.61 ± 0.03 1.27 ± 0.04 0.25 ± 0.06 496 ± 32 
      
S74L 53.4 ± 1.5 1.94 ± 0.09 2.37 ± 0.09 1.35 ± 0.10 200 ± 12 
      
S74I 44.4 ± 1.4 2.17 ± 0.03 2.22 ± 0.08 1.20 ± 0.09 189 ± 10 
      
S74M 30.3 ± 2.1 1.90 ± 0.03 1.35 ± 0.11 0.33 ± 0.12 255 ± 22 
      
N75A 27.9 ± 1.5 1.65 ± 0.02 1.06 ± 0.06 0.04 ± 0.08 644 ± 42 
      
D76A NF NF NF NF NF 
      
P77G ND ND ND ND ND 
      
P77A 38.4 ± 2.7 1.65 ± 0.05 1.41 ± 0.08 0.39 ± 0.09 406 ± 9 
      
P77L 39.5 ± 1.7 1.52 ± 0.08 1.38 ± 0.04 0.36 ± 0.06 381 ± 19 
      
F78A 69.5 ± 6.4 1.50 ± 0.10 2.14 ± 0.12 1.12 ± 0.13 161 ± 14 
      
N79A 45.6 ± 0.9 2.12 ± 0.04 1.98 ± 0.07 0.96 ± 0.09 179 ± 4 
      
V80A 43.7 ± 1.3  1.55 ± 0.02 1.39 ± 0.04 0.37 ± 0.06 258 ± 13 
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Y81A 74.7 ± 1.0 1.85 ± 0.02 2.88 ± 0.15 1.86 ± 0.16 112 ± 3 
      
I82A 59.4 ± 1.2 2.20 ± 0.03 2.67 ± 0.04 1.65 ± 0.06 145 ± 5 
      
E83A 34.6 ± 0.8 1.34 ± 0.02 1.06 ± 0.02 0.04 ± 0.05  630 ± 50 
      
S84A 44.6 ± 1.2 1.90 ± 0.06 1.95 ± 0.05 0.93 ± 0.05 317 ± 16 
      
S84L 37.5 ± 4.2 1.13 ± 0.03 0.97 ± 0.09 -0.05 ± 0.10 449 ± 52 
      
D85A 48.0 ± 2.5 1.98 ± 0.04 2.18 ± 0.13 1.16 ± 0.14 297 ± 20 
      
A86L 24.8 ± 0.8 1.61 ± 0.03 0.92 ± 0.03 -0.10 ± 0.06 874 ± 57 
a
 Data from individual activation curves and deactivation time constants in KD98, obtained from 
4–12 oocytes.  Activation curves were fit to a Boltzmann function as described in Materials and 
Methods.  V½ is the voltage of half-maximal activation and z is the slope factor.  Time constants 
of deactivation were fit to a single exponential as described in the Materials and Methods.  
Values are mean ± S.E.M.    NF, non-functional mutant, ND, no current detected. 
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Figure 3-2.  Periodicity of gating perturbations in the KCNE1 C-terminal domain.  
Center, helical wheel diagram of the 19 C-terminal E1 residues examined.  Red circles 
indicate residues with Giso > 1 kcal/mol, blue circles indicate Giso ≤ 1 kcal/mol.  
Power spectrum analysis indicates a peak angle of 125° and -PI of 1.77 for the entire C-
terminal segment. 
When residues above and below P77 are plotted on separate helical wheels (Left and 
Right), high impact residues (red) and low impact residues (blue) segregate to separate 
faces of each helical diagram.  Each high impact face is denoted by a red line. S68A is a 
high impact residue on the low impact face (filled blue with red outline).  D76A is a non-
functional mutant at the plasma membrane, as determined by cell surface luminometry 
(red fill).  
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has been previously detected in transmembrane segments of two voltage-gated K
+
 
channels by perturbation mutagenesis (Hong & Miller, 2000; Li-Smerin et al., 2000a).  
Therefore, we plotted amino acids above and below the proline on two separate helical 
diagrams.  The residues on the bottom helical wheel (Figure 3-2, right) segregated into 
two distinct faces.  Clustering of the high and low impact residues was also observed for 
the top helical diagram (Figure 3-2, left); however, there were two high impact serines 
(S68 and S74) and the non-functional mutant (D76A) that warranted further experimental 
investigation. 
 S68A is a noticeable outlier in the top helical wheel landing in the low impact 
face.  Sequence analysis indicates that S68 is within a putative protein kinase C (PKC) 
consensus sequence, suggesting that this serine may be phosphorylated.  Since the 
premise of perturbation mutagenesis is that alterations in side chain volume lead to 
disruption of protein-protein interactions and thus channel function, we wondered 
whether S68A scored as high impact due to the inability to posttranslationally place a 
negative charge at this position, and not due to a change in side chain volume.  To test 
this hypothesis, we mutated S68 to aspartic and glutamic acid:  two commonly used 
imperfect isosteres of phoshorylated serine.  Figure 3-3A shows the current-voltage 
relationships of the S68A, D, and E mutants.  Activation curves (Figure 3-3B) show that 
substitution with either aspartic or glutamic acid had less of an effect (Giso ~ 1 
kcal/mol) than the alanine mutant (Giso  ~ 2 kcal/mol).  If S68 is phosphorylated by 
PKC, mutation of the surrounding consensus sequence should also have a similar effect 
on Q1-E1 complex function.  Substituting K70 with glutamine is predicted by oriented  
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Figure 3-3. Negatively charged side chains produce smaller perturbations than alanine at 
position S68.  A, TEVC recordings of S68A and S68D channels expressed in Xenopus 
oocytes. Currents were recorded in KD98 solution.  Dotted line indicates zero current.  
Scale bars represent 1 A and 0.5 s.   Inset, protocol of 4 s depolarizations from – 80 mV 
to 60 mV at 10 mV increments used to elicit currents shown.  B, voltage activation curves 
for S68A, S68D and S68E mutant channels calculated from tail current analysis.  Solid 
curves represent Boltzmann fits to the data.  Dashed line indicates Boltzmann fit of WT 
activation curve.  Data was averaged from 8 – 10 oocytes each ± S.E.M.  
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peptide libraries to disrupt the PKC consensus sequence (Nishikawa et al., 1997), yet this 
polar residue produces a nominal change in side chain volume.  Like S68A, the K70Q 
mutant shifts the voltage-dependence of activation of the Q1-E1 complex in favor of the 
closed state (Table 3-1). 
Of the native serines in the E1 C-terminal region, S74 was unique in that the 
alanine mutant was defined as low impact whereas the leucine mutant was high impact.  
Upon breaking the region in two halves, S74 was positioned at the high/low impact 
interface of the helical wheel (Figure 3-2, left).  We hypothesized that if S74 was at the 
water-protein interface, side chains with a higher degree of rotational freedom could 
utilize the adjacent aqueous environment to adopt a conformation that would maintain 
productive protein-protein interactions without steric clashes whereas the more rigid, 
branched side-chains could not.  Conveniently, leucine, isoleucine and methionine have 
approximately the same Van der Waals volume (Creighton, 1992), yet their flexibility 
and the 3-dimensional space that they occupy is significantly different.  Figure 3-4 shows 
that mutating E1 S74 to the straight-chain methionine afforded a Q1-complex similar to 
WT whereas mutation to the -branched isoleucine resulted in a Q1-E1 complex similar 
to leucine, which was defined as high impact (Table 3-1). 
D76A was the only alanine mutation that did not express measurable current 
when co-injected with Q1 mRNA.  There are two possibilities to explain the negligible 
current observed with this mutation:  (1) the Q1-D76A complex is non-functional.  (2)  
The Q1-D76A complex cannot reach the plasma membrane.  To discern between these  
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Figure 3-4.  Branched amino acids cause larger perturbations at position S74.  A, TEVC 
recordings of S74L, S74M and S74I channels expressed in Xenopus oocytes. Currents 
were recorded in KD98 solution.  Dashed line indicates zero current.  Scale bars represent 
1 A and 0.5 s.   Inset, protocol of 4 s depolarizations from – 80 mV to 60 mV at 10 mV 
increments used to elicit currents shown.  B, voltage activation curves for S74 mutant 
channels calculated from tail current analysis.  Solid curves represent Boltzmann fits to 
the data.  Dashed line indicates Boltzmann fit of WT activation curve.  Data was 
averaged from 6 – 10 oocytes each ± S.E.M.  
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two, we used whole oocyte cell surface luminometry to determine whether an 
extracellularly HA-tagged version of D76A could reach the plasma membrane.  Figure 3-
5A shows that D76A protein is present at the plasma membrane similarly to WT and the 
Long QT causing mutant D76N, which has also been shown to be non-functional at the 
cell surface (Wang & Goldstein, 1995; Gage & Kobertz, 2004).  Since the Q1-D76A 
complex is at the plasma membrane but not conducting, this mutant was scored as a high 
impact residue. 
Splitting the E1 C-terminal region into two domains was based on our observation 
that the periodicity of high and low impact mutants shifted at P77, suggesting a kink or 
turn at this position.  To experimentally test whether the presence of a helix breaking 
residue at this position was required for proper Q1-E1 complex function, we mutated this 
proline to amino acids that are known to either induce flexibility or maintain -helicity.  
Both alanine and leucine are often found in helical regions and are considered helix-
inducing (Rohl et al., 1996).  Substitution of either of these residues at position 77 
produced Q1-complexes similar to WT (Table 3-1).  Exchanging the proline for the 
highly flexible glycine residue did not afford currents above uninjected controls. 
The lack of an obvious trend with this mutagenic discourse prompted us to use 
Fourier transform periodicity analysis to determine the amount of helicity in each 
segment and the location of the helical phase change.  This non-biased analysis has been 
used to define the helical segments within an entire voltage-sensing domain of a 
mammalian K
+
 channel (Li-Smerin et al., 2000a).  Determining the periodicity of a 
region using a power spectrum requires a Giso value for every residue.  To satisfy this 
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Figure 3-5.  The transmembrane-abutting C-terminal domain is comprised of two helical 
regions.  A, whole oocyte luminometry was used to quantify the surface expression of 
HA-tagged E1 peptides (E1, D76N, D76A) and uninjected controls (UN).  Luminescence 
is reported in relative light units (RLU).  Error bars represent standard error measurement 
(s.e.m.) from 10 – 20 oocytes.  B, periodicity analysis of the top (K69–D76) and bottom 
(P77–A86) segments of the E1 C-terminal domain.  P() is plotted as a function of 
angular frequency () to generate a power spectrum of the Giso values for each 
segment.  A value of 1 kcal/mol was assigned for the non-functional D76A mutant.  The 
primary peak occurs at 114° for the top segment and 112° for the bottom.  C, a cartoon of 
the cytoplasmic E1 C-terminal domain split into two helical regions by a kink or turn.  D, 
changes in deactivation rates mirror isochronal G measurements for the E1 C-terminal 
domain mutants.  Double bar graph comparing Giso and deactivation rates (d) for the 
E1 C-terminal alanine and leucine mutants.  Solid bars indicate Giso, open bars 
d
WT
/d
mutant
.  The dashed denotes the cut-off values for Giso and d
WT
/d
mutant
.
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requirement, we excluded D76A since it was non functional and S68A given the 
uncertainty of the native state of this side chain in the functioning Q1-E1 complex.  
Figure 3-5B shows the power spectra for K69 – N75 and P77 – A86 when the E1 C-
terminal region is broken into two halves at P77.  Both spectra show a peak angle within 
the boundaries of helicity (90˚ – 120˚) and with -periodicity index (-PI) greater than 2.  
These results are highly indicative of two helical domains (Figure 3-5C), as was observed 
using simple helical wheel models (Figure 3-2).  We then varied the position of the 
breakpoint to determine whether P77 was the ideal spot to divide the E1 C-terminal 
domain.  Since we cannot assign a Giso value for D76A, we used a placeholder value 
for D76 to maintain the helical trajectory of the K69 – N75 segment and asked whether 
this helical domain extended beyond this residue.  Propagation of the domain to include 
P77 and F78 resulted in sharp drop in -PI, indicating that residues past D76 should not 
be included in the top segment (Table 3-2).  For the bottom segment, the -PI increased 
as the analysis was extended to include the proline while the peak angle remained 
consistent for a helix.  However, inclusion of D76 using any high impact value greater 
than 1 kcal/mol decreased the -PI, indicating that this high impact residue was out of 
helical phase with the bottom segment.  Taken together, dividing the entire E1 C-terminal 
domain at any position other than P77 resulted in less helical character for either the top 
or the bottom segments. 
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DISCUSSION 
 We have used perturbation mutagenesis and helicity analysis to identify 
secondary structural elements in the conserved cytoplasmic region of the E1 -subunit.  
Previous perturbation studies have primarily relied on comparing the free energy of 
channel opening of mutant channels versus wild type (Monks et al., 1999; Hong & 
Miller, 2000; Li-Smerin et al., 2000a, 2000b).  To utilize this parameter for Q1-E1 
complexes, which do not reach equilibrium under standard-length test depolarizations, we 
measured isochronal Gs.  Although these values are not free energies, they allowed for 
a comparative analysis of the effect of mutations in E1 on Q1 function.  Half of the 
mutations studied in the E1 C-terminus gave | Giso | > 1 kcal/mol—an arbitrarily 
defined cut-off for a high impact residue, but an empirically supported definition (Monks 
et al., 1999; Hong & Miller, 2000; Li-Smerin et al., 2000a, 2000b).  Changes in 
deactivation kinetics have also been used to define high impact residues, though a 
specific cut-off value has not emerged from previous reports (Monks et al., 1999; Hong 
& Miller, 2000).  Graphing the deactivation kinetics of the E1 mutants reveals that a 3-
fold acceleration of channel closing rate mirrors the trend observed with isochronally 
measured Giso (Figure 3-5D).  Only one mutant, D76A, was refractory from this 
straightforward functional analysis since it did not generate measurable currents.  
However, cell surface labeling experiments show that this mutant is at the plasma 
membrane and is non-functional, and thus we can define it as high impact.  Although 
only two mutations (D76A and the Long QT causing D76N) have been examined at this  
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Table 3-2.  -helical Characteristics of C-terminal E1 Segments
b
 
Segment 
 
-PI 
 
Peak angle 
 
 
Segment 
 

-PI 
 
Peak angle 
      
K69 – N75 2.44 114° P77 – A86 2.69 112° 
      
K69 – P77 1.61 123° F78 – A86 2.53 109° 
      
K69 – F78 1.51 126° N79 – A86 2.20 111° 
      
b
 Data from power spectrum periodicity analysis of Giso for residues in each 
segment. Power spectra, -PI and peak angle values were calculated as 
described in Materials and Methods.  For the top segments that contain D76, a 
placeholder value of 1 kcal/mol was used, which maintains the helical trajectory of 
the K69 – N75 segment. 
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position, it is interesting that both substitutions render the Q1-E1 complex non-
functional, yet the complex traffics to the plasma membrane efficiently. 
Plotting the residues on a helical wheel resulted in no obvious clustering of high 
impact residues (Figure 3-2, center).  Periodicity analysis using a power spectrum 
confirmed that no helical pattern was present:  both the peak angle (125˚) and -PI (1.77) 
were inconsistent with the region being a continuous helix.  However, breaking the 
cytoplasmic region into two domains at a conserved proline (P77) segregated the high 
and low impact residues to distinct faces on helical wheels.  In addition, Fourier 
periodicity analysis indicate that both domains have significant helical character (Table 
3-2), which supports the arbitrarily defined 1 kcal/mol cut-off value used for the helical 
wheel diagrams (Figure 3-2).  Moreover, this depiction places all known Long QT 
mutants in this region on the high impact face.  Given that the mutants in the high impact 
face markedly shift the gating of Q1-E1 complexes, we predict that these residues 
directly interact with Q1.  This prediction is supported in high resolution detail with the 
crystal structures of voltage-gated K
+
 channels (Jiang et al., 2003a; Jiang et al., 2003b; 
Long et al., 2005a), which have verified that the high impact faces identified by previous 
perturbation studies are involved in protein-protein interactions within the voltage-
sensing domain. 
Although we observed a convincing pattern with helical wheel diagrams for the 
E1 C-terminal domain, S68A did not segregate to the high impact face, yet it had the 
highest Giso calculated.  S68 is within a putative PKC consensus sequence.  Disruption 
of the PKC site by mutation of the critical +2 basic residue (K70) to either glutamine or 
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alanine resulted in Q1-E1 complexes with right-shifted activation curves similar to S68A, 
which cannot be phosphorylated.  Although phosphorylation of E1 at this serine has not 
been observed experimentally, it has been detected in the homologous serine in E3 
(Abbott et al., 2006).  Substitution of S68 to either aspartic or glutamic acid, to mimic 
phosphoserine, showed that the more voluminous, but negatively charged side chains had 
less of an effect on Q1-E1 gating than the removal of hydroxyl group by alanine 
mutagenesis.  These preliminary data suggest that E1 may be phosphorylated at S68, but 
requires further biochemical support and verification in native tissues. 
Unlike S68 and S84, S74 was uniquely sensitive to changes in amino acid side 
chain volume in that only the bulkier S74L mutant scored as high impact.  Helical 
analysis revealed that this residue was at the edge of the high impact face, which 
prompted us to experimentally examine whether this was the case.  Isovoluminous 
substitution showed that branched amino acids (isoleucine, leucine) were less tolerated 
than the straight chain methionine side chain, which scored as a low impact residue using 
both criteria (Giso and d).  These results are consistent with the notion that S74 lies at 
the water-protein boundary since the flexible methionine side chain can adopt a 
productive protein-protein interaction between E1 and the Q1-channel complex while 
utilizing the adjacent aqueous environment without energetic penalty. 
Previous perturbation studies of voltage-gated K
+
 channels had identified a 
proline residue in the S3 helix that disrupted the helical pattern of this transmembrane 
domain (Hong & Miller, 2000; Li-Smerin et al., 2000a).  This functional analysis 
proposed that the S3 helix would be kinked at this proline residue, which was 
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subsequently confirmed by three high resolution crystal structures of voltage sensing 
domains (Jiang et al., 2003a; Jiang et al., 2003b; Long et al., 2005a).  Since our 
perturbation results afforded a strong helical pattern when the E1 C-terminal domain is 
divided in half at a proline residue, we hypothesized that P77 is inducing a kink or turn at 
this position.  We attempted to mimic this kink by mutation to the helix breaking residue, 
glycine, but were unable to measure any currents above background when this mutant 
was expressed with Q1.   To determine if the proline geometry was required for proper 
modulation of Q1 channels, we mutated P77 to alanine and leucine, two residues that 
have a high helix propensity (Rohl et al., 1996).  When these mutants were expressed 
with Q1 subunits, K
+
 currents and gating characteristics similar to wild type Q1-E1 
complexes were observed.  Identical results (with alanine and tryptophan) were also 
obtained for the helix kinking proline in the S3 segment of  K
+
 channel voltage sensors 
(Hong & Miller, 2000; Li-Smerin et al., 2000a), suggesting that detection of proline 
kinks using channel function and simple site-directed mutagenesis may not be possible.  
This conclusion is further supported by a systematic investigation of conserved proline 
residues in membrane proteins, which has shown that many protein-protein interfaces 
evolve ancillary interactions to stabilize kinked helices thus obviating the need for proline 
residues to maintain the bent geometry (Yohannan et al., 2004).   
Since mutagenesis could not elucidate whether a turn or kink was present at P77, 
we relied on power spectrum analysis to identify the location of the phase change in the 
E1 C-terminal domain.  Using this mathematical approach, breaking the domain at P77 
resulted in two segments with the greatest -PI and peak angles most consistent with 
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helices that are adjacent to transmembrane domains (Table 3-2).  This analysis indicates 
that the E1 C-terminal domain is helical with either a kink at P77 (Figure 3-5C) or the 
domain experiences a different protein environment above the proline residue, which may 
also be influenced by PKC phosphorylation.  Sequence similarity of this membrane-
abutting domain predicts that E2, E3 and E5 will possess a similar structural motif and 
protein environment when co-assembled with Q1 subunits. 
This conserved structural scaffold adds to the growing body of evidence that the 
E1 C-terminal domain is critical for Q1 channel modulation.  Initial E1 deletion studies 
showed that removal of the membrane-abutting cytoplasmic domain eliminates the 
hallmark slow activation/deactivation kinetics of the Q1-E1 complex (Tapper & George, 
2000).  In addition, a recent E3 deletion study also concluded that the E1 C-terminus was 
required for Q1 modulation, but not necessary for E3 modulation (Gage & Kobertz, 
2004).  Our alanine mutants also support this separation of KCNE modulation of Q1.  
Alanine mutants in E1 had significant effects on the voltage-dependence and deactivation 
kinetics of Q1-E1 complexes whereas the equivalent mutations in E3 had no measurable 
effect on the constitutively conducting Q1-E3 complex (unpublished results).  Similarly, 
tryptophan mutants in the E1 transmembrane domain—though structurally informative—
were consistently less perturbative on Q1-E1 complex function than C-terminal E1 
alanine mutants (SAN Goldstein, personal communication). 
 The cytoplasmic E1 C-terminal domain also provides a structural platform for 
potential interactions with tethered water soluble regulatory proteins.  Calmodulin was 
recently shown to bind to the Q1 C-terminus relatively close to the S6 transmembrane 
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segment and facilitates channel assembly and calcium sensitivity (Shamgar et al., 2006).  
Adjacent to the Q1 calmodulin binding site is a leucine zipper sequence that is required 
for yotiao, an A-kinase anchoring protein, to bind (Marx et al., 2002).  Anchoring of 
yotiao to the Q1 C-terminus targets cAMP-dependent protein kinase (PKA) and protein 
phosphatase 1 (PP1), which control the phosphorylation state of the Q1 N-terminus.  
Moreover, this PKA-mediated modulation can be disrupted by genetic mutations within 
the E1 cytoplasmic domain (Kurokawa et al., 2003).  Thus, the manifold nature of Q1-E1 
complex regulation suggests that high impact regions identified in the C-terminus of E1 
may be revealing protein-protein interactions not only with Q1 -subunits, but also with 
tethered cytoplasmic regulatory proteins.   
 
MATERIALS AND METHODS 
Mutagenesis and in vitro transcription - Human Q1 and E1 were subcloned into 
vectors containing the 5’ and 3’ UTRs from the Xenopus -globin gene for optimal 
protein expression.  Single point mutations were introduced into E1 using Quickchange 
site-directed mutagenesis (Strategene) and confirmed by DNA sequencing of the entire 
gene.  For all surface luminometry experiments, the hemagglutinin A (HA) tag, 
YPYDVPDYA, was incorporated into the N-terminus of E1 between residues 22 and 23 
(Wang & Goldstein, 1995).  The cDNA plasmids were linearized by MluI digestion, and 
cRNA synthesized by run-off transcription using SP6 or T7 RNA polymerase (Promega).   
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Electrophysiology - Oocytes were surgically removed from Xenopus laevis and 
defolliculated using 2 mg/mL collagenase (Worthington Biochemical Corp.) in OR2 
containing (mM): 82.5 NaCl, 2.5 KCl, 1 MgCl2, 5 HEPES, pH 7.4 for 75-90 min.  
Isolated oocytes were rinsed with and stored in ND96 bathing solution (ND96B) 
containing (mM): 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, 50 g/mL gentamicin 
(Sigma-Aldrich), pH 7.4 at 18°C.  Approximately 24 h after extraction, oocytes were 
microinjected with 27.6 nL total volume of cRNA containing Q1 (7.5 ng/oocyte) and E1 
(3.75 ng/oocyte).  After 3–6 days, currents were recorded using Warner Instrument (OC-
725) two-electrode voltage clamp (TEVC) and the data were acquired with Digidata 
1322A using pClamp 8 or 9 (Axon Instruments).  Electrodes were filled with 3 M KCl, 5 
mM EGTA, 10 mM HEPES, pH 7.6, and had resistance between 0.2 and 1.0 MFor 
each experiment, oocytes were held at – 80 mV in ND96 (in mM): 96 NaCl, 2 KCl, 0.3 
CaCl2, 1 MgCl2, 5 HEPES, pH 7.4, and pulsed to a command potential of 40 mV.  
Oocytes injected with Q1 and wild type or mutant E1 RNA were only recorded from if a 
4-s pulse to 40 mV produced current greater than 1 A to ensure that currents were 
coming from exogenously injected channel complexes.  Tail currents for activation 
curves were measured in KD98 (in mM): 98 KCl, 0.3 CaCl2, 1 MgCl2, 5 HEPES, pH 7.4.  
Oocytes were held at – 80 mV and the tail current protocol was a series of 4 s test pulses 
to potentials between – 100 and + 60 mV in 10 mV increments.   For severely right-
shifted mutants (F78A and Y81A), test pulses between – 100 and + 80 mV were used.  
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Data Analysis - The amplitude of tail currents was measured 6 ms after 
repolarization to – 80 mV and normalized such that the maximal current was equal to 1.  
Normalized tail currents were plotted versus the depolarized potential to produce 
activation curves for wild type and mutant E1 channel complexes.  Activation curves 
were fit to a Boltzmann function, I/Imax = A2 + (A1 – A2) / (1 + e
(V – V1/2)*(–zF/RT)
), where 
I/Imax is the normalized tail current amplitude,  V1/2 is the midpoint of activation, z is the 
maximum slope, F is Faraday’s constant, R is the gas constant and T is temperature in 
Kelvin. The upper and lower asymptotes, A1 and A2, were left to vary, allowing data to 
be fit since Q1-E1 complexes did not fully activate in the voltage ranges that can be used 
with oocytes (Gage & Kobertz, 2004).  The isochronal free energy of channel opening, 
Giso, was calculated for wild type (WT) and each mutant Q1-E1 complex using the 
equation Giso = zFV1/2.  For each mutant, Giso was calculated as Giso 
mutant – Giso 
WT
.  
The deactivation time constant (d) was measured by fitting the current at – 80 mV 
following a 40 mV depolarization to a single exponential.  
 
Periodicity Analysis - The periodicity of Giso was determined as previously 
reported by Swartz et al. using the following equation (Li-Smerin et al., 2000a): 
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where P() is the power spectrum as a function of angular frequency, , and was 
determined for E1 C-terminal segments of 7 to 10 residues where ‹V› is the average 
|Giso| for each segment, Vj is the Giso at position j, and n is the number of residues in 
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a segment.  Since -helices are defined as having 3.6 residues per turn, a peak angle at 
100° indicates an ideal -helix.  Transmembrane helices have shown peak angles shifted 
to higher frequencies, and since this membrane abutting C-terminal region is presumably 
an extension of the membrane spanning helix, we centered our analysis at 105°  (Rees et 
al., 1989; Li-Smerin et al., 2000a).  The -periodicity index (-PI) is the average value of 
P() in this helical range (90° – 120°) relative to the average value of P() over the 
entire power spectrum and is a quantitative assessment of helical character: 
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values for -PI greater than 2 are considered indicative of an -helix.  For mathematical 
analyses that necessitated the inclusion of the non-functional D76A mutant, a Giso 
value of 1 kcal/mole was used to maintain the -PI and peak angle calculated for the K69 
– N75 segment. 
 
Cell Surface Luminometry - The surface expression of HA-tagged E1 proteins 
was measured by luminometry (Zerangue et al., 1999).  Oocytes were injected with 7.5 
ng Q1 and 3.75 ng wild type (WT) or mutant E1-HA.  After 3-5 days, currents were 
recorded from a few oocytes expressing WT E1-HA complexes to ensure that functioning 
complexes were present at the cell surface.  ND96 containing 1% bovine serum albumin 
(BSA) was used to block and wash oocytes, as well as dilute antibodies.  Oocytes were 
cooled to 4°C, blocked for 30 min, and primary antibody (1 g/mL rat monoclonal -
HA, Roche) was applied for 1 h at 4°C.  Oocytes were washed (8 × 5 min), incubated for 
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40 min with secondary antibody (2 g/mL -rat F(ab)2, Jackson ImmunoResearch 
Laboratories), and washed again (5 × 10 min).  Oocytes were finally washed with ND96 
containing no BSA for 1 h at 4°C, individually placed in wells with 50 L of ND96 
solution and mixed with 50 L of the SuperSignal ELISA Femto Maximum Sensitivity 
Substrate (Pierce Chemical Co.).  The signal at 405 nm was integrated for 10 s after a 20 
s delay using a Veritas Microplate luminometer (Turner Biosystems).  Data is reported in 
relative light units, RLU. 
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CHAPTER IV 
THE INTRACELLULAR, JUXTAMEMBRANOUS DOMAIN OF KCNE1 
INTERACTS DIRECTLY WITH THE CYTOPLASMIC FACE OF THE KCNQ1 
PORE DOMAIN 
 
ABSTRACT 
KCNQ1 forms a homotetrameric, voltage-gated potassium channel found in a 
variety of tissues including heart muscle and epithelial cells.  To generate the diversity of 
potassium currents required by these different tissues, KCNQ1 subunits assemble with 
KCNE type I transmembrane peptides to produce membrane-embedded complexes with 
varied gating kinetics.  In cardiomyocytes, KCNQ1/KCNE1 (Q1/E1) complexes produce 
the IKs current, which contributes to the termination of action potentials and provides 
cardiac repolarization reserve.  IKs is essential for normal heart rhythmicity.  Mutations in 
both E1 and Q1 give rise to Long QT syndrome, a congenital arrythmicity that can cause 
torsade de pointes, fibrillation and sudden death.  The slow gating kinetics of IKs stem 
from potential interactions ostensibly between Q1 and the cytoplasmic C-terminal 
domain of E1 (Rocheleau et al. 2006 Journal of General Physiology  128, 721-729; 
Tapper & George 2000 Journal of General Physiology  116, 379-389).  We used oxidant-
mediated cysteine cross-linking to further resolve these protein-protein interactions to 
faces and discrete amino acid pairings between Q1 and E1 peptides.  We found within the 
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membrane-abutting C-terminal region of E1 side chains residues which are associated 
with discreet amino acids in the Q1 S4-S5 linker and the S6 gate; many of these pairings 
correspond well with Long QT mutations in both Q1 and E1.  Co-expression of cysteine 
pairings give rise to IKs oxidation sensitive currents in whole-cell perforated patch clamp 
experiments.  Our results demonstrate that Q1 and E1 interact on their cytoplasmic 
exposed surfaces and suggest Long QT mutations in this region of the channel complex 
disrupt native protein-protein interactions required for IKs function. 
 
INTRODUCTION 
KCNQ1 (Q1) forms homotetrameric, voltage-gated, potassium-conducting 
complexes found in a variety of tissues.  Despite the presence of Q1 in many different 
tissues, currents arising from over-expressed Q1 channels have not been physiologically 
observed.  When Q1 assembles with and is modulated by small, type I transmembrane 
peptides of the KCNE family, Q1 acquires its proper physiological and biosynthetic 
properties; it is through KCNE-interactions that Q1 channels are able to meet the tissue 
specific requirements for potassium conduction (McCrossan & Abbott, 2004).  In 
complexes shared with KCNE1 (E1), Q1 channels give rise to the IKs potassium current 
(Barhanin et al., 1996; Sanguinetti et al., 1996).  IKs is essential for normal heart 
rhymicity because IKs is responsible in part for repolarizing heart muscle after every 
depolarization and provides cardiac repolarization reserve.  Mutation in either IKs subunit 
can cause the cardiac dysfunction Long QT Syndrome, a lengthening of the Q-T time 
interval which can lead to seizures, torsades de pointes and fibrillation.  Recessive Long 
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QT syndrome associated with IKs is called Jervell and Lange-Nielsen syndrome and 
occurs with bilateral deafnesses (Splawski et al., 1997; Wollnik et al., 1997; Splawski et 
al., 2000; Keating & Sanguinetti, 2001; Silva & Rudy, 2005). 
The mechanism of KCNE modulation of Q1 channel complexes is not fully 
understood.  Chimeric and partially truncated KCNE peptides demonstrated KCNEs 
possess a bipartite modulation of Q1 channel complexes (Chapters II & III).  The 
modulation of KCNE peptides residing in the transmembrane domain is either permissive 
and allows C-terminal KCNE modulation, or it is active and masks the modulation of the 
KCNE C-terminus (Tapper & George, 2000; Melman et al., 2001; Melman et al., 2002a; 
Gage & Kobertz, 2004).  The KCNE transmembrane domain is in close proximity to both 
the pore and the voltage sensor of Q1 (Wang et al., 1996; Tai & Goldstein, 1998; Tapper 
& George, 2001; Melman et al., 2004; Panaghie & Abbott, 2007; Shamgar et al., 2008); 
therefore, the simplest model for KCNE modulation would entail KCNEs acting directly 
on the Q1 voltage sensor.  This appears to be the case with the active KCNE3 
transmembrane domain (Nakajo & Kubo, 2007; Rocheleau & Kobertz, 2008).  
Measurements of voltage sensor accessability to chemical modification within Q1/E1 
complexes have demonstrated voltage sensor movement and gating movements are 
uncoupled, an observation which neither confirms nor denies a transmembrane 
interaction (Nakajo & Kubo, 2007; Rocheleau & Kobertz, 2008).  E1 may also be able to 
interact with and alter the activity of the calmodulin-Q1 interaction (Ghosh et al., 2006; 
Shamgar et al., 2006). 
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Our understanding of KCNE modulation is also complicated by subunit 
stoichiometry within channel complexes.  Not only is E1 able to break the four-fold 
symmetry of Q1 channel complexes (MacKinnon, 1991; Schulteis et al., 1996; Doyle et 
al., 1998; Robbins, 2001; Zhou et al., 2001; Jiang et al., 2002b; Jiang et al., 2003a; Long 
et al., 2005a; Long et al., 2007; Morin & Kobertz, 2008), but E1 may be able to form 
complexes with other members of the KCNE family (Bendahhou et al., 2005; Lundquist 
et al., 2005; Toyoda et al., 2006; Morin & Kobertz, 2007; Manderfield & George, 2008).  
Were the 2:4 stoichiometry of KCNE:Q1 not disturbed in complexes containing other 
KCNEs, a single E1 peptide may be able to bestow upon four Q1 subunits the properties 
of IKs. 
We set out to better understand how E1 is able to modulate Q1.  Our goal in this 
work was to test potential protein-protein contact points between Q1 and E1.  Through 
oxidant-mediated disulfide bond formation between exogenous cysteine point mutations 
in a cysteine-null background (Schulteis et al., 1996; Kobertz et al., 2000), we 
demonstrated both proximity and juxtaposition of side chain residues between Q1 and E1 
in assembled channel complexes.  The particular cysteine pairings we identified occur 
within natively assembled and functional channel complexes on the plasma membrane, 
confirmed by a combination of cell-surface biotinylation, co-immunoprecipitation, 
PNGase F sensitivity, and IKs-like channel function determined by whole-cell perforated 
patch clamp.  The disulfide crosslink pairings we have identified occur between the C-
terminus of E1 and the cytoplasmic face of the pore region of Q1.  All amino acids in E1 
identified as interacting with Q1 were either previously identified as Long QT mutations 
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or proximal to Long QT mutations (Splawski et al., 2000).  Interacting E1 residues also 
corresponded precisely with high-impact amino acids identified by an alanine-
substitution scan performed on the C-terminus of E1 (Rocheleau et al., 2006).  These 
findings suggest the importance of a direct interaction between the C-terminal, 
juxtamembranous domain of E1 and both the gate and S4-5 linker helix of Q1, and 
confirm the importance of the C-terminus in giving rise to E1-like KCNE modulation. 
 
RESULTS 
In order to biochemically test whether side chain residues in Q1 and E1 are both 
close in proximity and juxtaposed to one-another within functional IKs channels, we had 
to be certain only non-native, engineered cysteines in both subunits were able to form 
disulfide bound heterodimers.  Therefore, we replaced all native membrane-embedded 
cysteines with alanine and all aqueously exposed cysteines with serine.  The utilization of 
cysteine-deficient constructs of Q1 and E1 precluded the possibility of false-positive 
disulfide bond formation involving native cysteine residues.  Our predictions of side 
chain environment were based on the X-ray crystal structure of highly homologous 
rKv1.2 (Long et al., 2005a) and hydrophobicity plots. 
However, cysteine replacement left an important caveat – did mutation of each of these 
cysteines result in channel complexes with a non-native structure?  We decided to 
indirectly test the structure of ―cysless‖ IKs by assaying the mutant channel complexes for 
their biophysical properties and comparing these biophysical properties with those of the 
wild type channels.  Perforated patch clamp was used in order to prevent ―rundown‖ of 
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IKs function observed by us and others (Selyanko et al., 2000; Kurokawa et al., 2004; 
Dong et al., 2006).  Shown in Figure 4-1, whole-cell perforated patch clamp experiments 
demonstrate IKs and ―IKs-cys‖ are mutually reminiscent, each possessing extremely slow 
activation and deactivation kinetics.  There were two differences we observed between 
wild type IKs and IKs-cys.  Activation curves for cysless IKs were left-shifted as compared 
with wild type channels; cysless IKs channels activated in response to much more 
negative membrane potentials.  We also observed a large increase in current density – 
CHO-K1 cells expressing cysless constructs possessed measurable currents a full day 
earlier after transfection as compared with wild type constructs (data not shown).  
Expression of Q1 or ―Q1-cys‖ alone gave rise to currents with much faster activation 
kinetics relative to IKs.  Q1 currents also possess obvious inactivation; this inactivation 
can be easily observed as a transient decrease in current upon membrane depolarization 
(please refer to Figure 2-1 (Gage & Kobertz, 2004), wild type Q1 recordings taken from 
Xenopus laevis oocytes using two-electrode voltage clamp running a similar voltage-
pulse protocol).  Because cysless Q1 and E1 gave rise to currents reminiscent of those 
arising from wild type Q1 and E1, we concluded our cysless construct possess native-like 
function and, therefore, native-like structure. 
With our native structure indirectly confirmed, we commenced our scan of 
cysteine point mutant pairings (Figure 4-2).  We conducted this scan in hypotonically 
lysed membranes.  Hypotonic lysis removes all non-specific aqueous proteins 
endogenous to CHO cells, preventing many native cysteines from forming disulfide 
bonds with our engineered cysteine point mutations.  After hypotonic lysis we maintained  
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Figure 4-1.  Native and ―cysless‖ IKs subunits give rise to currents which are mutually 
reminiscent.  Whole-cell perforated patch clamp recordings from CHO-K1 cells 
transiently transfected with IKs subunits as indicated.  Scale bars denote 25 pA/pF and 0.5 
s.  Dashed line indicates no net current.  Data are representative of n = 2 – 6 recordings 
per pairing.  Above, Q1-cys and empty vector.  Homotetrameric Q1-cys channels give 
rise to current which activates much more quickly compared with IKs (center), and 
displays inactivation, visualized by a transient decrease in current occurring just after 
very strong depolarizations.  Cysteine mutation in Q1 does not appear to substantially 
alter gating kinetics of Q1 homomeric channels (compare with Figure 2-1).  Center, 
heteromeric Q1/E1 channels give rise to IKs.  IKs lacks observable inactivation, and 
current increase for IKs is much slower compared with Q1-cys.  Below, Q1-cys/E1-cys 
channels give rise to IKs-cys.  IKs-cys also lacks inactivation and possesses very slow 
gating kinetics compared with Q1-cys alone.  However, cysteine mutation allows Q1-
cys/E1-cys channels to activate at much more negative membrane potentials as compared 
with native Q1/E1.  Inset, voltage-pulse protocol used to elicit these recordings.  
Membranes were held at – 80 mV, and depolarized for 3 s to potentials between – 100 
mV and + 60 mV in 20-mV increments.  Depolarizations occurred every 15 s.
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Figure 4-2.  The positions of exogenous cysteine mutants scanned in this study.  
Residues are projected onto net diagrams, and though helices in this region are known to 
contain joints and ―kinks‖ (Long et al., 2005a; Rocheleau et al., 2006), this projection 
assumes native alpha-helical secondary structure for ease of presentation.  Exogenous 
cysteines at positions highlighted in gray or black were able to form (any) higher 
molecular mass species upon oxidation with greatly varying efficiency.  Left, the 
cytoplasmic side of the S5 and S6 helices of Q1 are labeled, with membrane topology 
(relative to the intracellular face of the plasma membrane) based on homology to the 
crystal structure of Kv1.2 (Long et al., 2005a).  I257, highlighted in black, is the joint 
between the S5 helix and the S4-5 linker helix.  Right, transmembranous and C-terminal 
amino acid side chains of E1.  The membrane topology of E1 was a priori estimated by 
hydrophobicity.
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hypotonic conditions for fear of membranes resealing and preventing free aqueous access 
for H2O2 to all parts of the channel complex.  Formation of a disulfide bond must 
invariably result in an observable mass-shift of proteins resolved on SDS-PAGE (bound 
cysteine point mutant protein is covelantly attached to a second sulfhydryl-containing 
species). 
We began our scan of Q1 and E1 pairings with Q1 residues lining the aqueous 
reservoir on the cytoplasmic side of the selectivity filter within Q1 channel complexes.  
Engineered cysteine mutations were located in the fifth an sixth transmembrane helices of 
Q1.  A priori we also knew the high-impact transmembrane triplet identified by Melman 
and colleagues is believed to interact with membrane-embedded regions of Q1 (Melman 
et al., 2001; Melman et al., 2002a).  Only a hydrophilic environment would allow a 
deprotonated sulfhydryl to exist transiently before losing an electron to H2O2; therefore, 
attempting disulfide bond formation within the transmembrane domains of both IKs 
subunits was a gambit, considering membrane-embedded side chain residues, even those 
in close proximity to the aqueous vestibule, might not be able participate in disulfide 
bond formation.   
We were not able to visualize any disulfide bond formation in the transmembrane 
domain of E1, nor could we visualize any disulfide bond formation with putatively 
aqueous cysteines replacing R67, S68, R69, or K70 (summarized in Figure 4-2, no fill).  
Co-expression of all E1 cysteine point mutants (except E1 G60C) resulted in maturely 
glycosylated E1 peptides resolving between 37 – 50 kDa (Chandrasekhar et al., 2006), 
indicating our E1 mutant proteins were not rapidly degraded and were able to assemble 
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with Q1-cys. The nature of the lack of E1 G60C expression was never explored.  Our 
results allow two interpretations: the transmembrane domain of E1 is not close to the pore 
domain of Q1, or disulfide bond formation cannot occur with side chain residues located 
within the KCNE transemembrane domain. 
Failing to find any bona fide disulfide-bonding pairs within the aqueous vestibule, 
we turned our attention towards the cytoplasmic face of Q1 channels.  For these 
experiments we would not have to worry about the hydrophobicity of the local 
environment preventing disulfide bond formation, making our results easier to interpret.  
We identified E1 L71C and cysteine point mutants C-terminal to L71 which were readily 
able to form disulfide crosslink species (Figure 4-2, gray).  However, the number of 
erstwhile crosslinks, combined with relatively poor efficiency of disulfide bond 
formation, led to more stringent requirements for consideration.  We continued our scan 
until we observed disulfide bonding patterns demonstrating both periodicity in E1 
(another a priori expectation, given the results of the alanine scan performed by 
Rocheleau and colleagues (Rocheleau et al., 2006)) and greater efficiency.  We defined 
our ―hits‖ as all of our crosslinking combinations in which the percentage of signal in the 
crosslinked band is signicantly greater than three separate negative controls.  A ―bloody 
good‖ example of these crosslink pairings is presented in Figure 4-3. 
Q1-cys, H363C was co-expressed with a panel of E1-cys cysteine point mutants, 
resolved on 15% SDS-PAGE, and immunoblotted with antibodies raised against the HA 
tag of E1 (Fig. 4-3A).  Each pairing of Q1 and E1 yields a strong signal (observed as 
either a single, wide band or a doublet) measuring between 37 – 50 kDa, corresponding 
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Figure 4-3.  Q1-cys, H363C is able to form higher molecular mass species with a panel 
of E1-cys point mutations.  A – C, Representative western blots of proteins oxidized by 
10 min application of 0.01% H2O2 in hypotonically lyzed membranes, resolved on non-
reducing SDS-PAGE and immunoblotted with -E1.  E1-cys point mutants are labeled 
above and molecular weight markers are labeled on the left.  ―(-)‖ indicates our internal 
negative control, E1 C106S.  All E1 point mutants produce a strong banding between 37 
and 50 kDa, corresponding to maturely glycosylated E1 peptides (Chandrasekhar et al., 
2006).  A, Q1-cys, H363C was co-expressed with E1-cys or E1-cys cysteine point 
mutants in CHO cells through transient transfection.  Oxidation results in the observation 
of several higher molecular weight bands between 50 and 150 kDa.  B & C, Q1-cys, 
R360C (B) or Q1-cys, A370C (C) were co-expressed with the same panel of cysteine 
point mutants of E1-cys assayed with Q1-cys, H363C.  Mutant E1 also forms many 
higher molecular weight species running between 50 – 100 kDa, but lacks the high-
intensity species weighing just under 150 kDa.  D, absorbance for our putative 
crosslinked species normalized to the ―total‖ absorbance for each transfection pairing.  
The normalized absorbance is plotted against the position of the interacting cysteine in 
E1.  The strength of the ~ 150 kDa band varies depending upon the crosslink pairing and 
is highly reproducible.  Signal denotes the mean for n = 3 – 4 experiments ± S.E.M.  The 
statistical significance of each experiment (individually compared against three negative 
controls) is binned according to least significance: † (p < 0.05), ‡ (p < 0.01), § (p < 
0.001), * (p < 0.0001).  Legend, the identity of the Q1-cys point mutant.  Inset, cartoon 
depicting the location of H363C on the S6 gate of Q1 pore-forming subunits as well as 
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the location of our panel of cysteine point mutation in E1 (red peptide backbone).
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to maturely glycosylated E1 (Chandrasekhar et al., 2006).   Many other E1-containing 
species can also be observed with masses between 50 and 150 kDa.  Of these species, the 
band resolving to just below 150 kDa is of particular interest.  This 150 kDa band 
depends upon the presence of a cysteine in E1 and, of all of the higher molecular weight 
bands larger than 50 kDa, the signal intensity for the 150 kDa band is greatest and 
changes reproducibly depending upon the position of each E1 cysteine mutant.  In a 
reciprocal scan, in which a single cysteine point mutant of E1 is crosslinked with a panel 
of Q1 cysteine point mutants, we identified several Q1 cysteine point mutants which 
showed little propensity for crosslink formation in the vicinity of H363 (data not shown).  
Two of these Q1 point mutations, R360C and A370C, each within approximately two -
helical turns of H363, were used as the other two of our aforementioned negative controls 
(Fig. 4-3B & C).  No positive control exists for this experiment.  Both control disulfide 
bond scans almost completely lack our putative disulfide bound ~ 150 kDa species, but 
otherwise possess all of the features observed upon H363C co-expression.  We plotted 
percentage of crosslink at 150 kDa (normalized to ―total‖ protein signal) against position 
of cysteine replacement in E1 (Fig. 4-3D).  The percentage of protein in the ~ 150 kDa 
band is also highly reproducible.  The statistical significance of pairings of H363C with 
each cysteine point mutant in E1 mirror the measured ―isochronal G‖ of alanine 
replacement (Rocheleau et al., 2006). 
 During our investigation we identified other Q1 cysteine point mutants which 
displayed intriguing crosslinking patterns with E1 cysteine point mutants.  Crosslink 
formation ends abruptly C-terminal to the cysteine mutant P369C.  P369C is unique in 
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that it forms a strong intensity ~ 150 kDa species only upon co-expression with a single 
E1 point mutant, D76C (Fig. 4-4A & E).  One other Q1 cysteine mutant displayed 
statistically significant disulfide bond formation with E1, I257C.  We discovered this 
cysteine point mutant by extending our scan towards the cytoplasmic, N-terminal end of 
the fifth transmembrane domain.  I257C, the amino acid residue homologous to the hinge 
between the S4-5 linker helix and S5 in Kv1.2, forms crosslinked species with the same 
residues that were identified by H363C (Fig. 4-4B).  However, crosslink formation 
required five-fold more oxidant relative to oxidation involving S6 cysteine mutants.  In 
order to generate background disulfide bond formation for the S4-5 linker, V254C and 
F256C were used as negative controls (Fig. 4-4C & D).  Neither residue, nor any other 
residue between V254C and H258C (data not shown), was able to generate the 150 kDa 
crosslinked species.  A comparison of the percentage of mass shift for experiments 
involving I257C and background controls was plotted (Fig. 4-4F).  Lastly, S253, a 
residue on the cytoplasmic side of the S4-5 linker helix, was able to form disulfide bound 
species with much less oxidant as compared with I257C.  However, the higher molecular 
weight species identified with S253C did not include our suspect 150 kDa species, nor 
was there any evidence of a discernable crosslinking pattern (data not shown). 
Having found these putative crosslinked species, we sought to demonstrate the 
150 kDa species was the Q1-E1 disulfide-bound heterodimer of Q1 and E1.  Our 
expected mass of a Q1-E1 heterodimer would be ~ 120 kDa (Q1 is ~ 70 kDa while 
maturely glycosylated E1 is ~ 50 kDa); the species we identified could be one of several 
experimental artifacts.  These artifacts include E1 covelantly linked with any membrane- 
 143 
 144 
Figure 4-4.  Cysteine point mutations residing in the S6 gate and the S4-5 linker are able 
to form higher molecular mass species with E1 cysteine point mutants.  A – D, 
representative western blots of proteins oxidized as decribed (vide infra) but otherwise 
treated and presented as in Figure 4-3A – C.  All combinations of cysteine point mutants 
shown give rise to maturely-glycosylated E1.  The identity of the co-transfected Q1 and 
E1 cysteine point mutants is labeled above and molecular mass markers are labeled on 
the left.  A, Q1-cys, P369C is co-expressed with our panel of E1 cysteine point mutants 
and oxidized with 0.01% H2O2 for 10 min prior to resolution on non-reducing SDS-
PAGE.  Oxidation of only one pair of Q1 and E1 cysteine point mutants, P369C with 
D76C, results in a significantly intense ~ 150 kDa band.  B, Q1-cys, I257C co-expressed 
with our panel of E1 cysteine point mutants and oxidized with 0.05% H2O2 for 10 mins.  
Oxidation results in many of the higher molecular weight species observed with H363C 
or P369C co-expression, including the suspect 150 kDa species identified before.  C & D, 
cysteine point mutants Q1-cys, V254C (C) or Q1-cys, F256C (D), located within one 
helical turn of I257 on the S4-5 linker helix of Q1, are co-expressed with our panel of E1 
cysteine point mutations.  Samples were oxidized for 10 min with 0.05% H2O2.  
Oxidation results in many of the higher molecular weight species resolving between 50 
and 100 kDa, however there is very little signal from the ~ 150 kDa band.  E & F, 
normalized signal intensity of the ~ 150 kDa species of Q1-cys, P369C co-plotted with 
R360C and A370C (E) or Q1-cys, I257C co-plotted with V254C and F256C (F), as 
presented in Figure 4-2D.  Signal denotes the mean for n = 3 – 6 experiments ± S.E.M.  
The statistical significance of each experiment (individually determined versus three 
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negative controls) is binned according to least significance: † (p < 0.05), ‡ (p < 0.01), * 
(p < 0.0001).
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associated endogenous CHO-K1 protein, an E1 homodimer, or any non-specific proteins 
which can be recognized by our -HA antibodies.  Alternatively, our crosslinked species 
may resolve at a different apparent molecular mass due to the species being a disulfide 
bound dimer. 
We could not test our crosslink band directly for the presence of Q1 on an 
immunoblot.  Immunoblots with -Q1, in the absence or presence of a co-expressed E1 
subunit, reveal an aggregation band around 150 kDa, obscuring the crosslink species we 
sought (data not shown).  However, we were able to immunoprecipitate the channel 
complex using the -Q1 antibody.  In Figure 4-5A, ghosts were first oxidized, then 
subsequently immunoprecipitated using -Q1 antibodies and probing for E1 in the 
immunoblot.  Only the ~ 150 kDa band was both dependent upon co-expression of Q1 
and E1 cysteine mutants, and was depleted in the supernatant of the immunoprecipitation.   
Please note several of the other higher molecular weight species identified by oxidation 
must result from endogenous CHO proteins, as these bands were present in the absence 
of transfection. 
Upon DTT elution of our crosslink band from -Q1 antibodies, all HA-containing 
E1 peptides pulled down by Q1 immunprecipitation collapsed to between 37 and 50 kDa, 
consistent with our 150 kDa band possessing multiple disulfide bound species.  The size 
of this HA-tagged peptide corresponds well to maturely glycosylated E1, the E1 species 
expressed on the cell surface.  We confirmed this species indeed was glycosylated by 
deglycosylating with PNGase F, which removed all N-linked glycans.  Though 
deglycosylation left a species 3 – 5 kDa larger than the predicted mass of deglycosylated 
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Figure 4-5.  The ~ 150 kDa species is a Q1-E1 disulfide-bound heterodimer found on the 
cell surface.  A, co-immunoprecipitation confirms the identity of the crosslinked species.  
Membrane proteins were oxidized with 0.1% H2O2 for 10 min and subsequently 
immunoprecipitated by -Q1 antibodies.  Proteins were then resolved on SDS-PAGE and 
immunoblotted with -E1.  The identities of the transfected Q1 or E1 cysteine point 
mutants are labeled above; ___ denotes ―cysless‖, numbers denote the position of the 
cysteine mutation.  Molecular mass markers are as indicated, while PNGase F treatment 
of samples is denoted by ―+‖.  (Left) representative western blot of whole-cell lysates and 
non-immunoprecipitated supernatant proteins from non-transfected CHO cells ―(-)‖ or 
transfected CHO cells resolved on non-reducing SDS-PAGE.  Only the ~ 150 kDa 
species is depleted from the supernatant upon immunoprecipitation with -Q1 antibodies.  
(Right) representative western blot of DTT-eluted proteins immunoprecipitated with -
Q1 antibodies.  Upon reduction, antibodies release the heterodimeric species and the 
disulfide bond holding the species together is reversed.  The resulting monomeric E1 
peptides resolved between 37 and 50 kDa.  This band possesses N-linked glycosylation 
because the band collapses to ~ 22 kDa upon treatment with PNGase F.  B, cell surface 
biotinylation recognizes maturely glycosylated E1 peptides and the ~ 22 kDa 
deglycosylated species.  Molecular weight markers are as indicated, antibody used for 
immunoblotting is labeled on the right, and the identity of the Q1/E1 pairing as well as 
cell surface biotinylation is labeled above.  Samples treated with PNGase F subsequent to 
protein harvest are denoted with a ―+‖.  (Above) co-expression of wild type Q1+E1; Q1-
cys, H363C + E1-cys, D76C; and Q1+ E1, N26Q (E1 possessing only one N-linked 
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glycosylation site) gives rise to maturely glycosylated E1 peptides on the cell surface.  
Upon deglycosylation, the signal from these peptides collapses to a species ~ 22 kDa.  
The ~ 22 kDa band is distinct from immaturely glycosylated E1, the dominant species 
obtained from whole-cell lysates of E1 transfected alone (left-most two lanes), and 
appears at the exact same molecular mass in the lane containing N26Q (N26Q possesses 
only a single N-linked glycosylation site).  (Below) representative experiment, run in 
parallel, demonstrating cell surface biotinylation for each sample modifies only ~ 5% of 
intracellular calnexin.  Weak labeling of intracellular calnexin indicates labeled CHO 
cells maintained an intact cell membrane during the biotinylation procedure.
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HA-tagged E1, the deglycosylated bands obtained through immunoprecipitation 
correspond well with species obtained by deglycosylation of cell-surface wild type HA-
tagged E1 peptides (Fig. 4-5B). 
These results indicate our deglycosylated species resides in the plasma membrane 
and is not an artifact of cysteine mutation or non-native structure.  These data also 
implicitly demonstrate our cysteine mutant channels are correctly folded and were 
allowed to traffic to the cell surface.  Further, we were able dismiss the possibility that 
the observed mobility shift resulted from incomplete deglycosylation of immature 
glycans by PNGase F – E1 N27Q, which contains only one of two N-linked glycosylation 
sites, displays the same shift in mobility upon deglycosylation with PNGase F.  The 
reason for this 3 – 5 kDa mobility shift has not been ascertained; we believe it results 
from the same post-translational modification observed by Chandrasekhar and colleagues 
(Chandrasekhar et al., 2006). 
Once we identified the positions of cysteine mutants in Q1 and E1 able to form 
disulfide bound pairings in our biochemical assay, we wanted to determine how cysteine 
mutations at these particular positions effects IKs channel function.  We returned to 
whole-cell perforated patch clamp with two goals in mind.  1) Mutant pairing must give 
rise to whole-cell currents – native-like function demonstrates we have not disrupted the 
native structure.  2) Oxidant-mediated current modification observed through patch 
clamp might reciprocate our cysteine crosslinking scan. 
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We began by assaying our cysteine point mutant pairing for wild type function.  
In Figure 4-6A – C, whole-cell currents from CHO-K1 cells were elicited by holding 
cells at – 80 mV and depolarizing with a 3-s test pulse to + 20 mV.  The channel spends 
20% or its time in the depolarized state (a 3-s test pulse performed every 15 s).  Current 
for all disulfide bond pairings clearly exhibits the slow gating kinetics of IKs and lacks the 
quick rise-time or inactivation observed upon repolarization with Q1-cys expressed 
alone.  Though current density varies by cysteine point mutant, all pairings tested give 
rise to IKs-like currents within 3 days of transfection. 
We determined the effect of disulfide bond formation on our mutant pairings by 
oxiding our cells and measuring changes in current.  IKs-cys, our negative control, 
averaged approximately 5% current reduction after five minutes of oxidant treatment.  
For pairings of Q1 and E1 identified as high-impact biochemically (Fig. 4-6C), for 
instance H363C+H73C, we observed between 80% and 90% inhibition in current, with 
the reaction reaching completion within 5 minutes.  In cysteine mutant pairings 
possessing a single cysteine point mutant, oxidant treatment also resulted in current 
reduction (Fig. 4-6A & B).  However, the rate inhibition was far slower as compared with 
our bona fide disulfide pairings, and equilibrium current inhibition for these pairings 
never reached 80–90%. 
We hypothesize cysteines in the S6 gate of Q1 are able to form disulfide bonds 
with either an endogenous aqueous protein in CHO-K1 cells or the cysteine point mutant 
from second gate helix within the channel complex.  The fast inhibition observed 
between a bona fide crosslinking pair is indicative of both subunits being held in close 
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Figure 4-6.  Whole-cell perforated patch clamp recordings of CHO cells transfected with 
point mutants of Q1 and E1.  A – C, recordings of CHO cells held at – 80 mV and 
depolarized to + 20 mV for 3 s with a 12-s interpulse interval.  This protocol holds CHO 
cell membranes at depolarizing potentials for 20% of the time.  Once currents remain 
unchanged for at least a full minute (normally occurring within 5 min of seal formation), 
0.1% H2O2 is perfused through the external solution.  Current measured at the end of 
oxidant treatment is marked with ―*‖.  Zero current is labeled by a dashed line.  Scale 
bars denote 25 pA/pF and 0.5 s.  Recordings are representative or n = 2 – 7 samples per 
pairing.  Inset, voltage-pulse protocol used to elicit the depicted recordings.  A, ―negative 
controls‖ for disulfide bond formation.  Only E1 contains a cysteine.  B, ―negative 
controls‖ in which either a poor disulfide bond pairing is expressed, or only Q1 contains a 
cysteine.  Currents arising from these channel subunit pairings display greater current 
inhibition in response to oxidation, probably as a result of H363C forming a homodimer 
with a second gate helix or forming a heterodimer with an endogenous, aqueous CHO-K1 
protein.  C, cysteine point mutant pairing identified as high impact through our 
biochemical assay.  D & E, Representative time course of current inhibition for the data 
shown in A (D) or Q1-cys, H363C co-expressed with E1 cysteine point mutants (E).  The 
time courses of current inhibition are overlaid with single-exponential decay.  The 
identity of the Q1 and E1 cysteine point mutants are as labeled.  The kinetics of oxidant-
mediated current inhibition occur much faster compared with the ―negative controls‖, and 
steady-state inhibition of current is much greater for bona fide crosslink pairs compared 
with the ―negative controls‖.
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proximity and juxtaposition within the native structure, increasing the effective local 
concentration of chemically labile sulfhydryl groups and greatly increasing the kinetics of 
reaction.  This increase in effective local concentration can not be replicated in the 
absence of cysteine point mutants in both IKs subunits.  We tested our hypothesis by co-
expressing of H363C and E72C (a very poor disulfide binding pair), which should behave 
much like cysless E1.  Percent inhibition of IKs current was similar in the presence or 
absence a cysteine residue at position 72 in E1 (Fig. 4-6B).  The results from our whole-
cell perforated patch clamp are summarized in Table 4-1. 
Lastly, we tested the reversibility of our disulfide-mediated current inhibition by 
perfusing 2 – 5 mM DTT.  Unfortunately, all cells treated with DTT quickly lost their 
gigaohm patch pipette seals within 30 s of application (data not shown).  Though we were 
not able to reverse our crosslink formation, the observed rates of current inhibition 
accurately model the propensity of each crosslink pairing to form heterodimeric disulfide 
bonds.
 155 
 
 
 
Table 4-1.  Oxidant-mediated current inhibition of cysteine mutant IKs
a
 
 
transfection 
 
n = % current inhibited rxn (s) 
 
Q1-cys+E1-cys 
 
5 4.5 ± 2.2 NA 
 
Q1-cys+73 
 
1 19.8 188 
 
Q1-cys+74 
 
3 15.8 ± 4.2 145 ± 19 
 
Q1-cys+76 
 
4 31 ± 4.1 115 ± 41 
 
363+E1-cys 
 
7 45.6 ± 9.8 64.4 ± 15.4 
 
363+72 
 
2 57.6 ± 2.5 148 ± 47 
 
363+73 
 
2 85.9 ± 7.8  46.5 ± 8.7 
 
363+74 
 
4 85.2 ± 1.5 62.4 ± 1.3 
 
a
 Data was obtained from individual CHO-K1 cells transiently transfected with cysteine 
point mutants of Q1 and E1 as labeled.  Current versus time plots were fit to single-tau 
exponential decay as decribed in Materials and Methods.  Percent current inhibition and 
rxn are reported as mean ± S.E.M.  NA, not applicable.
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DISCUSSION 
 Cysteine replacement of residues in the C-terminus of E1 and the cytoplasmic 
pore domain of Q1 has led to the identification of close contacts between these IKs 
subunits (Figure 4-7).  Both Q1 and E1 required mutation of all endogenous cysteines in 
order to conduct this biochemical scan, coupled with the introduction of single, 
exogenous cysteines point mutations.  Despite the introduction of so many cysteine point 
mutations, all mutant IKs channels observed electrophysiologically have given rise to 
currents reminiscent of native IKs.  As channel function is a property of structure, we 
hypothesize all of the cysteine point mutations have maintained wild type-like structure.  
Confirmation of our high-throughput biochemical assay is also important.  Demonstration 
that our cysteine pairings are able to associate during whole-cell perforated patch clamp 
experiments and maintain this association in hypotonically lyzed membranes is 
heartening, confirming the robust nature of channel structure. 
Our results may provide a relatively simple explanation for bipartite KCNE 
modulation of the Q1 channel complex.  The permissive transmembrane modulation of 
E1 allows unfettered voltage sensor movement in response to changes in membrane 
potential.  Upon depolarization, the voltage sensor reaches equilibrium with the 
depolarized conformation quickly in the presence or absence of E1 peptides (Rocheleau 
& Kobertz, 2008).  Fast IKs voltage sensor movement must be uncoupled with gating 
motions.  An association between E1 and the S6 gate of Q1 may allow a rigid E1 to 
sterically hinder or block S6 transition between the closed and open conformation.   
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Figure 4-7.  Close contacts within the cytoplasmic face of IKs channel complexes.  Net 
diagrams of those regions of Q1 (outside nets) tightly associated with E1 (inside nets) are 
depicted.  White, residues incapable of forming any disulfide bonds.  Gray, positions of 
non-native cysteines able to form ~ 150 kDa disulfide bound heterodimer (with varying 
efficiency).  Red, positions of non-native cysteines found to be tightly associated.  
Statistically significant interactions are denoted by lines connecting the interacting 
residues; the line width relates to the statistical significance of each crosslink (compared 
individually with three negative controls), with larger width indicating higher 
significance.  Left, I257C, an exogenous cysteine positioned at the joint between S5 and 
the S4-5 linker helix of Q1, loosely associates with membrane-proximal C-terminal 
cysteine mutations in E1.  This association required five-fold more oxidant to visualize 
relative to comparable ―hits‖ between the S6 helix of Q1 and E1.  Cysteines positioned at 
any other location within or near the S4-5 linker were not able to form heterodimers with 
E1 unless forced to do so through use of harsher oxidizing conditions (data not shown).  
Right, the positions of exogenous cysteines within the S6 helix of Q1 able to associate 
tightly with membrane-proximal C-terminal cysteine point mutants.  H363C dimerizes 
very well with cysteines mutations previously identified as ―high impact‖ within the E1 
C-terminal tail (Chapter III).
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Alternatively, a rigid, tightly bound E1 C-terminus may provide ―spring-like‖ resistance 
to gate motions, thus slowing the gating of IKs. 
 E1 interaction with the S4-5 linker of Q1 channels may also result in IKs 
properties.  Voltage sensor movement normally results in tension on the S4-5 linker.  If 
E1 prevents S4-5 linker movement, voltage sensor movement will not be quickly 
transduced into gating motions. 
The S4-5 linker helix and the gate of Q1 are able to adopt multiple conformations 
as part of normal channel function.  Though we have definitively demonstrated an 
interaction between Q1 and E1, our biochemical scan does not give us insight regarding 
the state-dependence of the Q1-E1 association.  As resting potential is a function of the 
electrochemical gradients of a membrane and the relative conductance of each ion, lyzed 
membranes would completely lack a transmembrane potential, allowing channels to rest 
at 0 mV; crosslinking could occur with the gate residing in the closed or open (or any 
heretofore unknown?) conformation.  We intend to use electrophysiology in the future to 
distinguish between these possibilities. 
 Our electrophysiological results were obtained using a voltage-pulse protocol in 
which cysteine mutant channel complexes are depolarized 20% of the time.  In order to 
determine a state-dependence for our disulfide bond formation, we will vary the 
percentage of time in the depolarized state, and observe any changes in the rate of 
disulfide-mediated current alteration.  Changes in the rate of inhibition may be indicative 
of the state of channel subunits caught in a disulfide bound species. 
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 For instance, a four-fold reduction in the dwell time at + 20 mV would only result 
in a modest increase in percentage of time spent at – 80 mV (0.75 s+20 mV/15s = 95%, 
versus 3 s+20 mV/15 s = 80%).  A more open protocol is also possible.  Maintaining 
membrane potential at + 20 mV would completely remove any time spent at negative 
membrane potentials.  If a particular disulfide pairing occurs within the open state, 
performing the reaction using a closed protocol would slow the kinetics of reaction 
significantly, while oxidizing in the open state would significantly speed reaction 
kinetics.  In contrast, if disulfide bond formation occurs within the closed state, the closed 
protocol will not produce a significant change in reaction kinetics, but the open protocol 
will significantly slow the rate of reaction. 
 If there is no current alteration in response to disulfide bond formation, other 
possibilities present themselves.  Disulfide bond formation may not alter the S4-5 linker 
or the gate in such a manner inhibitting normal function for these structures.  In this case, 
E1 may associate with the gate or the S4-5 linker helix and move in conjunction with Q1 
movements.  Our biochemical assay may also find a channel state which is not 
electrophysiologically observable, at least not utilizing conventional methods.  For 
instance, inactivation in Q1/E1 has never been definitively dismissed; 
electrophysiological recordings are not able to observe the transition to or from an 
inactivated state, if it does exist.  Given our biochemical assay is performed in 
membranes which dwell at 0 mV for long periods of time, it is possible crosslink 
formation may occur in a heretofore unobserved inactivated state.  In the unlikely event 
of extremely slow open to inactivated state transition, it may be possible to select for 
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inactivated channels by conducting oxidation experiments with long depolarizations.  
Alteration of current might be observable as a reduction in peak current for exceptionally 
long pulse (if we trap inactivated channels in a non-conducting state, fewer channel 
complexes could respond to subsequent membrane repolarization and depolarization). 
 In a parallel experimental approach for our disulfide bond scan, in which single 
cysteine mutations of E1 were co-expressed with a panel of Q1 cysteine point mutations, 
we observed a sudden drop in disulfide bond efficiency just C-terminal to P369.  The 
binding partner for P369 also appears to be in close proximity to E1 P77, the proline 
residue inducing the ―kink‖ in the C-terminal -helix of E1.  Though it is clear these 
structures diverge from one another, the identity of any other protein contacts in this 
region remains to be elucidated, save a contact between the IQ domain of Q1 and 
calmodulin (Ghosh et al., 2006; Shamgar et al., 2006).  This interaction is required for 
calcium sensitivity for the channel complex.  Furthermore, calmodulin has been shown to 
be able to co-immunoprecipitate E1 with the IKs channel complex.  We do not have 
evidence at this point, but it would be intriguing to speculate E1 may also contact 
calmodulin directly, perhaps forming a ternary complex on the cytoplasmic face of the 
channel complex. 
 Though the results of our disulfide crosslinking scan of the C-terminus of E1 
corroborate the biochemical evidence for C-terminal E1/Q1 interaction, a recent NMR 
structure of E1 peptides reconstituted in lyso-myristoylphosphatidylglycerol micelles has 
provided an alternative structure (Kang et al., 2008).  This NMR structure depicts E1 as a 
bent transmembrane alpha-helix which contains flexible linkers on the extra- and 
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intracellular sides of the transmembrane domain.  The aqueous exposed -helices of this 
structure appear to adhere to the predicted surface of the micelle in which E1 was 
reconstituted.  The authors then modeled the structure onto Kv1.2, a homologous 
structure of the Q1 channel complex.  This model for Q1/E1 does agree with the 
experimental evidence derived from disulfide bond formation in that E1 contacts the S4-5 
linker of the Q1 channel complex.  However, the NMR structure for E1 does not 
recapitulate the interactions biochemically observed between the S6 gate and the C-
terminus of E1, nor does it maintain an alpha-helical structure as demonstrated by 
Rocheleau et al (Tapper & George, 2000; Rocheleau et al., 2006). 
 In this study, we used disulfide bond formation as an indicator for close 
juxtaposition of cysteine side chain residues between the cytoplasmic pore of Q1 and the 
C-terminus of E1.  Though further work is required to fully understand the interaction 
between E1 and the cytoplasmic pore of Q1, our results supports a role for the C-terminus 
of E1 in giving rise to IKs-like biophysical properties, strengthening the bipartite model of 
KCNE modulation. 
 
MATERIALS AND METHODS 
Molecular Biology- hKCNQ1 (Q1) and hKCNE1 containing an extracellularly 
exposed hemagglutinin A (HA) tag (YPYDVPDYA) (Wang & Goldstein, 1995) (E1), 
both residing on an expression vector containing the Xenopus laevis 5’ and 3’ -globin 
UTRs, were mutated by Quikchange
®
 (Stratagene) site-directed mutagenesis combined 
with cassette mutagenesis to remove all native cysteines.  Based on hydrophobicity, 
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cysteines were either mutated to serine (aqueous) or alanine (membrane embedded).  
Mutagenesis was done iteratively in groups of three in order to check each construct for 
wild type-like function in Xenopus oocytes using TEVC (data not shown).  Upon 
confirmation that each construct behaved like wild type, mutant constructs were then 
combined to produce a completely cysteine-deficient construct, which also behaved like 
wild type.  E1 C106S was also checked and behaved like wild type.  Q1, E1 and both 
―cysless‖ constructs were then subcloned into a mammalian expression vector under the 
CMV promoter.  Individual cysteine mutations were reintroduced using the same 
procedure as above.  All mutations were confirmed by automated PCR covering the 
entire mutated cassette or, in the case of the original cysless constructs, the entire open 
reading frame was sequenced. 
 
Cell Culture - CHO-K1 cells (CHO) were grown in F-12K media (Invitrogen) 
supplemented with 10% Fetal Bovine Serum (Hyclone) and 1% Penicillin/Streptomycin 
(Invitrogen) and transiently transfected using Lipofectamine
TM
 (Invitrogen) in Opti-
MEM
®
 (Invitrogen). 
For Biochemistry: Each well of a six-well plate was transfected with (in g): 0.75 
Q1, 1.5 E1, for 6 ± 0.25 hours, then allowed to incubate in F-12K for ~ 42 hours before 
harvest. 
For Electrophysiology: Two different cDNA quantities were empirically 
determined to produce IKs-like currents.  For wild type and ―cysless‖ IKs, two wells of a 
six-well plate were transfected with (in g): 0.375 Q1, 3 E1, 0.25 pEGFP-C3.  For 
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cysless point mutants as well as wild type and ―cysless‖ Q1, two wells of a six-well plate 
were transfected with (in g): 0.75 Q1, 1.5 E1 or empty vector, 0.25 pEGFP-C3.  
Transfection media is left on cells for ~ 2 hours, and then subsequently incubated in F-
12K 1 – 2 days before harvest. 
 
Electrophysiology – Whole-cell perforated patch clamp was used to measure 
currents arising from transiently transfected CHO cells.  Prior to recording, CHO cells 
were trypsinized and replated on glass coverslips.  CHO cells on broken glass chips were 
used 1 – 5 hours after replating (Hamill et al., 1981; Horn & Marty, 1988).  Gigaohm 
seals were formed in a modified Tyrode’s solution (in mM): 145 NaCl, 5.4 KCl, 10 
HEPES, 5 CaCl2, pH 7.5 with NaOH.  Once seals were formed, the bath solution was 
switched for recordings to External Solution (Suh & Hille, 2002; Liu et al., 2006) (in 
mM): 160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 8 Glucose, pH 7.5 with NaOH.  
Oxidant was applied to patches by adding small volumes of 30% H2O2 to a final 
concentration of 0.1% in External Solution.  Perforations were formed using 
amphoterecin B (Horn & Marty, 1988; Rae et al., 1991) (Sigma).  60 mg/ml stock 
solutions of amphotericin B in DMSO were made once daily, and then diluted to a final 
concentration of 60 g/ml in Inside Solution (Melman et al., 2001; Liu et al., 2006) (in 
mM): 126 KCl, 4 K2-ATP, 2 MgSO4, 5 EGTA, 0.5 CaCl2, 25 HEPES, 0.4 Na-GTP, pH 
7.5 with CsOH (~ 40 mM Cs
+
).  Once amphotericin B was added, Inside Solution was 
used within 20 min before being discarded.  Access to the inside of the cell was 
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monitored by measuring peak current with 3-s test depolarizations to + 20 mV taken 
every 15 s from – 80 mV, and reached plateau within 5 min. 
Voltage clamp was performed with an Axopatch 200B (Axon Instruments) using 
pClamp 10 (Molecular Devices Corporation), and measured current was digitized with 
Digidata 1440A (Axon Instruments).  Transfected (EGFP-expressing) cells were 
visualized using an Axiovert 40 CFL inverted light microscope (Zeiss).  Patch pipette 
access resistance was between 1.5 – 3.5 M.  Neither prediction nor correction were 
used in these recordings; cells with an IR drop >10 mV at 20 mV were not considered.  
Q1 has been shown to possess small basal activation (Gage & Kobertz, 2004), therefore 
recordings were not leak-subtracted.  Perforated patch can lead to Donnan potential, 
predicted to be ≤ 11 mV for CHO cells (Horn & Marty, 1988; Selyanko et al., 2000).  
Both of these factors will affect the accuracy of the voltage clamp. 
Wild type and ―cysless‖ Q1 and IKs were assayed for native-like function using a 
―family‖ protocol, in which cells held at –80 mV were stepped every 15 s to potentials 
between – 100 mV and + 60 in + 20-mV increments for 3 s, followed by a 1-s command 
to – 30 mV.  Disulfide bond formation was monitored by holding cells at – 80 mV and 
recording current during a 40-ms window at the end of a 20-mV, 3-s test depolarization 
taken every 15 s. 
  
Biochemistry - Crosslinking of Q1 and E1 point mutants was mediated through 
disulfide bond formation (Schulteis et al., 1996; Kobertz et al., 2000).  For scanning 
experiments, wells of CHO cells on a six-well plate expressing Q1 and E1 mutants were 
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harvested at 4 
o
C by thoroughly aspirating media and scraping ghosts in 250 l/well 
Hypotonin Lysis solution plus Protease Inhibitors (in mM): 10 KCl, 1.5 MgCl2, 10 
HEPES pH 8.0.  Protease Inhibitors: 1 mM phenylmethylsulfonyl fluoride (EM Sceince) 
(from 100X stock in ethanol) and 1 g/ml each of leupeptin (Roche), pepstatin (Roche) 
and aprotinin (Sigma) (from 100X stock in ethanol/acetic acid/water).  After scraping, 
samples were pelleted (10 krpm, 10 min, 4 
o
C).  Aqueous proteins in the supernatant were 
used for BCA quantitation (Pierce).  Samples were then resuspended and reduced with 10 
mM dithiothreitol (DTT) for 10 min.  Membranes were pelleted (10 krpm, 10 min, 4 
o
C) 
and washed once in Hypotonic Lysis solution, and then resuspended again in Hypotonic 
Lysis solution. 
Each sample was oxidized with a total of 0.01% H2O2 for 10 min at RT.  
Oxidation was quenched at RT for 1 hour with N-ethyl maleimide to 30 mM final 
concentration.  Membranes were pelleted (10 krpm, 10 min, 4 
o
C) removing the 
supernatant, and then solubilized by rolling for 30 min at 4 
o
C in 1.5% Digitonin 
(Calbiochem) Solution plus Protease Inhibitors (in mM): 290 NaCl, 10 KCl, 1 MgCl2, 7 
Tris pH 7.5, 1.5% Digitonin.  Debris were pelleted (14 krpm, 10 min, RT), the 
supernatant kept and diluted 1:1 with 7.2% (w/v) SDS, 100 mM Tris pH 6.8, 20% (v/v) 
glycerol and a trace of dye.  Load volume was weighted based on BCA quantitation 
before resolution on non-reducing 10% SDS-PAGE. 
 
Co-Immunoprecipitation - Harvest, oxidation and quench of membrane proteins 
proceeded exactly as above, except that samples were oxidized with a total of 0.1% H2O2 
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for 10 min.  Once samples were quenched, membranes were pelleted (10 krpm, 10min, 4 
o
C) and solubilized by rolling for 30 min at 4 
o
C in RIPKA plus Protease Inhibitors (in 
mM): 140 NaCl, 10 KCl, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate, 10 
Tris-HCl pH 7.4, 1 EDTA pH 8.0.  Debris was then pelleted (14 krpm, 10 min, RT) and 
the supernatant collected.  Before further treatment, 1/5 input samples were saved. 
Samples were then split, diluted with 10% (v/v) 500 mM Na3PO4 pH 7.5, and 
deglycosylated or mock treated with ~ 1% PNGase F (NEB) for 1 hour at 37 
o
C.  
Following deglycosylation, samples were chilled, and -Q1 (Santa Cruz) was added 
directly to the reaction mixture (~ 7.1% v/v) and allowed to roll overnight at 4 
o
C.  
Antibody was then bound to Immobilized Protein G beads (Pierce) (washed three times 
in excess RIPKA and reconstituted as a 50:50 bead:RIPKA slurry) rolling at 4 
o
C 
overnight.  Total slurry:immunoprecipitation used was ~ 14% (v/v). 
Before elution, 1/5 supernatant samples were saved.  Bound proteins were washed 
3x in excess RIPKA and eluted from beads using Elution Solution (in mM): 140 NaCl, 10 
Tris pH 7.4, 1 EDTA pH 8.0, 100 DTT, 1% SDS; rolling for a total of 30 min at 4 
o
C.  
Beads were pelleted (14 krpm, 2 min, RT) and the collected supernatant diluted 2:1 with 
10.75% (w/v) SDS, 150 mM Tris pH 6.8, 30% (v/v) glycerol and a trace of dye.  Load 
volume was weighted for samples and 1/5
th
 inputs by BCA quantitation and dilution 
during deglycosylation and immunoprecipitation before resolution on non-reducing 10% 
SDS-PAGE (for inputs and supernatants) or 15% SDS-PAGE (for 
immunoprecipitations). 
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Cell Surface Labeling - All cell surface labeling is performed in ice-cold buffers.  
Transfected CHO cells were washed four times with PBS
2+
 (PBS supplemented with 1 
mM MgCl2 and 0.1 mM CaCl2).  Cell surface proteins were then labeled with two 15 
min, 1 ml/well washes of 1 mg/ml sulfo-NHS-SS-biotin (Pierce) in PBS
2+
.  After the 
second labeling, the reaction was quenched by rinsing three times with and then washing 
twice for 15 min with PBS
2+
 plus 100 mM glycine.  Each well was then solubilized by 
shaking in RIPKA plus Protease Inhibitors for 30 min.  Debris was pelleted (14 krpm, 10 
min) and samples were quantitated by BCA.  Solubilized proteins were then split and 
deglycosylated by PNGase F or mock treatment directly in RIPKA.  Labeled proteins 
were bound to Immunopure
®
 immobilized streptavidin beads (Pierce) by rolling 15 g 
protein/well 1/5
th
 inputs without beads or 75 g protein/well labeled proteins with 25 l 
of streptavidin bead slurry overnight (reconstituted 50:50 streptavidin bead:RIPKA slurry 
from dry streptavidin beads washed three times with excess RIPKA).  The supernatants 
of the streptavidin-bound proteins were removed and the beads were washed three times 
in SDS Buffer (in mM): 150 NaCl, 10 Tris pH 7.4, 1 EDTA pH 8.0, 0.1% (w/v) SDS.  
Proteins bound to beads and 1/5
th
 inputs were then eluted/mixed with 200 mM DTT, 100 
mM Tris pH 6.8, 0.5% w/v SDS, 20% v/v glycerol.  Beads were washed a second time 
with an equal volume of 200 mM DTT and combined.  Eluted proteins were resolved on 
15% SDS-PAGE or in duplicate on 10% SDS-PAGE for calnexin ER-labeling controls.   
 
Immunoblotting and Signal Quantitation - Proteins were transferred from SDS-
PAGE to nitrocellulose for 1 hour at 0.3 A on ice.  Once on nitrocellulose, proteins were 
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blocked and then immunoblotted with rat -HA (Roche) or rabbit -calnexin (for ER-
labeling controls) (Stressgen) 1:1000 or 1:4000, respectively, overnight at 4 
o
C.  
Secondary antibodies goat -rat HRP (Santa Cruz) or goat -rabbit HRP (Cell 
Signalling) were applied 1:2000 or 1:8000, respectively, for 30 min at room temperature.  
Super Signal
®
 (Pierce) luminol was then applied to western blots for 5 min.  Fluorescence 
was captured using an LAS-3000 dark box (Fujifilm) using LAS-3000 Image Reader 
version 2.0 (Fujifilm).  Luminescence from SDS-PAGE resolved proteins was quantified 
using MultiGauge version 3.0 (Fujifilm). 
 
Data analyis - for Biochemistry: Absorbance data for each experiment was 
collected, corrected for background noise, and normalized using the equation:  
150kDa
150kDa 37 50kDa
abs
y
abs abs 


 . 
The resulting normalized absorbance was then plotted as a function of the position of 
each cysteine mutation (or lack of cysteine mutation) in KCNE1 using Origin 6 
(Microcal). 
Statistical significance was determined in two steps.  A model of all absorbance 
data was calculated, and model residuals were collected.  The natural logarithm of the 
calculated residuals fit well to a normal distribution (the Kolmogorov-Smirnov Z value 
was reduced two-fold by taking the natural logarithm, Z ≈ 1.6).  The natural logarithm of 
each normalized absorbance was subsequently used in a general linear mixed model 
(Tukey-Kramer) to determine an adjusted p-value.  Each experimental set was tested 
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against three negative controls (crosslink between KCNE1 cysteine point mutations and 
two non-labile cysteine point mutations in KCNQ1, or an internal negative control in 
each data set – HA-tagged KCNE1 C106S crosslinked with cysteine point mutations in 
KCNQ1).  Only those experimental data sets displaying adjusted p < 0.05 for all three 
negative controls are labeled.  These data are binned according to the least significant p-
value. 
For Electrophysiology: Current normalized to pre-oxidant levels were plotted 
against time.  The resultant time courses of oxidant-mediated current reduction fit well to 
single-tau exponential decay.  Single-tau exponential time courses are overlaid on the 
data (Fig. 4-6D & E). 
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CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
GENERAL DISCUSSION 
In the body of work presented in this thesis, we addressed the nature of KCNQ1-
KCNE subunit interaction.  Chapter II concerned the nature of KCNQ1 modulation by 
KCNE peptides, and reconciliation of two separate sets of observations, the function of 
truncated KCNE1 reported by Tapper and George, and the function of KCNE 
transmembrane chimeras reported by Melman and colleagues (Tapper & George, 2000; 
Melman et al., 2001; Melman et al., 2002a).  Having established the importance of both 
the transmembrane domain and C-terminus of KCNE1 in giving rise to KCNE 
modulation in Chapter II, we sought to learn more about the structure and interactions of 
the C-terminus of KCNE1 with the KCNQ1 channel complex.  Chapter III focused on 
determining the structure of the C-terminus of KCNE1, while Chapter IV focused on 
discovery of close contacts between KCNQ1 and the C-terminus of KCNE1, contacts 
which may prove crucial in native IKs function considering the presence of multiple Long 
QT mutations within this region. 
 In Chapter II, co-expression of KCNQ1 with partial truncation mutants of KCNE3 
demonstrated the transmembrane domain was solely responsible for providing 
modulation of KCNQ1 channel complexes; these obserations were consistent with 
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evidence obtained from transmembrane chimeras of KCNE peptides (Melman et al., 
2001; Melman et al., 2002a).  However, KCNE1 and KCNE3 are highly homologous in 
the juxtamembranous C-terminal domain, meaning transmembrane chimeras of each 
subunit will possess a nearly native KCNE C-terminus.  This homology may have led to 
the erroneous conclusion the transmembrane domain is solely responsible for giving rise 
to KCNE modulation (Melman et al., 2001; Melman et al., 2002a).  Our results were also 
in apparent conflict with the presence of known Long QT mutations in the C-terminus of 
KCNE1 and data obtained through partial truncation of the KCNE1 C-terminus (Tapper 
& George, 2000).  We considered possible caveats resulting from homologous KCNE 
amino acid sequences, and rather than dismiss the observations from KCNE1 truncation, 
we considered another option: two distinguishable albeit adjacent sites within KCNE 
peptides give rise to modulation. 
Reconciliation of all data obtained through KCNE truncation and chimera 
formation led to the proposal of a bipartite modulation of KCNE peptides (Figure 5-1).  
One KCNE modulation resides in the transmembrane domain, and the second modulation 
resides in the juxtamembranous, C-terminal domain.  In the context of the permissive 
transmembrane modulation observed with KCNE1, C-terminal modulation dominates.   
 C-terminal modulation of KCNQ1 gives rise to the extremely slow gating kinetics 
(with activation half-times and deactivation kinetics on or near the seconds time scale) 
(Gage & Kobertz, 2004).  The slow kinetics of the KCNQ1-KCNE1 channel complex do 
not reflect changes in the kinetics of voltage sensor movement, because voltage-sensor 
accessibility to chemical modification occurred at depolarizing potentials independent of  
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Figure 5-1.  The bipartite model for KCNE modulation of KCNQ1 channels.  Net 
diagrams for the transmembrane helices of both KCNE1 and KCNE3 are shown, along 
with the juxtamembranous C-terminal domain of each peptide.  Identical amino acid 
residues between the two peptides are colored red.  Similar amino acids are colored 
yellow.  The KCNE triplet identified by Melman and colleagues (Melman et al., 2001) is 
colored blue.  The bipartite model proposes that transmembrane KCNE modulation is 
either permissive or active.  Permissive modulation allows C-terminal modulation to 
determine the biophysical properties of the channel complex, while active transmembrane 
modulation completely overrides C-terminal modulation.  Notice that the 
juxtamembranous region in these two KCNE peptides is extremely homologous, allowing 
KCNE transmembrane chimeras a context that might mirror the wild type peptide, thus 
explaining the dramatic change in KCNE modulation observed by swapping the 
modulatory triplet.  The bipartite model improves our understanding of KCNE peptides, 
as it reconciles the data obtained from partial truncations and chimeras of KCNE peptides 
(Tapper & George, 2000; Melman et al., 2001; Melman et al., 2002a). 
 
Adapted from Gage, S.D. and W.R. Kobertz, KCNE3 truncation mutants reveal a 
bipartite modulation of KCNQ1 K+ channels. J Gen Physiol, 2004. 124(6): p. 759-71 
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measurable gating events (Rocheleau & Kobertz, 2008). Unperturbed voltage sensor 
movement is not surprising considering that bipartite transmembrane modulation of 
KCNE1 is permissive.  Instead, one would expect the modulation of KCNE1 giving rise 
to IKs to occur away from membrane-embedded regions of KCNQ1, considering C-
terminally truncated peptides possessing an unaltered KCNE1 transmembrane domain 
can not give rise to KCNE1-like modulaton of KCNQ1 channels (Takumi et al., 1988; 
Tapper & George, 2000).  The computer model of KCNE1 modulation possesses a slow 
and fast gating transition for each pore-forming subunit; this fast transition may be akin 
to the movement of the KCNE1-modulated KCNQ1 voltage sensor, which is unimpeded 
perhaps because transmembrane modulation of KCNE1 is permissive (Silva & Rudy, 
2005; Rocheleau & Kobertz, 2008). 
The transmembrane modulation resident in KCNE3 is active and masks the 
modulation intrinsic to the C-terminus of KCNE3.  For this reason and despite the large 
degree of sequence homology between the C-termini of KCNE1 and KCNE3, KCNE3 
does not give rise to slow gating kinetics but instead to almost instantaneous kinetics and 
large basal activation.  KCNE chimeras possessing the KCNE3 transmembrane domain 
display KCNE3-like modulation and are insensitive to mutations that disrupt the C-
terminal modulation (Melman et al., 2001; Melman et al., 2002a; Gage & Kobertz, 
2004).  Though still unclear, transmembrane modulation of KCNQ1 by KCNE3 may act 
directly through the KCNQ1 voltage sensor, explaining the increase in KCNQ1 voltage 
sensor accessibility and the KCNE-like effects of point mutations within the voltage 
sensor (Panaghie & Abbott, 2007; Rocheleau & Kobertz, 2008). 
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 The bipartite model of KCNE modulation supports an important role for the C-
terminus of KCNE1 in producing the modulation required for native IKs function.  As our 
experiments were performed in chimeras or in KCNE3, we wanted to test our hypothesis 
further through experimentation within KCNE1 itself.  In Chapter III, we used 
perturbation mutagenesis to directly test the C-terminus of KCNE1 for secondary 
structure.  High-impact mutations (those resulting in large changes in the free energy of 
gating) occured at discreet amino acid residues.  These amino mutations clustered 
precisely to a single face of an alpha-helix, a structure which is kinked but continues past 
a native proline residue, P77.  Our results not only directly demonstrate a secondary 
structure for the C-terminus of KCNE1, but also implicitly indicate the C-terminus of 
KCNE1 is involved in a protein-protein interface or contact.  
 Elucidating the nature of this protein-protein contact was the focus of the work 
presented in Chapter IV.  Knowing KCNE1 resides close to the ion conduction pathway, 
we attempted to form disulfide bonds between the C-terminus of KCNE1 and the 
aqueous-exposed intracellular face of KCNQ1 channel complexes.  A priori, we did not 
know if KCNE1 actually interacted with KCNQ1 or with another aqueous protein (for 
instance, calmodulin) on the cytoplasmic face of the channel complex.  Identification of 
several crosslink pairings between the two IKs subunits resolved any concerns as to the 
identity of the interacting protein. 
 All identified crosslink pairings occurred between KCNE1 and structures of 
KCNQ1 known to be able to adopt many conformations, implying either KCNE1 is 
flexible and able adjust to movement in the channel complex or KCNE1 modulation 
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occurs as a result of maintenance of a rigid structure.  The association of KCNE1 and the 
gate of KCNQ1 may result in the slow gating kinetics observed in IKs through steric 
hindrance of normal gating transition.  Alternatively, the association between the S4-5 
linker helix of KCNQ1 and KCNE1 may result in uncoupling the transduction of voltage 
sensor movement with movement of the S6 gate. 
 Taken together, the work in this thesis reestablishes the importance of the C-
terminus of KCNE1 in giving rise to IKs function.  The modulation of KCNE1 is not only 
provided by the transmembrane domain, but also by the association of the C-terminus 
with the cytoplasmic structures within the pore domain of KCNQ1 (Figure 5-2).  The 
thesis also proposes the bipartite model for modulation of KCNE peptides.  Diverse 
regions of the KCNE peptide give rise to equally diverse modulations of KCNQ1 channel 
complexes.  The hypothesis proposed does not speculate as to the nature of these distinct 
KCNE modulations, only to the location and juxtaposition of KCNE modulatory 
subdomains with the KCNQ1 channel complex.  For example, it is possible tight 
anchoring of KCNE subunits to multiple regions of the channel complex could result in 
the behavior or modulated KCNQ1 channel complexes.  Furthermore, evidence from 
KCNE3 truncation clearly raises the possibility of mixed populations giving rise to 
diverse macroscopic electrophysiological phenotypes even within over-expression 
systems. 
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Figure 5-2.  Bipartite KCNE modulation: transmembrane and C-terminal association.  
Though completely speculative, the location of each modulation implies two separate 
mechanisms of modulation.  Red, the pore of KCNQ1; green, KCNE1 (E1); purple, a 
cartoon of a potassium ion (K
+
).  The intracellular and extracellular faces of the 
membrane are labeled.  Above, the transmembrane domain of KCNE peptides is believed 
to associate with the pore domain (and possibly the voltage sensor) of KCNQ1.  Only the 
pore domains of two KCNQ1 subunits are shown for clarity.  The nature of 
transmembranous KCNE association remains to be fully elucidated.  Below, the C-
terminal domain of KCNE1 peptide has been shown to associate tightly with the 
cytoplasmic face of the KCNQ1 pore domain (Chapters III and IV).  As passive 
transmembrane modulation in KCNE1 allows the C-terminus to give rise to IKs current, 
tight association between the gate of KCNQ1 and KCNE1 may be responsible for giving 
rise to IKs current.  If KCNQ1-KCNE1 association is maintained in all gate 
conformations, increased rigidity provided by the KCNE C-terminus may be responsible 
for slowed IKs gating kinetics.  Alternatively, transient or state-dependent associations 
between KCNQ1 and KCNE1 may result in steric hindrance or excess drag, slowing 
motion of the S6 gate in response to changes in membrane potential.
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FUTURE DIRECTIONS 
Several lines of research remain unexplored, and would be fitting continuations of the 
research present in Chapters II-IV. 
 
What is the state-dependence of KCNQ1-KCNE1 crosslink formation? 
  Protein interactions between the C-terminus of KCNE1 and the cytoplasmic face 
of the KCNQ1 pore domain have been identified through disulfide bond formation in 
Chapter IV.  Utilization of disulfide bond formation in combination with an altered 
voltage-pulse protocol can give us insight as to the state-dependence of crosslink 
formation.  Crosslink formation between KCNQ1 and KCNE1 has occurred exclusively 
in regions of KCNQ1 which are able to adopt multiple conformations.  For example, 
reducing the time spent in the depolarized state should decrease the reaction kinetics of 
crosslink formation if the crosslink occurs in the open state, but not if the reaction occurs 
in the closed state.  Alternatively, IKs is so slow it does not reach equilibrium; current 
simply continues to increase.  Holding membranes at depolarizing potentials (for 10-100 
s) and subsequently treating cells with oxidant during this depolarization may slow 
activation kinetics or allow activation to reach equilibrium if crosslink occurs in the 
closed state; oxidant treatment would rapidly reduce currents if crosslink occurs in the 
open state. 
Thus far, all crosslink formation results in diminished IKs conductance.  Does 
crosslink formation always occur in such a way that there is reduction in conductance?  If 
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disulfide bond formation can occur without a resulting change in conductance, KCNE1 
may be able to move and adopt multiple conformations with the channel complex. 
 Another outlandish possibility presents itself: what if crosslink formation does not 
occur in either the closed, open or a transition state?  Though unobserved using 
electrophysiology, an inactivated state for IKs has never been conclusively dismissed; if 
an inactivated state exists, then the transition to and from this state must be much slower 
or much faster than gating transitions between activated and deactivated (Pusch et al., 
1998).  During the cysteine crosslinking scan, channels dwell in membranes with no 
transmembrane potential (0 mV) for hours before the reaction can commence (there are 
simply too many steps occurring in membrane harvest to reduce this long dwell time).  
Even for an extremely slow transition between open and inactivated states, hours of dwell 
time at 0 mV may allow enough channels to become inactivated, allowing crosslinking 
specific to these channel complexes to occur. 
 
Can mixed populations of channel complexes be identified? 
Chapter II left a conundrum: is the KCNQ1-behavior observed with some of the 
mutant KCNE3 constructs a result of altered modulation or reduced biosynthetic 
efficiency?  While titration of cRNA co-injection ratios produced resulted in changes in 
KCNE3-like charcter consistent with inefficient assembly, direct measurement of current 
arising from mutant KCNE3-assembled KCNQ1 channel complexes would be more 
conclusive.  Direct measurement of KCNE3 modified currents could be accomplished 
through use of tethered channel blockers, using the method reported by Morin and 
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Kobertz (Morin & Kobertz, 2007, 2008).  KCNQ1-like character may result from 
inefficient or substoichiometric assembly, either of which would be easily distinguished 
through use of selectively irreversible channel blockade.  Resolution of channel identity 
(mixed populations or stoichiometries versus heteromeric channel complexes, including 
M-channels) could also be conclusively accomplished using this method. 
 
Can cysteine point mutants in the N-terminus of KCNE peptides form disulfide bonds 
with the extracellular side of the KCNQ1 voltage sensor?  If such a pairing exists, is 
disulfide bond formation state-dependence between the voltage sensor of KCNQ1 and 
KCNE peptides? 
We know the C-terminus of KCNE1 is able to associate with the cytoplasmic gate 
of KCNQ1 (Chapter IV), but the location of the N-terminus of KCNE1 remains to be 
elucidated.  Given the importance of the transmembrane modulation of KCNE peptides 
(especially KCNE3) and the close proximity of KCNE peptides to both the pore domain 
and the voltage sensor, one could speculate some (if not all) KCNE peptides may be able 
to associate directly with the voltage sensor (Figure 5-3).  If KCNE peptides do associate 
directly with the voltage sensing domain, does this association vary depending on voltage 
sensor conformation? 
 Crosslink formation between the N-terminus of KCNE peptides and the 
extracellular face of the channel can be mediated through disulfide bond formation (given 
pretreatment of the channel complex with membrane-impermeant TCEP) and can be 
performed in intact CHO-K1 cells (aqueous intracellular proteins can not form disulfide 
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Figure 5-3.  State-dependent crosslink formation.  In this speculative example, KCNE 
peptides reside in close proximity to the voltage sensor of KCNQ1 channel complexes.  
The voltage sensor of KCNQ1 possesses an exogenous cysteine which is both close and 
juxtaposed to an exogenous cysteine in KCNE1 in the resting voltage sensor 
conformation (above); the proximity of these cysteine residues allows the formation of a 
disulfide bond in oxidizing conditions.  For ease of depiction, our model assumes 
translational motion in the voltage sensor in response to changes in membrane potential.  
The intracellular and extracellular faces of the membrane are labeled, and membrane 
potential is indicated by ―+‖ or ―–‖.  If association between KCNE1 and the voltage 
sensor of KCNQ1 is loose or non-existent, voltage sensor motions will not transducer 
into movement of KCNE1, and KCNE1 will not be able to form a state-dependent 
disulfide bond (middle).  If KCNE1 does associate tightly with the voltage sensor of 
KCNQ1, motion may occur in a concerted fashion, and disulfide bond formation may 
occur in either state (below).  If the voltage sensor of KCNQ1 is free to move relative to 
KCNE1, transmembrane KCNE modulation may have little or no influence on voltage 
sensitivity.
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bonds with our engineered cysteine mutants and do no need not be removed through 
hypotonic lysis).  With identification of even one disulfide-bound pair of cysteines 
between KCNQ1 and the KCNE peptide in the closed state, the state-dependence of 
disulfide bond formation could be performed in a time-dependent manner with Xenopus 
oocytes and TEVC.  The voltage sensing domain must move in response to 
depolarization.  Any cysteine mutant on the voltage sensor must therefore also move in 
response to changes in membrane potential.  If the KCNE peptide does not move, a 
rotational change in the voltage-sensor would prevent juxtaposition, while a translational 
movement would increase the distance between the pair of cysteines.  Either change 
would result in a reduction in disulfide bond formation. 
 One could therefore ask: can the cysteine in the KCNE peptide also form a 
disulfide bond with this cysteine while the voltage sensor is in the depolarized state?  
Oocyte membranes would be held at positive membrane potentials while oxidant 
mediates crosslink formation.  Even if disulfide bond formation between the voltage 
sensor and a KCNE peptide does not lead to modification of current, the membrane-
bound proteins from oocytes treated with oxidant in a state-dependent manner could be 
harvested and resolved using SDS-PAGE.  Through SDS-PAGE, disulfide bond 
formation could be observed as a change in apparent molecular mass. 
A comparison of crosslink formation observed biochemically and 
electrophysiologically could provide profound insight regarding the mechanism of KCNE 
modulation.  For instance, if current is not modified but disulfide bond formation is 
clearly present (as evidenced by mass shift on SDS-PAGE), KCNE peptides would have 
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to move with the voltage sensor and adopt multiple conformations, in a manner which 
does not disrupt voltage sensor response to changes in membrane potential.  Voltage 
sensor accessibility assays, even accessibility assays involving state-dependence, have 
been performed often (Larsson et al., 1996; Mannuzzu et al., 1996; Gandhi et al., 2003; 
Ruta et al., 2005; Darman et al., 2006; Nakajo & Kubo, 2007; Rocheleau & Kobertz, 
2008); performing state-dependent disulfide bond formation should not prove difficult.  
Whether or not KCNE peptides move with the voltage sensor, the results from this 
project would be significant and publishable. 
 
With which regions of KCNQ1 does the transmembrane domain of KCNE1 interact? 
Though disulfide bond formation is not an option for crosslink formation 
involving membrane-embedded cysteines, cysteine-specific crosslink formation may be 
possible.  A covalent bond between a mercurial compound and a sulfhydryl is possible in 
a non-aqueous environment.  However, chemically crosslinking polypeptides using 
HgCl2 or other mercury compounds require several steps and increases the number of 
caveats for the project.  First, the membrane-embedded channel complex is covalently 
tethered utilizing mercury-mediated crosslink.  Native structure must subsequently be 
completely denatured following crosslink formation.  The bound polypeptides must then 
be covalently tethered using a second crosslinking reagent, one which is non-selective 
and will bind both the mercury-tethered subunits (for instance, hexamethylene 
diisocyanate) (Soskine et al., 2002).  Because the covalent bond between the cysteine 
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sulfhydryl and mercury is not irreversible, this type of experiment is much more likely to 
produce ambiguous data.  
 
How does the S4-5 linker helix interact with KCNE1? 
From the results of Chapter IV, KCNE1 appears to interact with the S4-5 linker 
helix of KCNQ1.  Mutation of the S4-5 linker may therefore be able to compliment 
mutations within the C-terminus of KCNE1.  A perturbation scan of the S4-5 linker helix 
may also provide evidence for a direct interaction with KCNE1 occurring within the S4-5 
linker helix. 
 
Does the bipartite modulation of KCNE1 and KCNE3 extend to the entire gene family? 
Through utilization of KCNE chimeras as well as partial truncations, it may be 
possible to determine how KCNE4 and KCNE5 are able to modulate KCNQ1 channel 
complexes.  Chimeras incorporating regions of 1) KCNE1 and KCNE3 (Melman et al., 
2001; Melman et al., 2002a), 2) KCNE1 and KCNE2 or sodium channel 1 subunit 
(Tapper & George, 2000), or 3) KCNE2 and KCNE3 (Heitzmann et al., 2007), have 
already been studied, leading to further understanding of how subdomains of KCNE 
peptides are required for modulation and pH sensitivity.  Partial truncations of KCNE 
peptides have also provided invaluable contributions to our understanding KCNE 
modulation (Tapper & George, 2000; Gage & Kobertz, 2004).  Extending this line of 
evidence to KCNE4 and KCNE5 may also lead to further understanding of KCNE 
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modulation.  Several questions regarding how KCNE4 and KCNE5 could be addressed 
quickly, including: 
 
1.  Does the small size and relative lack of putative glycosylation sites on the N-terminus 
of KCNE4 (Figure 1-3) lead to diminished current or reduction in dwell time on the 
plasma membrane? 
2.  Does the large size of the C-terminus of KCNE4 (Figure 1-3) result in current 
suppression of KCNQ1 complexes, and if so, how?  Does this region alter gating, 
stabilize an inactivated state, or encode a ball peptide which permanently inactivates 
KCNQ1 channels? 
3.  Which regions of KCNE5 are able to produce such a large apparent change in voltage 
sensitivity? 
4.  If modulation of all KCNE peptides is bi- or multipartite, can chimeras combine the 
modulations of two distinct KCNE peptides? 
 
However, this line of research may prove difficult, especially with KCNE4.  
KCNE4 represses current from KCNQ1 channel complexes, and KCNE5 results in 
significant change in voltage sensitivity of IKs-like currents towards activation at very 
positive membrane potentials, leading to diminished macroscopic currents. 
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Do all KCNE peptides interact with the gate of KCNQ1? 
Given the results of Chapter IV, this project should not be difficult.  Production of 
cysteine-free KCNE peptides and co-expression of these peptides with our cysteine-free 
KCNQ1 construct would allow visualization of direct protein-protein interactions through 
crosslink formation dependent upon site-directed cysteine mutagenesis.  Several 
questions present themselves: 
 
1.  Where within the KCNQ1 channel complex does the KCNE3 C-terminus interact?  C-
terminal mutations of KCNE3 homologous to Long QT mutations in KCNE1 impeded 
proper assembly of KCNE3 with KCNQ1; these results imply a direct association is 
required for assembly of the channel complex (Gage & Kobertz, 2004).  The large degree 
of homology in the C-termini of KCNE1 and KCNE3 also argues KCNE peptides may 
interact with the same region of the channel complex. 
2.  Does KCNE4 suppress KCNQ1 currents by stabilizing the gate in the closed 
conformation?  We might not be able to determine state-dependence, but protein-protein 
interactions between the C-terminus of KCNE4 and the gate of KCNQ1 may provide 
more insight concerning KCNE4 modulation.  Furthermore, if KCNE4 stabilizes either 
the closed or inactivated states of KCNQ1 by direct protein-protein contacts, scanning 
cysteine mutants in KCNE4 may serendipitously lead to KCNE4 dysfunction, resulting in 
KCNQ1 complexes with measurable currents. 
3.  Does KCNE5 also interact with the gate of KCNQ1 channels (as observed with 
KCNE1)? 
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Are there direct protein-protein interactions between KCNE1 and calmodulin within IKs? 
Both KCNQ1 and KCNE1 appear to possess interacting alpha-helices on their 
cytoplasmic faces before diverging at proline residues.  KCNE1 maintains an alpha helix 
past this divergence, but it is unclear with what (if anything) KCNE1 interacts with 
beyond P77 (Rocheleau et al., 2006).  KCNQ1 P369, the proline which diverges in 
KCNQ1, is very close in space to KCNE1 P77, given P369C is able to form a strong 
disulfide bond with KCNE1 D76C (Chapter IV).  Given Long QT point mutants just C-
terminal to KCNQ1 P369 have been shown to impede KCNQ1-calmodulin association, 
perhaps both KCNQ1 and KCNE1 diverge from one another to interact with (different 
faces of…?) calmodulin (Shamgar et al., 2006).  A KCNE1-calmodulin interaction has 
been implied by co-immunoprecipitation of KCNQ1-KCNE1-calmodulin complexes.  
Disruption of the KCNE1-calmodulin association may explain the Long QT phenotype 
exhibited by KCNE1 W87R, a Long QT point mutation in beyond P77 in the C-terminus 
of KCNE1 (Splawski et al., 2000).  IKs channel function may be perturbed if this 
particular mutant is not able to interact properly with calmodulin. 
Direct amino acid side chain interactions may again be detectable through 
disulfide bond formation (Chapter IV).  However, production of cysteine-free calmodulin 
may prevent wild type-like function and should be assayed before the project 
commences. 
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CONCLUSION 
The interaction of KCNE peptides and KCNQ1 gives rise to channels displaying 
dramatically altered biophysical and pharmacological properties.  KCNE peptides are 
biophysically and physiologically fascinating; a small modulatory subunit is able to 
intercalate into the KCNQ1 channel complex and provide modulation of the KCNQ1 
channels that apparently acts through directly through the gate and voltage-sensing 
domains of the channel complex.  The question remains, how are KCNE peptides able to 
alter the stability of the associated channel complex?  Biophysical interest and the proven 
roles of both pore forming subunits and KCNE peptides in leading to disease phenotypes 
redouble the importance of our understanding.  It has been a pleasure studying KCNE 
peptides, and this research will provide a foundation for understanding channel function 
and therapeutic discovery. 
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